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ABSTRACT 
 
 
Hyperpolarized noble gas MRI using 3He and 129Xe has allowed void space 
imaging of the lungs for several years. Hyperpolarized 83Kr MRI has also been 
shown to provide an MRI contrast sensitive to the surface-to-volume ratio and 
chemistry of synthetic porous systems. Ex vivo animal models of pulmonary 
diseases and in vitro experiments were used in this thesis to examine three 
methodological advances allowing for the measurement of pulmonary 
physiological parameters using 129Xe and 83Kr. 
The 83Kr quadrupolar property was explored in a rat model of pulmonary 
surface-to-volume ratio degradation, i.e. emphysema. The surface quadrupolar 
relaxation (SQUARE) of the noble gas provided maps of the longitudinal 
relaxation in control and emphysematous rat lungs. The relaxation observations 
were regionally correlated to the histological measurements of the alveolar 
degradation. 
The 129Xe solubility in the lungs, blood, and more generally liquids, was the 
basis for the design of a new biosensor composed of a cryptophane cage 
tethered to a paramagnetic agent. The depolarization of the 129Xe atoms 
encapsulated by the cryptophane, followed by chemical exchange with the 
surrounding medium was investigated in vitro. This model biosensor will lead 
to a future switchable biosensor that will be deactivated by the enzymatic 
cleavage of the encapsulating cage and the paramagnetic agent. 
Finally, the 129Xe solubility was further utilised to study the gas transfer 
through ex vivo rat lungs after blood replacement by a perfluorocarbon 
emulsion. The large chemical shift separating the 129Xe peaks for the gas 
phase, the tissue and the perfluorocarbon emulsion, allowed for a selective 
excitation of each phase and the independent observation of their signal build-
up after inhalation. This mechanism will be used as a biomarker for gas 
transfer impairment in animal models of pulmonary fibrosis. 
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CHAPTER 1 
INTRODUCTION 
 
1.1. Motivation 
The decrease of the number of infectious diseases and their virulence led to a 
shift of the worldwide main causes of death to chronic conditions such as 
pulmonary or heart diseases. Moreover, the environmental changes and the 
increase of tobacco exposure in the population induced a dramatic increase in 
chronic pulmonary diseases (COPD), which include number of non-reversible 
respiratory conditions (e.g. emphysema) with a slowly progressing decrease in 
lung function. The annual cost for taking care of the 3 million patients with 
COPD in the UK (although 2 million are undiagnosed) represents £36 million 
(1). According to the WHO, COPD is predicted to become the third leading 
cause of death in 2030 (2). Idiopathic pulmonary fibrosis is another respiratory 
disease related to tobacco smoking. This chronic and progressive interstitial 
disease occurs in 4200 new patients each year in England (3). Chronic 
pulmonary diseases show variable symptoms and are often not diagnosed in the 
early stage of the disease. They often require the collaboration of numerous 
medical specialists, and necessitate X-rays and spirometry tests. 
Some early stage biomarkers would be beneficial for an earlier diagnosis of 
these pulmonary diseases and would allow for targeted treatments and a better 
management of the symptoms.  
1.2. Imaging lung disease 
The most commonly used clinical method to diagnose or longitudinally 
monitor lung disease is high-resolution computed tomography (HRCT). Even 
though this imaging technique provides excellent anatomical features, it also 
involves the use of ionising X-rays radiations. Lung function tests such as 
spirometry or plethysmography give a global evaluation of the lung volumes 
and the ability to exchange gas, without spatial resolution. But the anatomical 
and functional changes caused by pulmonary diseases are not homogeneous 
over the organ. 
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At the difference of CT, magnetic resonance imaging (MRI) is a non-invasive 
tool that can be used to investigate lung disease. However, the low proton 
density of the lung (4), and the short relaxation times caused by the air-tissue 
interface (5) are major drawbacks for the technique. Fast acquisitions have 
been developed to overcome the fast relaxation in the pulmonary tissue (6), but 
the low tissue density is the main feature of the organ that cannot be amended. 
MRI has however the advantage to be able to image different nuclei such as the 
noble gases 3He, 129Xe or 83Kr, enabling harmless imaging of the airspace after 
the inhalation of a noble gas. Recent developments in spin exchange optical 
pumping (SEOP) in the past three decades have allowed for a great increase of 
the hyperpolarized noble gas signal intensity, and therefore high-resolution 
ventilation imaging. Ventilation imaging gives a spatial resolution of the 
ventilation defects, whereas the spirometry test is only providing a global 
evaluation of the ventilation function. 
Different methods using hyperpolarized noble gases have been giving 
functional parameters. For example, the inhaled gas being subject to a 
restricted diffusion in the alveoli, the 3He apparent diffusion coefficient (ACD) 
can define the alveolar dimensions (7, 8). Changes in this diffusion can be used 
as a biomarker for the alveolar degradation caused by emphysema (8-10). 
Hyperpolarized 129Xe ADC was also demonstrated to be able to distinguish 
emphysematous lung to healthy lung (11). 
129Xe also presents the unique property to dissolve in the lung tissue after 
inhalation. The large 129Xe chemical shift when dissolved in the pulmonary 
tissue or the blood has been used as an advantage to study the lung gas 
exchange using MRI. 129Xe gas exchange through the lung barrier is used as a 
biomarker for parenchymal thickening caused by pulmonary fibrosis (12). 
Finally, hyperpolarized 83Kr MRI has been demonstrated to be an alternative 
biomarker for the alveolar destruction. Its nuclear electric quadrupole moment 
is a probe for surfaces. Such interactions are detected by measuring the 83Kr 
longitudinal relaxation (𝑇1) in the gas phase (13-15). 
Hyperpolarized noble gas imaging is a method allowing longitudinal 
pharmacological studies without an over-exposition to ionising radiations and 
providing functional biomarkers that cannot be obtained using HRCT. 
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1.3. Small animal study of pulmonary pathology 
Small animal models of human pulmonary diseases have been commonly used 
for both pharmacological development and imaging methodology 
development. Rodents are often used because of their fast breeding and their 
low cost. The use of small animals however requires the improvement of most 
techniques that were developed for humans. Various difficulties are 
encountered when using small animals for in vivo imaging experiments. 
Beyond the need of higher resolution, the main issue is the impossibility to 
make the animals breath-hold and stay still like a human subject would do. By 
a matter of fact, a ventilator and neuromuscular blocking agents are necessary 
to force the animal having a controlled behaviour similar to a human (16). 
Some other groups have developed free breathing hyperpolarized rodent lung 
imaging, involving increased motion artefact, the necessity for averaging and 
data post-processing (17). 
Ex vivo lung experimentation was used to study the pulmonary physiology (18-
20) but has also been utilised by our group as a tool for hyperpolarized lung 
imaging methodology development. Ex vivo lung imaging comports the 
advantage to avoid all of the in vivo numerous difficulties, whilst producing 
physiologically relevant measurements for new hyperpolarized noble gases 
imaging technique developments (15, 21, 22). 
1.4. Thesis overview 
Research outlined in this thesis has the objective to investigate potential 
pulmonary disease biomarkers using hyperpolarized gas NMR and MRI. The 
two noble gases 129Xe and 83Kr are hyperpolarized to probe ex vivo rat lungs, 
taking advantage of their unique characteristics to provide spatially resolved 
diseases biomarkers. These biomarkers provide information on the lung 
physiopathology such as the alveolar radius, the presence of an enzyme or a 
fibrotic thickening.  
Chapter 2 presents an overview of the interdisciplinary background of this 
thesis, from the concepts of magnetic resonance and hyperpolarized noble 
gases technologies, to the ex vivo rat lung experimentation. 
Chapter 3 demonstrates the promising hyperpolarized 83Kr MRI as a novel 
biomarker for the alveolar microstructure. The surface sensitive 83Kr relaxation 
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allows for the discrimination of diseased and healthy lungs in an ex vivo rat 
model of the COPD emphysema. 
Chapter 4 presents the first results obtained with a newly designed biosensor 
able to host hyperpolarized 129Xe in solution. The encapsulation of the 129Xe 
into a cryptophane A cage tethered to a paramagnetic group induces its fast 
relaxation. The biosensor relaxivity on the hyperpolarized 129Xe is investigated 
and an in vivo enzymatic biosensor is demonstrated. 
Chapter 5 examines the use of synthetic blood as a potential source of 129Xe 
MRI contrast for interstitial diseases. Two perfluorocarbon emulsions are used 
as a blood replacement in ex vivo rat lungs to evaluate the gas transfer through 
the lung parenchyma. 
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CHAPTER 2 
INTRODUCTION TO MAGNETIC NUCLEAR 
RESONANCE AND NOBLE GAS HYPERPOLARIZATION 
2.1. Purpose of the chapter 
This chapter aims to provide the reader with background knowledge in basic 
nuclear magnetic resonance techniques, and an introduction to noble gas 
hyperpolarization technique, used in all of the described research in this thesis. 
Most of this chapter’s material that is related to nuclear magnetism and 
resonance are taken and adapted from the textbooks published by A. Abragam 
(1), P. T. Callaghan (2), M. H. Levitt (3), and E. Mark Haacke (4). In addition 
to these four books, the theoretical parts associated to the hyperpolarization 
were supported by numerous relevant publications illustrating some 
applications using hyperpolarized noble gases for spectroscopy and imaging. 
Some more specific background about pulmonary diseases and animal models 
will be given in the next chapters of this thesis. 
2.2. Basics of Nuclear Magnetic Resonance (NMR) 
Nuclear Magnetic Resonance (NMR) is a physical phenomenon widely used in 
research and medical imaging applications. The NMR spectroscopy and 
imaging techniques are both based on the fact that nuclei placed in a magnetic 
field will interact with radiofrequency radiation. This interaction will cause a 
coherent precession of the nuclear spins that, in turn, will induce an electric 
signal in a surrounding receiving coil. 
2.2.1. Nuclear spin properties 
NMR and MRI are techniques using the properties of the atomic nuclei. The 
nuclei are composed of protons and neutrons that will determine the nuclear 
spin 𝐼 . The spin is an intrinsic property of all of the subelements of the 
nucleons, namely the quarks. The angular momenta of all the nuclear quarks 
are added up, defining the nuclear spin angular momentum 𝑚. The angular 
momentum is used to describe the direction of the spin polarization axis. 
Nuclei with an odd atomic number 𝑍 or an odd mass number will have an 
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integer of half integer nuclear spin value 𝐼 > 0 and will be considered NMR 
active. The nuclei used in this work and their properties are listed in Table 2.1. 
 
Isotope Spin Natural 
abundance 
(%) 
Gyromagnetic 
ratio 
𝛾 106⁄  
(rad.s-1.T-1) 
NMR frequency 
at 9.4 T 
(MHz) 
1H 1 2⁄  100.00 267.522 400.228 
3He 1 2⁄  0.000137 -203.802 -304.899 
19F 1 2⁄  100.00 251.815 376.729 
83Kr 9 2⁄  11.58 -10.331 -15.456 
129Xe 1 2⁄  26.44 -74.521 -111.488 
131Xe 3 2⁄  21.18 22.091 33.049 
Table 2.1 Nuclear isotopes used in this work and their properties. Table adapted from reference 
(5). 
In the case of a single spin placed in a static magnetic field 𝐵0, the total energy 
of the nuclear spin is defined by the Hamiltonian operator ?̂?𝑧. The Hamiltonian 
contains the gyromagnetic ratio 𝛾, the magnetic field 𝐵0 and the nuclear spin 
operator 𝐼𝑧 which eigenvalues are the magnetic quantum numbers 𝑚𝑧 (Eq. 2.1 
and 2.2). 
 ?̂?𝑧 = −𝛾ℏ𝐵0𝐼𝑧 
Eq. 2.1 
 ?̂?𝑧 = −𝜔𝐼𝑧 
Eq. 2.2 
where 𝛾  is the gyromagnetic ratio of the nucleus, and ℏ =
ℎ
2𝜋
 with ℎ  the 
Planck’s constant. 
The eigenvalues of the Hamiltonian describe the energy of a spin state. In the 
absence of a magnetic field, the different nuclear energy levels of the spin 
states are degenerate; they all have the same ground state energy. If a magnetic 
field 𝐵0 is applied along the z-axis, an energy splitting is therefore observed, 
producing 2𝐼 + 1 sublevels taking the values 𝑚𝑧 = 𝐼 , 𝐼 − 1 , …, −𝐼 , this is 
called the Zeeman splitting. NMR is the detection of this nuclear Zeeman 
splitting sublevels. In the energy diagram on Figure 2.1, these states are 
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represented by horizontal lines. The energy levels 𝐸  are directly calculated 
from the above Hamiltonian. 
 𝐸 = −𝛾ℏ𝐵0𝑚𝑧 
Eq. 2.3 
 
Any nucleus with a spin 𝐼 = 0, will not present any Zeeman splitting at all, 
making them NMR silent. 
 
 
Figure 2.1 Energy level diagram for a population of two 129Xe spins (𝐼 = 1 2⁄ ). In the absence 
of an external magnetic field 𝐵0, the energy levels are degenerate. The presence of an external 
magnetic field along the z-axis induces a Zeeman splitting of the different spin states. 
Another intrinsic property of the nucleus is the magnetic moment 𝜇 caused by 
the nuclear magnetism. The magnetic moment 𝜇 and the nuclear spin angular 
momentum 𝐼 are proportionally linked by a constant 𝛾 called the gyromagnetic 
ratio (Eq. 2.4). Magnetic moments can be described as vectors ?⃗? defining the 
spin polarization. The magnetic moment takes the value: 
 𝜇 = 𝛾. ℏ. 𝐼 Eq. 2.4 
where 𝛾  is the gyromagnetic ratio (see Table 2.1), ℏ  the Planck’s constant 
divided by 2𝜋 and 𝐼 the nuclear spin angular momentum. 
In the absence of magnetic field, the vectors are randomly oriented, resulting in 
no net magnetization (∑ 𝜇 = 0) (Figure 2.2.a). In the presence of a static 
magnetic field 𝐵0, the magnetic moments will align with the direction of the 
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field, inducing an anisotropic spin polarization distribution (∑ 𝜇 > 0) (Figure 
2.2.b). This positive net magnetization at thermal equilibrium is called the 
macroscopic magnetization, 𝑀0 = ∑ 𝜇. 
 
 
Figure 2.2 (a) Isotropic distribution of the magnetic moments in the absence of magnetic field. 
(b) Anisotropic distribution of the magnetic moments in the presence of a static magnetic field 
𝐵0 yielding a macroscopic magnetization 𝑀0 > 0. 
As discussed in the previous paragraph, the external magnetic field will 
orientate the spin polarization. The angular momenta will precess around the 
axis formed by the magnetic field 𝐵0. The frequency of precession is called the 
Larmor frequency 𝜔0  (Eq. 2.5), and is directly proportional to the 
gyromagnetic ratio 𝛾 of the nucleus and the magnetic field 𝐵0 applied to the 
nucleus: 
 𝜔0 = −𝛾. 𝐵0 
Eq. 2.5 
The Larmor frequency can be positive or negative, depending on the sign of 
the gyromagnetic ratio (see Figure 2.3). That implies the angular momentum of 
different nuclei may precess in different directions around the magnetic field 
axis. For a positive gyromagnetic ratio, the Larmor frequency is negative, and 
the nucleus will precess clockwise around the field (when looking from the top 
of the field). For both noble gases nuclei 129Xe and 83Kr used in this thesis, the 
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gyromagnetic ratio is negative, implying an anticlockwise Larmor precession 
around 𝐵0. 
 
 
Figure 2.3 Precession of the nuclear spin magnetic moment around the external magnetic field 
axis for a spin with positive or negative gyromagnetic ratio. Figure adapted from (3). 
2.2.2. Polarization at thermal equilibrium 
The uneven spin population distribution in each Zeeman energy levels will 
induce a very small magnetization. This macroscopic magnetization 𝑀0  is 
oriented parallel or anti parallel to the external magnetic field (Figure 2.2.b). It 
is called the longitudinal magnetization 𝑀𝑧. This magnetization will be directly 
dependent on the difference of population of the spin orientations. 
At thermal equilibrium, given a temperature 𝑇, the spin population in each 
energy state follows the Boltzmann distribution. This means the spin density 
𝜌𝑒𝑞,𝑖 at a spin state 𝑖 will be equal to: 
 𝜌𝑒𝑞,𝑖 =
𝑁𝑖
∑ 𝑁𝑖
=
exp (
−𝐸𝑖
𝑘𝐵𝑇
⁄ )
∑ exp (
−𝐸𝑖
𝑘𝐵𝑇
⁄ )𝐼−𝐼
 Eq. 2.6 
where 𝐸𝑖 = −𝛾ℏ𝐵0𝑚𝑖 is the energy at the spin state 𝑖. 
The polarization of a spin system is proportional to the longitudinal 
magnetization at thermal equilibrium. It corresponds to the ratio of the 
longitudinal magnetization over its maximum value. Therefore, for a spin 1 2⁄ , 
e.g. 129Xe, where 𝑁 ↑ and 𝑁 ↓ are the number of spins in each energy level, the 
polarization 𝑃 is equal to: 
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 𝑃 =
𝑁 ↑ −𝑁 ↓
𝑁 ↑ +𝑁 ↓
 
Eq. 2.7 
 𝑃 =
exp (
−𝛾ℏ𝐵0
2𝑘𝐵𝑇
⁄ ) − exp (
𝛾ℏ𝐵0
2𝑘𝐵𝑇
⁄ )
exp (
−𝛾ℏ𝐵0
2𝑘𝐵𝑇
⁄ ) + exp (
𝛾ℏ𝐵0
2𝑘𝐵𝑇
⁄ )
 Eq. 2.8 
The thermal energy is always much bigger than the energy between two 
Zeeman sublevels, therefore making the thermal equilibrium spin populations 
difference very small. Because the high temperature limit is met, i.e. 
𝐸𝑖
𝑘𝐵𝑇
≪ 1, 
the polarization equation for a spin 1 2⁄  can be simplified to: 
 𝑃 =
|𝛾|ℏ𝐵0
2𝑘𝐵𝑇
 Eq. 2.9 
The polarization is directly dependent on the magnetic field 𝐵0 but also, the 
gyromagnetic ratio 𝛾. This is of particular importance when handling nuclei 
with low gyromagnetic ratio such as 83Kr. 
The longitudinal magnetization 𝑀𝑧 , or thermal equilibrium polarization, 
corresponds to a very small population difference between the energy levels 
and is almost undetectable. It is defined by: 
 𝑀𝑧 = 𝑀0 =
𝑁𝛾ℏ
2
𝑃 =
𝑁𝛾2ℏ2𝐵0
4𝑘𝐵𝑇
 
Eq. 2.10 
 
We will see in the next section how the polarization induced by the magnetic 
field can be measured. 
2.2.3. Excitation and detection of the NMR signal 
This section describes how to excite the nuclear spin in the system and detect 
the signal from it. Some considerations for the construction of a custom-built 
129Xe coil for the in vivo preclinical MRI Bruker scanner, located in the 
psychology department of the University of Nottingham, are given in the 
Appendix 1. 
The application of an oscillatory field in the radio frequency (RF) range, with a 
frequency 𝜈 equal to the Larmor frequency of the sample spins will induce a 
Zeeman energy level transition. The energy absorbed by the system to induce 
the energy levels transition is equal to the difference between 𝐸−1 2⁄  and 𝐸1 2⁄  
(Eq. 2.11). 
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 Δ𝐸 = 𝐸−1 2⁄ − 𝐸1 2⁄ = γℏ𝐵0 = −𝛾𝜔0 
Eq. 2.11 
The RF pulse induces a phase coherence of the spins, generating a non-zero 
transverse magnetization 𝑀𝑥𝑦, polarizing the bulk polarization off the z-axis 
(Figure 2.4). When the RF pulse is turned off, all of the spins will start 
precessing around the z-axis again, inducing the rotation of the transverse 
magnetization 𝑀𝑥𝑦  in the xy-plane at the Larmor frequency. The transverse 
magnetization 𝑀𝑥𝑦  will decay from 𝑀0  to zero, while the longitudinal 
magnetization 𝑀𝑧  will recover its equilibrium value 𝑀0  over time. The 
precession of the bulk magnetization produces an oscillating electric current in 
the detection coil (usually the same as the excitation coil). The signal will 
decay because of dephasing described by the rate constant 𝑇2
∗  (transverse 
relaxation) and the decaying signal detected by the coil is called the free 
induction decay (FID). Relaxation mechanisms related to hyperpolarized 
systems are explained further on this chapter. 
 
 
Figure 2.4 Excitation of a sample of spins 1 2⁄ . (a) The Boltzmann distribution of the spins at 
thermal equilibrium produces a bulk magnetization along the z-axis (along 𝐵0), the spins have 
random phases. (b) The application of a RF pulse induces the phase coherence of the spins, 
leading to a magnetization 𝑀𝑦 in the transverse plane. 
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2.3. Hyperpolarization through spin exchange optical pumping 
(SEOP) 
NMR and MRI of gas phase nuclei is challenging as compared to conventional 
MRI that images hydrogen atoms contained in the human tissue. This is due to 
the low density of a gas as compared to nuclei in the condensed state, and its 
associated low signal intensity. One way to increase the signal would be to 
increase the number of spins by increasing the gas pressure. Highly pressurised 
thermal samples are used to measure the thermal polarization of a gas sample; 
it is however not a practical option when used for pulmonary application for 
example. 
Different strategies can be used to enhance the polarization. The polarization 
equation (Eq. 2.9) states that the polarization is dependent on the gyromagnetic 
ratio of the nucleus 𝛾, the static magnetic field 𝐵0 and the temperature 𝑇. By 
consequence, in identical conditions 129Xe will provide a 7-fold stronger 
polarization than 83Kr. However, an increase of the magnetic field often limits 
the working space in the magnet bore, and cooling down a sample can be 
impracticable when doing preclinical or clinical studies. 
Hyperpolarization is a technique that creates a low spin temperature, enabling 
high polarization values at low pressure and ambient temperature. The work 
presented in this thesis utilises the spin exchange optical pumping (SEOP) 
hyperpolarization technique, which is the most commonly used method to 
hyperpolarize noble gases such as 3He, 129Xe and 83Kr. Other existing 
techniques to hyperpolarize noble gases are being developed, for example 
metastability exchange optical pumping (MEOP) that has been efficiently used 
to hyperpolarize 3He (6), dynamic nuclear polarization (DNP) has been applied 
to 129Xe in its liquid phase, directly followed by its sublimation (7), and 129Xe 
‘brute-force’ hyperpolarization by placing the system at very low temperature 
of the mK range to hyperpolarize the spins, followed by a rapid heating of the 
system (8). 
The primary aim of SEOP is to increase the sensitivity of the spectroscopy by 
increasing the longitudinal magnetization 𝑀𝑧  to overcome the low signal as 
discussed above (Figure 2.5). The purpose of this method is to obtain highly 
non-equilibrium nuclear spin polarization. 
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Figure 2.5 (a) Spin energy levels distribution and 129Xe signal at thermal equilibrium and 
corresponding spectrum, acquired with 1024 averages (scan duration: 4h 40min) (b) Spin 
energy levels distribution and 129Xe signal after enhancement by spin exchange optical 
pumping hyperpolarization and its corresponding spectrum, acquired in a single scan (scan 
duration: 6 s). At thermal equilibrium the spin population difference is very small, the signal 
has been averaged, producing a signal-to-noise ratio, 𝑆𝑁𝑅 = 3000. After hyperpolarization, a 
single scan allows for a 5-fold SNR enhancement (𝑆𝑁𝑅 = 14000). Note that the thermal 
sample was containing 8 bar Xe – 1 bar O2 (total pressure, 9 bar), and the hp gas mixture 25 % 
Xe – 75 % N2 was hyperpolarized for 6 min at 316 K and 682 mbar, for a detection pressure of 
0.42 bar after recompression. Representative spectra acquired for recompression unit tests (see 
Section 2.3.3.). 
The studies in this thesis only employ the SEOP technique with the existing 
laboratory equipment, and without analysing nor improving the method, a brief 
description of spin exchange optical pumping hyperpolarization is given in this 
section to provide a general understanding to the reader. The SEOP 
hyperpolarization process can be divided into two steps, optical pumping of the 
alkali metal and spin exchange with the noble gas. 
  
 16 
2.3.1. Optical pumping of the alkali metal 
The SEOP cell containing the noble gas and the alkali metal rubidium is placed 
in a magnetic field produced by Helmholtz coils (15.54 mT) to induce the 
Zeeman splitting of rubidium (Rb). The SEOP cell is also heated with warm air 
to produce a rubidium vapour of appropriate density. Alkali metals such as 
rubidium or cesium are used because they have a single unpaired electron on 
their valence shell. 
 
Figure 2.6 Schematics of the optics components of the polarizer. The laser light is transmitted 
to an optic fibre. A collimator focuses the light on a beam splitter, placed 25 mm away. The 
beam splitter linearly polarizes the light beam. The light then goes through a quarter-wave 
plate (λ/4 plate) that circularly polarizes the beam. Finally, the beam is expended with a 
telescope to create a parallel beam having a diameter of the size of the SEOP pumping cell 
holder front window. 
The laser light is circularly polarized using a beam splitter and a quarter-wave 
plate as described in Figure 2.6. In general words, the circularly polarized laser 
is tuned to the D1 transition of the valence electron of the Rb (794.7 nm), 
present in the vapour state in the SEOP pumping cell. It will induce the 
transition of the angular momentum from the light to the electron spin. 
Resulting to the selection rule, the angular momentum is preserved and 
excitation will only happen from the 𝑚 = − 1 2⁄  sublevel of the 2S1/2 state to 
𝑚 = + 1 2⁄  of the 2P1/2 state (Figure 2.7). We say the electrons are in their 
excited state. Some collisions between Rb atoms will induce mixing of the 
excited states. The electrons will then decay back to their ground state. Due to 
ongoing laser pumping, the population of spins in the 𝑚 = − 1 2⁄  sublevel of 
the 2S1/2 state is continuously depleted by the circularly polarized light 
excitation, therefore increasing the population in the 𝑚 = + 1 2⁄  sublevel. 
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Figure 2.7 A left circularly polarized laser optically pumps the alkali metal electron. The 
sublevel 𝑚𝑠 = + 1 2⁄  is populated through the continuous pumping of the 𝑚𝑠 = − 1 2⁄  by the 
laser, tuned at its D1 transition. 
Nitrogen (N2) is included to the gas mixture, alongside with the noble gas, in 
order to quench the radiation caused by the relaxation of the excited electrons 
to their ground states. Instead of releasing the energy by emitting a photon that 
would be deleterious for the polarization build-up of the Rb, the energy is 
converted into the N2 vibrational mode. 
2.3.2. Spin exchange to the noble gas 
The transfer of polarization is done by spin exchange that will transfer the 
angular momentum from the alkali metal electron spin to the noble gas nuclear 
spin. As illustrated in Figure 2.8, it can be accomplished by two processes: 
binary collisions or van der Waals complexes formation. Binary collision is the 
main spin exchange mechanism for 83Kr, whereas 129Xe will also undergo spin 
exchange through van der Waals complexes. In both cases, the energy transfer 
happening during the contact between the alkali electron spin and the noble gas 
nuclear spin induces a flip flop of the Rb electron spin and the noble gas 
nuclear spin, increasing the populations of noble gas atoms with the same 
nuclear spin orientation. 
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Figure 2.8 Alkali metal spin exchange between a rubidium electron spin and a 129Xe nuclear 
spin by (a) collision and (b) van der Waals interaction (three-body collisions). 
2.3.3. Parameters involved in the polarization efficiency 
The use of very diluted noble gases mixtures requires cryogenic separation 
after SEOP hyperpolarization. However, this cryogenic concentration is not a 
feasible process in the case of 83Kr, due to its fast quadrupolar relaxation in the 
condensed phase that would lead to almost complete depolarization (9). An 
alternative to this is to hyperpolarize a higher concentration of noble gas, but at 
lower pressure. The polarization equipment in our laboratory has been adapted 
to such applications. Most parameters involved in the polarization level have 
been studied by Six et al. and published in the online journal PloS One in 2012 
(9). 
The polarization level of any nucleus placed in a magnetic field is defined by 
Eq. 2.9. The polarization of a known sample (see Figure 2.5(a) for example) at 
thermal equilibrium is calculated before each hyperpolarized gas experiment. 
This measurement will be used to define the polarization of the hyperpolarized 
gas after SEOP. The signal intensity recorded during shuttle delivery 
hyperpolarized gas experiments also requires taking into account the N2 buffer 
gas. It is easy to understand that the actual noble gas polarization has to be 
scaled to the dilution of the noble gas in the gas mixture. The apparent 
polarization 𝑃𝑎𝑝𝑝 takes into account this dilution factor: 
 𝑃𝑎𝑝𝑝 = 𝑃 ∙
𝑃𝑁𝐺
𝑃𝑡𝑜𝑡
 Eq. 2.12 
where 𝑃𝑁𝐺  is the polarization in the pure noble gas, and 𝑃𝑡𝑜𝑡  the SEOP 
pressure, including the buffer gas. The highest polarization levels were 
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obtained using 40-50 % xenon and 25 % krypton gas mixtures, with 𝑃𝑎𝑝𝑝
𝑚𝑎𝑥 =
15.5% and 𝑃𝑎𝑝𝑝
𝑚𝑎𝑥 = 4.4% respectively. 
The polarization is shown to increase as the total SEOP cell pressure was 
decreased from 3.5 bar to a maximum polarization reached at around 0.2 – 0.3 
bar for 129Xe and 0.35 – 0.5 bar for 83Kr. When the pressure decreased from the 
optimum pressure, the polarization is rapidly decreasing to zero. 
The temperature is another important parameter involved in the formation of a 
high-density rubidium vapour. A higher SEOP hyperpolarization temperature 
has been shown to be beneficial to 83Kr, counteracting the lower Rb-83Kr 
exchange rate, but also reducing the quadrupolar relaxation on the SEOP cell 
surface. The highest polarizations have been reached with 373 K for 129Xe and 
433 K for 83Kr. 
To summarize, our laboratory settings allow the steady state spin polarization 
to be reached after 6 min of hyperpolarization at 373 K for 129Xe and 8 min at 
433 K for 83Kr. 
The drawback of using the highest polarization pressure conditions is that it 
cannot be delivered without recompression to ambient pressure. The idea of 
recompression of the gas was already used for metastability-exchange optical 
pumping applications (10). Similarly, for all imaging experiments in this work, 
a piston has been used to recompress the gas to ambient pressure before being 
delivered to excised lungs. This method consists in delivering the gas directly 
from the SEOP cell to a pre-vacuumed recompression chamber by gas 
expansion, and to subsequently recompress it by pushing a piston in the back 
of the chamber with pressurized nitrogen gas (11). Recompressed 
hyperpolarized gas was shown to not significantly alter the polarization of the 
noble gas. Up to 100 % and 75 % of the spin polarization was maintained for 
129Xe and 83Kr respectively. 
2.4. Relaxation mechanisms 
Instead of directly measuring the longitudinal magnetization, NMR will 
measure the magnetization that is perpendicular to the magnetic field 𝐵0, called 
the transverse magnetization 𝑀𝑥𝑦. At thermal equilibrium in a large magnetic 
field, this transverse magnetization is null. 
  
 20 
2.4.1. Transverse relaxation 
After the application of a 90 ° RF pulse, the spins will be in phase coherence, 
forming a transverse magnetization as seen in Figure 2.4. From the time the RF 
pulse is off, the spins start losing their synchrony due to the presence of 
slightly difference local magnetic fields from the influence of neighbouring 
spins. Their phase will start cancel each other out over time; this loss of phase 
coherence will therefore induce an irreversible transverse magnetization 
relaxation, also called the spin – spin relaxation, or 𝑇2  relaxation. The 
relaxation behaviour of 𝑀𝑥𝑦  can be describe by an exponential decay as 
follow: 
 𝑀𝑥𝑦(𝑡) = 𝑀0𝑒
−𝑡 𝑇2⁄  Eq. 2.13 
where 𝑡 is the time after tipping the magnetization in the xy-plane and 𝑀0 is 
the initial transverse magnetization. 
 
Figure 2.9 Transverse magnetization (𝑀𝑥𝑦) relaxation of 
129Xe after full excitation with a 90 ° 
RF pulse. The transverse relaxation constant 𝑇2 corresponds to the time passed where 𝑀𝑥𝑦 =
37 %. 
On the envelope of the FID, the transverse decay that is actually observed is 
the T2
∗ relaxation decay that also takes into account 𝐵0 field inhomogeneities. 
T2
∗ is directly measured from the envelope of the FID and is linked to 𝑇2 and 
𝑇2,𝑖𝑛ℎ𝑜𝑚𝑜 by the relation in Eq. 2.14. 
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1
𝑇2
∗ =
1
𝑇2
+
1
𝑇2,𝑖𝑛ℎ𝑜𝑚𝑜
 Eq. 2.14 
 
 𝑇2 (ms) 𝑇2
∗ (ms) 
129Xe 32.9 ± 0.5  1.77 ± 0.37  
83Kr 166 ± 11  13.1 ± 0.8  
Table 2.2 Transverse relaxation constants of the two nuclei of interest 129Xe and 83Kr, in the 
gas phase in the absence of oxygen, in ex vivo rat lungs, recorded at 9.4 T in the laboratory 
Bruker spectrometer. Data taken from J.S. Six PhD thesis (12). 
Experimental 𝑇2 and 𝑇2
∗ were measured in ex vivo lungs and displayed in Table 
2.2. The transverse relaxation is of particular importance in imaging sequences 
such as the gradient-echo sequence, where the signal is recorded a long time 
after the RF excitation pulse, making it more complicated for systems with 
short 𝑇2. 
2.4.2. Longitudinal relaxation 
First let’s consider a thermal system, e.g. an ensemble of 1H. After a RF 
excitation pulse, as the transverse magnetization 𝑀𝑥𝑦  decreases, the 
longitudinal magnetization 𝑀𝑧 grows back to its initial thermal value 𝑀0. The 
𝑀𝑥𝑦  regrowth process is called the longitudinal relaxation, or spin – lattice 
relaxation and is defined by Eq. 2.15. 
 𝑀𝑧(𝑡) = 𝑀0(1 − 2𝑒
−𝑡 𝑇1⁄ ) Eq. 2.15 
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Figure 2.10 Longitudinal magnetization (𝑀𝑧) evolution as a function of time after a full 90 ° 
excitation pulse. Magnetization recovery resulting to 𝑀𝑧 = 63 % occurs when the time passed 
equals the longitudinal relaxation constant 𝑇1  
This phenomenon is caused by interactions of the nuclear spins with the 
surrounding nuclear spins magnetic fields (the lattice). The spins will return to 
their lower energy state with time. 
In the case of hyperpolarized noble gases, the system has been hyperpolarized 
such that the initial longitudinal magnetization before RF excitation is much 
greater than the thermal equilibrium polarization. The 𝑇1  relaxation is the 
mechanism by which the spins will return to their thermal equilibrium, 
inducing the decay of the longitudinal magnetization to thermal equilibrium 
magnetization. 
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Figure 2.11 (a) Small flip angle train of spectra. A fit of the Eq. 2.16 is displayed in blue, 
illustrating the longitudinal relaxation mechanism. (b) Schematics of the small flip angle pulse 
sequence. Example taken from Chapter 4. 
𝑇1 is obtained by using a small flip angle train of excitation pulses (Figure 
2.11.b). The longitudinal magnetization after the 𝑛-th pulse will be dependent 
on the 𝑇1 relaxation (s), but also on the flip angle 𝜃 (rad) as described in Eq. 
2.16 (13). 
 𝑀𝑧(𝑛) = 𝑀𝑧(0)×𝑐𝑜𝑠
𝑛(𝜃)×𝑒−𝑛×𝜏 𝑇1⁄  Eq. 2.16 
where 𝜏 (s) is the repetition time between two pulses. 
The flip angle was set to 6 to 24 °, depending on the signal intensity of the hp 
gas in the medium. A weak signal such as dissolved 129Xe signal will require a 
high flip angle, whereas a strong gas phase signal will allow the use of a very 
low flip angle. Flip angles and delays were calibrated before each experiment, 
and are specified in each experimental chapter’s methodological part. 
Experimental 𝑇1 values for hyperpolarized 
129Xe and 83Kr recorded in ex vivo 
lungs are displayed in Table 2.3. The longitudinal relaxation of 129Xe is 
drastically shortened to ~20 s by the presence of 21 % oxygen in the case of in 
vivo experiments. 
 
 𝑇1 (s) 
129Xe 200 ± 20 
83Kr 1.25 ± 0.07 
Table 2.3 Longitudinal relaxation constants of the two nuclei of interest 129Xe and 83Kr, in the 
gas phase in the absence of oxygen, in ex vivo rat lungs, recorded at 9.4 T. 129Xe and 83Kr data 
are taken from reference (11), and (14) respectively. 
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2.6. Magnetic Resonance Imaging (MRI) methods using 
hyperpolarized systems 
When NMR defines the sample at the atomic and molecular levels, it however 
does not give any spatial information inside the RF coil. MRI allows the spatial 
resolution of quantitative NMR data. More precisely, a spatial dependency of 
the frequency and the phase properties of the nuclear spin is created by varying 
the magnetic field across the sample. Multi-dimensional data sets are acquired 
in the form of a spatial frequency image called k-space. The k-space is the 
Fourier transform of the image. The image is reconstructed by calculating the 
inverse Fourier transform of its corresponding k-space. 
An overview of the mechanisms involved in the k-space discrete sampling is 
given in this section, adapted to the construction of a typical image oriented the 
zy-plane of the MRI scanner, with a slice oriented along the x-axis, which was 
the most used geometry in this thesis. 
2.6.1. Spatial encoding using magnetic field gradients 
The spatial encoding of the NMR signal is realised by applying magnetic field 
gradients to the sample in addition to the static magnetic field 𝐵0 . The 
magnetic field gradients are linear along the x-, y- and z- axes, and will 
produce a very unique local magnetic field aligned with 𝐵0 at every point of 
the sample. The spins will experience different local magnetic field 
corresponding to a combination of the static magnetic field and the linear field 
gradient, 𝐵0 + 𝑥𝐺, where 𝐺 is a given gradient in x, y or z (Figure 2.12). 
 
Figure 2.12 Magnetic field representation along the x-, y- or z-axis. The linear gradient field is 
added to the static field from the superconducting magnet, generating a very unique total 
magnetic field, dependent on the spatial location along the gradient axis. 
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Frequency-encoding gradient In the presence of a magnetic field gradient 
along the z-axis, the spins experience different local magnetic fields, and 
therefore resonate at slightly different Larmor frequencies when located at 
different coordinate along the z-axis. Eq. 2.17 describes how a spin located at 
the coordinate 𝑧  will precess under a total magnetic field composed of the 
static magnetic field 𝐵0 and a gradient field 𝐺𝑧. 
 𝜔0 = 𝛾(𝐵0 + 𝑥𝐺𝑧) Eq. 2.17 
The local spatial distribution of the spins across the sample at a given location 
can be directly determined from the frequency content of the MR signal. This 
frequency-encoding gradient is used to define the direct direction of the k-
space (Figure 2.13.A). The inverse Fourier transform of the signal made of 
spatial frequencies will be directly proportional to the spin density at a location 
𝑥, giving a spin density profile. The field-of-view (FOV) in the frequency-
encoding gradient direction is defined by: 
 𝐹𝑂𝑉𝑧 =
1
𝜐×𝐺𝑧×𝐷𝑊
 Eq. 2.18 
where 𝜈 is the gyromagnetic ratio of the nucleus in Hz/T, 𝐺𝑥 is the strength of 
the frequency-encoding gradient in T/m and DW is the dwell time (sampling 
interval) in s. 
Phase-encoding gradient After a flip angle in applied, identical spins in an 
identical environment will spin at the same Larmor frequency. This can be 
altered by a gradient applied along the y-axis. The spins will now experience 
different local magnetic fields, and will be precessing at different frequencies. 
The gradient causing this dephasing is called the phase-encoding gradient. The 
number of phase-encoding gradient increments and the phase-encoding 
gradient strength will define the resolution in the second direction of the image 
Figure 2.13.A). The FOV in the phase-encoding gradient direction is defined 
by: 
 𝐹𝑂𝑉𝑦 =
1
𝜐×Δ𝐺𝑦×𝛿
 Eq. 2.19 
where 𝜈 is the gyromagnetic ratio of the nucleus in Hz/T, Δ𝐺𝑦 and 𝛿 are the 
strength of the phase-encoding gradient step in T/m and the duration of the 
phase-encoding gradient in s respectively. 
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Figure 2.13 (A) Example of k-space sampled using a gradient-echo pulse sequence with 256 
complex points echo acquisition and 64 phase-encoding steps. The frequency-encoding 
gradient was set along the z-axis, and the phase-encoding gradient along the y-axis. (B) 
Corresponding 128 x 64 image after inverse Fourier transform and rotation of the matrix. 
Slice selection The selective excitation of a slice is realised thanks to the use of 
a gradient in the third direction, combined to the application of a spatially 
selective RF pulse. The best slice profile is reached using a sinc RF pulse that 
will give, after inverse Fourier transform a frequency distribution with 
rectangular profile, or bandwidth. A linear gradient is applied in the z-direction 
orthogonal to the x-axis of the slice, so that only a slice will be excited by the 
RF pulse. The frequency of the RF pulse will define the position of the slice 
and its spin density profile. The slice thickness is defined by the RF pulse 
bandwidth BW in Hz and the gradient strength 𝐺𝑧 in T/m: 
 𝑆𝑙𝑖𝑐𝑒 𝑡ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠𝑧 =
𝐵𝑊
𝜐×𝐺𝑧
 Eq. 2.20 
where 𝜈 is the gyromagnetic ratio of the nucleus in Hz/T. 
The slice-encoding gradient is followed by a rephasing lobe (Figure 2.14.A) to 
compensate the dephasing of the slice spins during the slice-selective gradient. 
In this work, all imaging experiments have been conducted using gradient-echo 
imaging with a linear sampling of the k-space, from negative to positive phase-
encoding gradient. The next sections outline the gradient-echo imaging 
method, and the rapid acquisition technique gradient-echo technique fast low 
angle shot (FLASH). Finally, the variable flip angle (VFA) adaptation of the 
FLASH sequence for hyperpolarized systems is described. 
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2.6.2. Gradient-echo imaging 
Imaging sequences consists in building a k-space by putting together the 
frequency encoding, the phase encoding, and the slice selection if necessary. In 
order to fill the k-space with negative and positive frequency values, an echo is 
formed by the use of gradients. The echo was first introduced in spin-echo 
sequences in 1950 by Erwin Hahn (15), constituted of two RF pulse, a 90 ° 
pulse followed by a second pulse (ideally a 180 ° pulse), also called refocusing 
pulse. The spins will begin to dephase just after the 90 ° pulse. The 180 ° pulse 
will induce the tipping of the spins in the xy-plane, inversing their phase. All 
the spins will return to the zero-phase point at the same time equal to two times 
the interpulse delay, called the echo time. 
 
 
Figure 2.14 (A) Gradient-echo sequence diagram for the coverage of a 16 x 16 k-space matrix 
with 16 RF excitations. A sinc RF pulse is applied in concomitance with the slice-selection 
gradient. The echo is induced by a set of two lobes of frequency-encoding gradients of 
opposite polarity. The k-space is covered using a step increment of the strength of the phase-
encoding gradient. The echo time TE is the time between the centre of the RF pulse and the 
centre of the echo. The repetition time TR is the time for each phase-encoded loop. (B) k-space 
diagram of the coverage by linear sampling of a 16 x 16 matrix, starting from the most 
negative phase-encoding gradient value. The red dot represents the (0,0) point where the phase 
and the frequency are null. The dashed arrows represent the trajectory in the k-space when the 
phase-encoding and frequency-encoding gradients are applied simultaneously. The discrete 
sampling of the 16 data points is illustrated by the green dots. 
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In the gradient-echo imaging sequence, the same idea of refocusing the spins is 
used. The spins are dephased by a first gradient, and will be rephased using a 
gradient of opposite sign. The echo will be created by a frequency-encoding 
gradient composed of two lobes of opposite sign. The gradient-echo sequence 
is illustrated in Figure 2.14. The slice-selection gradient is applied with the RF 
pulse, and followed by a rephasing gradient, so that the spins in the slice are in 
phase. The first frequency-gradient lobe is negative and dephases the spin. A 
phase-encoding gradient is applied simultaneously with the dephasing 
frequency-encoding gradient, to encode the second direction of the k-space. 
The second frequency-gradient positive lobe is of the same amplitude as the 
defocusing frequency-encoding gradient, but twice as long and of positive sign. 
The change of sign of the gradient induces a rephasing of the spins and creates 
an echo similar to the spin-echo, in the middle of the positive rephasing 
gradient. The frequency-gradient lobe producing the echo is also called the 
read-gradient as the data are discretely sampled during the echo time. 
The phase-gradient encoding strength is incremented N times from −𝐺𝑚𝑎𝑥 to 
+𝐺𝑚𝑎𝑥 to cover the k-space. The maximum signal intensity is reached when the 
phase-gradient strength is set to zero. 
2.6.3. Variable flip angle (VFA) fast low angle shot (FLASH) 
imaging sequence 
The gradient-echo sequence presented in the previous section implies the 
transverse magnetization has completely depleted before the next incremental 
loop is started. This way, we get a steady-state magnetization for each k-space 
line. The introduction of low flip angle gradient-echo sequence has 
significantly fastened image acquisition of thermal systems, such as 1H, by 
reducing the TR to values lower than 𝑇2  (16). This fast low angle shot 
(FLASH) sequence is commonly used for hyperpolarized noble gas imaging, 
allowing the utilization of only a small part of the initial non-renewable 
longitudinal magnetization for each RF excitation pulse. The remaining 
longitudinal polarization after 𝑛  RF excitation pulses is proportional to 
(𝑐𝑜𝑠𝜃)𝑛 , where 𝜃  is the flip angle, leading to a signal decrease during the 
course of the k-space acquisition. Zhao et al. developed the variable flip angle 
FLASH pulse sequence (VFA FLASH) (17). This imaging method adapted 
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from the FLASH sequence maximises the amount of polarization that is used 
during the image acquisition by increasing the flip angle during the course of 
the image acquisition, up to 90 °, compensating for the polarization loss 
created by the preceding pulse (i.e. for the preceding phase-increment). In the 
case a total acquisition much shorter than 𝑇1 , the n-th excitation pulse will 
produce a flip angle 𝜃𝑛 defined by the relation in Eq. 2.21. 
 𝜃𝑛 = 𝑡𝑎𝑛
−1 (
1
√𝑁 − 𝑛
) Eq. 2.21 
2.7. Hyperpolarized noble gases MRI of rodents’ lungs 
To date the most widespread atom used for hyperpolarized gases MRI is 3He. 
The larger 3He gyromagnetic ratio leads to a higher NMR and MRI signal 
intensity that led to a boost in the human hyperpolarized 3He imaging research 
in the past two decades (18-20). The main source of 3He comes from the 
nuclear weapons program (i.e. from tritium decay). The demand of 3He supply 
exceeding the available quantities, the world is facing a drastic shortage and a 
price inflation (21). The non-sustainable production of 3He pushed the 
researchers to extend their effort to hyperpolarized 129Xe pulmonary MRI. 
Xenon is a naturally occurring element and represents 0.05 ppm of air, and can 
be extracted by fractional distillation of liquefied air. The 129Xe isotope of 
interest for MRI represents 26.4 % of xenon gas. The first noble gas imaging 
actually was the image of a mouse lung preparation using hyperpolarized 129Xe 
(22). Because 129Xe has a 2.7 times smaller gyromagnetic ratio than 3He (Table 
2.1), 129Xe MRI was initially a much difficult task. Recent improvements in the 
hyperpolarization techniques compensated for the inherent lower signal and 
allowed 129Xe imaging to reach SNR values comparable to 3He MRI (23-25). 
The purpose of this thesis is to demonstrate some new sensor application in ex 
vivo rat lungs and in solution. An overview of the progress in hyperpolarized 
129Xe and 83Kr research in rodent pulmonary imaging research related to this 
work is presented in this section. A description of the ex vivo imaging protocol 
is given at the end of this chapter. 
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2.7.1. Hyperpolarized 129Xe MRI 
2.7.1.1. Ventilation imaging 
As discussed in the first part of this chapter, the NMR signal intensity is 
defined by the energy difference between the spins orientations, and is 
therefore directly proportional to the gyromagnetic ratio and the field strength. 
Therefore, identical conditions will lead to smaller 129Xe signal intensity than 
3He. The increasing interest in 129Xe spin exchange optical pumping in the last 
decade led to a significant progress in noble gas SEOP polarizers (23-27). 
Static ventilation imaging, usually realized using a FLASH (Flash Low Angle 
SHot) pulse sequence, allows imaging of the gas distribution within the lungs. 
An abnormal gas distribution may be the indication of one or more ventilation 
defects. Quantitative explorations of chronic obstructive pulmonary disease 
(COPD) and asthma in human have shown correlation between effective 
ventilation and gold standard clinical spirometry and plethysmography (28). 
The variable flip angle (VFA) FLASH sequence has been implemented to 
reduce the exponential signal decay due to a train of constant flip angles (17). 
Sequence imaging using VFA FLASH has been shown to create excitation 
field inhomogeneity artefacts when using human-size excitation coils (29), 
requiring field correction. This technique is however ideal for rodent lung 
imaging FOV of a few cm, using small probes (30, 31). 
2.7.1.2. Diffusion imaging 
The change of location of the gas atoms during the signal acquisition due to 
diffusion is often a problem causing imaging artefacts. It can however be used 
as a tool to evaluate the gas diffusion in restricted environment. During a 
breath hold, the gas is restricted by the pulmonary anatomy. As a consequence, 
the dimensions of the alveolar microstructure will directly affect the apparent 
diffusion coefficient (ADC) mapping. The diffusion in lungs has recently been 
defined as anisotropic, even in the more distal parts as mostly following 
cylindrical structures (32). The gas diffusion changes caused by destructive 
diseases such as emphysema seem to induce more variations in the transverse 
direction, perpendicular to the main diffusion axis (33). 
Because of its high signal intensity, and almost insolubility in tissue, most 
ADC studies were realised using 3He. Free 3He diffusion coefficient in air is 
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equal to 𝐷𝐻𝑒 = 0.86𝑐𝑚
2/𝑠 (34). This value is significantly decreased when 
restricted by boundaries such as the alveolar walls (𝐴𝐷𝐶 = 0.14 ± 0.02𝑐𝑚2/𝑠 
in healthy rat lungs alveolar space, measured at the end of expiration). An 
increased 3He ADC was observed in emphysematous rats ( 𝐴𝐷𝐶 = 0.17 ±
0.02𝑐𝑚2/𝑠) (34). 
Although the 3He is the gas of choice for ADC MRI investigation, the progress 
in the 129Xe hyperpolarization overcoming the weaker signal, and the inflation 
of the 3He price induced a shift of the research effort to 129Xe ADC MRI. 129Xe 
self-diffusion in air is slower than for 3He, with 𝐷𝑋𝑒 = 0.14𝑐𝑚
2/𝑠, allowing 
for some smaller scale diffusion measurements. Boudreau et al. measured a 
significant increase of the transverse component of the anisotropic gas 
diffusion from 𝐷𝑇 = 0.0021 ± 0.0005𝑐𝑚
2/𝑠 in a control rat to 𝐷𝑇 = 0.005 ±
0.001𝑐𝑚2/𝑠 in the emphysematous rat lungs (35). 
3He ADC and 129Xe ADC have been correlated in control and emphysematous 
rabbits, providing equal results in quantifying the microstructure impairment 
(36). Finally, the longer diffusion times when using 129Xe would involve lower 
gradients strengths, which would be easier to implement on clinical MRI 
scanners. 
Note that the 83Kr hyperpolarized technique described further in this section 
can also be used to evaluate the alveolar microstructure. The work presented in 
chapter 3 correlates the hyperpolarized 83Kr relaxation behaviour to the 
alveolar geometry changes caused by emphysema in rat lungs. 
2.7.1.3. Dissolved phase imaging 
Since its discovery at the end of the 19th century, 129Xe has been a rich topic for 
the scientific community. 129Xe’s solubility has been of particular interest from 
the late 1940’s, when the first anaesthetic effect was observed in mice (37). 
The solubility of the noble gas has been further studied in aqueous media and 
in the different compartments of the body. 
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 Ostwald solubility coefficient 
Noble 
gas 
Water 
(mL/mL) 
Plasma 
(mL/mL) 
RBC 
(mL/mL) 
Adipocytes 
(mL/g) 
Human lung 
homogenate 
(mL/g) 
3He 0.0094 (a) - - - 0.01325 (b) 
129Xe 0.1217 (a) 0.1277 (a) 0.4312 (a) 2.0184 (a) - 
83Kr 0.0672 (a) 0.059 (b) 0.107 (b) 0.4622 (b) - 
Table 2.4 Ostwald solubility coefficient in water and biological compartments of interest. 3He, 
129Xe and 83Kr data were taken from references (38), (39, 40) and (40, 41) respectively. Note 
that measurements were taken at (a) at 20 °C and (b) 37 °C. 
Table 2.4 reports literature measurements of the Ostwald solubility coefficient 
for 3He, 129Xe and 83Kr in water and tissues. The Ostwald solubility coefficient 
is defined by the ratio of the volume of gas absorbed by the volume of the 
absorbing liquid at a given temperature. 129Xe presents a solubility 13 times 
larger than 3He, and 2 times larger than 83Kr. In addition, 129Xe’s solubility is 
enhanced by a factor 16 in fat tissue, with an Ostwald coefficient of 2 mL/g 
(39). The 129Xe higher solubility has been used to explore and image the 
hyperpolarized 129Xe transfer from the airspace to the bloodstream, whereas 
3He remains confined in the alveoli, used as a morphological marker in 
ventilation and diffusion imaging. 
Dissolved phase imaging is possible thanks to the relatively long 𝑇1 of 
129Xe 
with 200 s in the alveolar gas phase in absence of oxygen (11), 15 s in presence 
of 20 % of oxygen (42), 12 s in the lung parenchyma (43), and 4.0 – 6.4 s in 
the blood (44), allowing for the transfer of hyperpolarized gas before the signal 
decay occurs. 
129Xe exhibits different chemical shifts when experiencing different chemical 
environments due to its large electron cloud making it precess at slightly 
different rates. Furthermore, there are significant differences in the resonance 
frequency when 129Xe is bound to a variety of molecules, including 
hemoglobin (45, 46). The different 129Xe chemical shifts observed in rodents 
and humans spread over 200 ppm, and allow us to differentiate the different 
compartments, from the gas phase, through the parenchyma, to the 
bloodstream. Rodents and human static and dynamic studies have shown four 
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peaks arising from the 129Xe in the lungs. The gas phase peak is used as a 0 
ppm reference, and three peaks appear at 191, 199 and 213 ppm, representing 
129Xe dissolved in plasma, lung parenchyma and red blood cells respectively 
(47). 
This large chemical shift between the 129Xe present in the alveoli and dissolved 
in the lung tissue allowed for chemical shift selective imaging of the dissolved 
phase, thus giving a spatially resolved information of the gas transfer over time 
(48). The dissolved 129Xe unfortunately represents less than 1-2 % of the total 
129Xe present in the lungs after inhalation. This low proportion makes chemical 
shift imaging of the dissolved phase more complicated, but can be 
accomplished through signal averaging, selective RF excitation, and radial 
acquisition (49, 50). 
This property has been used to show gas transfer impairment in rodents and 
human. For example, gas transfer is reduced in interstitial diseases such as 
idiopathic pulmonary fibrosis (51, 52). Dynamic spectroscopy showed a 
delayed and decreased 129Xe signal arising from the lungs’ vascular system 
(47). The first exploration in rodents showed a decreased signal in the blood 
compartment was observed due to a fibrotic thickening of the alveolar 
membrane (48). 
An imaging techniques has been derived from the fact that the signal intensity 
arising from the dissolved 129Xe is a lot smaller than that of the gas phase. This 
imaging technique called xenon transfer contrast (XTC), inspired from CEST, 
compensates the low dissolved 129Xe signal by detecting it indirectly through 
the gas phase after saturation of the dissolved phase and subsequent gas 
exchange (53, 54). Two gas phase images have to be acquired, the first one 
following a saturation of a region without 129Xe signal (-200 ppm), and the 
second one following the saturation of the dissolved 129Xe (200 ppm). A 
decrease of signal intensity in the gas phase would indicate a gas transfer from 
the lung parenchyma to the alveolar space (55, 56). 
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2.7.1.3. Gas carriers for dissolved 129Xe signal 
enhancement and contrast 
Because the hyperpolarized 129Xe signal arising from the lungs tissue is a 
factor of 100 times smaller than the gas phase signal after inhalation of the gas, 
methods to increase the concentration of 129Xe in the bloodstream have been 
investigated using various biocompatible carrier agents and membrane 
technologies (50, 57, 58). 
In vivo imaging however is still limited by the poor solubility of 129Xe in the 
blood requiring continuous perfusion of hp 129Xe directly into the bloodstream 
via a gas exchange module (Membrana MicroModule®, Charlotte, North 
Carolina, USA). These hollow-fiber membranes used in blood oxygenators 
have been employed to increase the concentration of dissolved 129Xe both in 
blood and in solutions (50, 57-60). Membranes have been used as they greatly 
reduce the degree of foaming that occurs when the relatively insoluble gas is 
delivered to solution as only small bubbles diffuse across. This method is 
suitable for in vivo animal experimentation but is unlikely to find widespread 
clinical acceptance due to issues with invasiveness and coagulation within the 
gas exchange device itself. This extracorporeal circulation composed of a gas 
exchange module has been used in rats to observe the hp 129Xe transferring 
back from the bloodstream to the alveoli, by imaging the gas phase (50). 
It has been shown to be less technically demanding and less invasive to prepare 
hp 129Xe into a solution and then infuse the prepared solution into the animal 
itself (61, 62). Biologically “inert” substances that produce little coagulation 
can avoid the need for delivery through extracorporeal circulation of blood. 
Carrier agents with high solubility have been investigated, as it is known that 
129Xe has a much higher solubility in lipid and perfluorocarbon based 
compounds (Ostwald coefficient > 1) (63). Hyperpolarized 129Xe imaging and 
spectroscopy using gas carrier have been used to investigate the dissolved 
129Xe signal by angiography (64), in the brain (65, 66), heart and kidneys (67), 
but also the gas exchange in the lungs (68). 
Table 2.5 lists the particle size, 129Xe solubility and 𝑇1 in gas carrier agents. 
Perfluorocarbon emulsions (PFCE) have been developed from the late 1980’s 
as blood substitutes taking advantage of their faster exchange with oxygen than 
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hemoglobin. 1st and 2nd generation PFCE blood substitutes, and perflurooctyl-
bromide (PFOB) have been investigated as hp 129Xe carrier agents (57, 63, 69). 
 
 Diameter 
(μm) 
Ostwald 
solubility 
𝑇1 (s) Chemical shift 
(ppm) 
Plasma - 0.13 47.2 ± 5.1 194 
RBC 7.0 0.43 2.2 – 7.8 ¶ 213 
PFCE 1st generation 
Fluosol 
0.20 N/A N/A ~110 
PFCE 2st generation 
Oxygent 
0.16 – 0.19 N/A N/A ~110 
PFOB 0.4 – 5.0 § 1.2 83.4 ± 3.3 106 
Liposomes 8 N/A 116.2 ± 6.2 0.6 
Intralipid suspension 20 % N/A 0.62 40.0 ± 3.0 197 
Table 2.5 Ostwald solubility and 129Xe 𝑇1  longitudinal relaxation times in different carriers 
from references (39, 57, 62, 64, 69). ¶ in deoxygenated and oxygenated blood respectively. § 
eggyold concentration dependent. 
When introduced to the PFCE such as Fluosol (Green Cross, Osaka, Japan) or 
Oxygent (Alliance Pharmaceutical Corp., Wiltshire, UK), hyperpolarized 129Xe 
displays a broad peak with a chemical shift relative to the gas phase at 110 ppm 
as compared to the RBC peak at 216 ppm (57). 
PFOB emulsions show a narrower peak centered at 106 ppm. The linewidth 
with PFOB is emulsion-dependent, with larger droplets producing the least 
exchange and a narrower peak (62). The best peak resolution was obtained 
with droplets bigger than 5 μm, but such particle size has been associated with 
various side effects such as thrombocytopenia in some patients after synthetic 
blood transfusion (70). 
Liposomes-filled 129Xe provides a narrow peak located at 0.6 ppm, that could 
be used as a 129Xe sensor in vivo, providing the organ of interest is not in the 
proximity of the lungs where the 129Xe gas phase signal would overlap with the 
liposome signal (69). 
Although better 129Xe spectral results (narrower dissolved phase peak) are 
expected with PFOB or liposome agents, most interest should be given to the 
less harmful gas carriers, such as PFCE with diameter under 0.2 μm. 
The peaks associated with the 129Xe in the tissue and in the blood are adjacent, 
at 191 ppm and 213 ppm in the rodent 198 and 218 ppm in human, and can be 
difficult to differentiate. The introduction of a carrier agent injected in the rat’s 
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lung pulmonary bloodstream has been explored in Chapter 5, taking advantage 
of the different chemical shift of 129Xe dissolved in two different 
perfluorocarbon emulsions (PFCE). 
2.7.1.3. 129Xe biosensors 
129Xe’s solubility and wide chemical shift have also been used for molecular 
sensing. Some encapsulating molecules have been synthetized to host the 129Xe 
in the dissolved phase. Spence et al. designed the first 129Xe biosensor in 2001 
(71), composed of a cryptophane A tethered to a ligand able to target a protein. 
The 129Xe dissolved in the solvent will be encapsulated in the cryptophane 
cage. The signal from the encapsulated 129Xe in a free biosensor appears at 70 
ppm, whereas the binding of the ligand to its target induces a chemical shift to 
72.5 ppm. Cryptophane E was also used as a 129Xe host for molecular 
biosensing, with a chemical shift close to 40 ppm (72). More in vitro essays 
have used human proteins targets (73), but the chemical shift created by the 
molecular biding was always below 7.5 ppm, leading to overlapping 129Xe 
NMR peaks. Although this 129Xe NMR is feasible in vitro, using high 
resolution NMR probes, in vivo detection of such small chemical shift change 
remains highly difficult. Taratula et al. thought of increasing the local 
concentration of encapsulated 129Xe by using dendrimers able to congregate 
several cryptophanes without tethering them (74). 
HyperCEST technique based on the XTC was developed (75). This NMR and 
MRI technique uses the detection of the dissolved phase (medium signal at 193 
ppm) after the saturation of the encapsulated 129Xe at 65 ppm or control at -65 
ppm. This technique inspired from CEST was also used by Garcia et al (76) to 
improve the sensitivity of the very low encapsulated signal. 
Finally, Klippel et al. used a combination of two 129Xe hosts, cryptophane A 
(60 ppm) and perfluoroctyl bromide (PFOB, 120 ppm) (77). Two cell cultures 
were labelled with one of each allowing a selective CEST saturation of each 
cell population. 
Chapter 4 uses an encapsulating cryptophane A, tethered to a paramagnetic 
gadolinium-DOTA (GdDOTA) group. The transient vicinity of the 129Xe and 
the GdDOTA induces its fast depolarisation. The relaxivity of the biosensor 
has been evaluated. 
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2.7.2. Hyperpolarized 83Kr MRI 
Nuclei with nuclear spin 𝐼 = 1 2⁄  have a completely spherical electric charge 
distribution; the nuclear electric energy will be entirely independent of the 
orientation of the spin in space, and of its electrical environment. On the other 
hand, nuclei with nuclear spin 𝐼 > 1 2⁄  such as 131Xe (𝐼 = 3 2⁄ ) or 83Kr (𝐼 =
9 2⁄ ) have a non-spherical electric charge distribution, called quadrupolar 
electric charge distribution. The electric quadrupole moment of the nucleus 
interacts with the electric field gradient (EFG) generated by external distortions 
of the electronic cloud. This electric quadrupolar interaction in typically an 
intramolecular process caused by chemical bonding, except for noble gas 
isotopes that are inherently monoatomic. Figure 2.15 illustrates how adsorption 
or collision cause a deformation of the electronic cloud, inducing the formation 
of an Electric Field Gradient (EFG) that will interact will the nuclear 
quadrupolar moment. The resulting fast quadrupolar driven relaxation will 
depolarize the 83Kr nuclear spin. 
 
Figure 2.15 83Kr collisions and surface adsorption causing quadrupolar relaxation. 
The 83Kr quadrupolar relaxation was shown to provide a 𝑇1 contrast dependent 
on the surface-to-volume ratio in the porous medium, but also on the surface 
hydration. 
Porous media made of glass beads have been used to demonstrate the 
quadrupolar relaxation. A high surface-to-volume ratio increases the 
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probability of adsorption or collisions of the 83Kr atoms with the surface. 
Shorter 𝑇1  were observed with high surface-to-volume ratio media (78). 
Furthermore, hydrophobic surfaces cause shorter 𝑇1 than hydrophilic surfaces 
due to stronger interaction with the surface during the adsorption (78, 79). 
The surface quadrupolar relaxation (SQUARE) previously described in 
synthetic porous media was also validated in ex vivo rat lungs. Excised healthy 
rat lungs were used as a biological model for porous media with an increasing 
surface-to-volume ratio from trachea to alveoli. 
Stupic et al. used non-localized 𝑇1  spectroscopy with different inhalation 
schemes to demonstrate the relaxation behaviours in the different lung 
compartments (14). The inhalation of smaller volumes of hyperpolarized 83Kr 
followed by thermal gas allows to specifically localize the signal without 
spatially resolve the spectroscopy (Figure 2.16.a). 83Kr is shown to relax faster 
in the distal parts of the pulmonary system (Figure 2.16.b). 
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Figure 2.16 (a) Gas distribution for four inhalation schemes in ex vivo rat lungs using 
hyperpolarized 83Kr in blue and thermal gas in pink. Scheme 1: only hp 83Kr inhaled. Scheme 
2a: 6 mL of thermal gas followed by hp 83Kr to the total volume. Scheme 2b: 12 mL of thermal 
gas followed by hp 83Kr to the total volume. Scheme 3: 6 mL of hp 83Kr followed by thermal 
gas to the total volume. (b) Longitudinal relaxation for the different inhalation schemes and 
total volumes. Composite figure adapted from reference (14). 
These results have been further demonstrated using hp 83Kr MRI. Six et al. 
acquired an image of the excised lung at different delay post-inhalation (80). 
Figure 2.17 A to E shows the hyperpolarized 83Kr gas distribution in the lungs 
at 0.0, 0.5, 1.0 and 1.5 s after inhalation. The signal decay is already visible by 
simple observation of the 83Kr ventilation images, with brighter airways after 
long pre-imaging delays. The incremented delay post-inhalation is necessary 
for the calculation of the spatially resolved 83Kr longitudinal relaxation in the 
lungs (Figure 2.17 E). A faster 𝑇1 decay is observed in the distal alveolar areas 
(iv) (0.9±0.1 s) as compared to the trachea (i) (5.3±1.9 s) where the surface-to-
volume ratio is small. 
 
Figure 2.17 SQUARE contrast demonstrated in ex vivo Sprague-Dawley rat lungs. (A-D) show 
the signal decay within the lungs when acquiring 83Kr MRI images after increasing pre-scan 
delays. (E) Regional 𝑇1 value calculated from the signal decay in (A-D). Figure taken from 
reference (80). 
This 83Kr surface-to-volume ratio sensor has been spatially resolved in healthy 
rat lungs. This property has been used in an animal model of emphysema, 
characterized by a destruction of the alveolar structure. The close relationship 
between 𝑇1 relaxation and surface-to-volume changes caused by emphysema is 
discussed in Chapter 3. 
2.8. Ex vivo rat lung protocol 
When hyperpolarized noble gases imaging has already been performed in vivo 
in small rodents such as mice, rats or guinea pigs, it is however an undeniable 
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very complex task. Advances have been made on ventilators allowing the 
delivery of the hyperpolarized gas to the animal while keeping the animal 
anaesthetised, but also on fast imaging sequences. 
High temporal and spatial resolution for hyperpolarized 129Xe 2D and 3D MRI 
have been reached by using radial acquisition that allowed a faster sampling of 
the k-space over the course of several inhalations (81, 82). Cartersian k-spaces 
are reconstructed by Fourier transform whereas radially collected k-spaces 
require projection reconstruction techniques. The variable flip angle concept 
has also been implemented to radial acquisition protocols in order to 
compensate for the flip-angle-induced hyperpolarization loss (83). Different 
flip angles have also allowed for selective enhanced resolution in the airways 
or the peripheral area (82). Acquisition time has also been reduced by using 
sparse sampling of the k-space (84). 
Small animal ventilators have been customised for hyperpolarized gas MRI 
purpose. They are built from non-magnetic components in order to preserve the 
gas hyperpolarization. They are usually able to deliver either the normally 
oxygenated gas mixed with anaesthetic gas, or the hyperpolarized gas mixture 
in a well-controlled manner (85, 86). Small tubing and valves have to be used 
to limit the dead space (87). Moreover, small rodents inhale only small volume 
of gas under 2 mL, and at a rate of 80-160 breaths per minute, requiring a tidal 
volume delivery high precision and high temporal precision for the MRI 
acquisition triggering. Whilst most hyperpolarized noble gases compatible 
ventilators are performing positive pressure forced inhalation (85, 86, 88, 89), 
another approach has been used to achieve in vivo 129Xe gas phase and 
dissolved phase in mice under passive spontaneous breathing and using low 
noble gas concentration mixture (90, 91). This technique has the advantage to 
be less invasive as to not require treating the animal with neuromuscular 
blocking drug nor excessively deep anaesthesia to control the breathing rate. 
Indeed, damages have been observed in mice after prolonged mechanical 
ventilation (92). 
Ex vivo lungs experiments have been shown to be technically less demanding 
and allow for MRI protocols development and study animal models of 
pulmonary diseases such as asthmatic bronchoconstriction (80, 93, 94). They 
do not require maintaining the animal under constant anaesthesia nor complex 
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intubation. The inhaled volume is reproducible over the course of the 
experiment, and breath holds can be maintained for extended durations. Some 
more extreme conditions can be applied to the lungs such as the complete 
absence of oxygen, prolonging the hyperpolarized signal in the lungs. Finally, 
the ex vivo lungs hyperpolarized noble gases MRI reduces the regulatory 
requirements for animal care and handling. In fact, it allows for the 
experiments to be realised in buildings that are not compliant to small animal 
research, and also reduces the approvals needed for the project to be realised in 
term of animal suffering regulation. A description of the lung excision surgery 
as used in Chapters 3 and 5 is given in the following section. 
The rat was euthanized using an overdose of pentobarbital sodium 200 mg/mL 
(Euthatal, Merial Animal Health Ltd, Harlow, UK). The permanent cessation 
of the circulation was checked before pursuing the dissection. From this point, 
the dissection has to be proceeded as quickly as possible in order to prevent 
blood clotting in the pulmonary circulation. An incision is done along the mid-
ventral line; the aorta is severed under the diaphragm in order to quickly drain 
the blood out of the heart and pulmonary system. A catheter is positioned in the 
isolated trachea and clamped after pushing 4 mL of air though it, in order to 
inflate the lungs to a minimal volume to avoid collapsing of the airways. A 
catheter is placed in the caudal vena cava and the lungs are perfused with 20 – 
30 mL heparin/saline 100 IU/mL to flush the remaining blood from the heart 
and the lungs. A midline thoracotomy gives access to the pulmonary and 
cardiac area. The thymus is removed, and the anterior vena cava is ligated. For 
the purpose of Chapter 5 only, synthetic blood is administrated to the lungs 
through the caudal vena cava. The lungs are finally loosened from the neck and 
thorax. A cannula is tied off in the trachea, and the lungs are tested several 
times for leaks. The lungs are suspended in a ventilation chamber whose 
dimensions fit the MRI detection coil. 
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Figure 2.18 Schematics of the principal surgery key locations during the lung extraction for 
hyperpolarized noble gases MRI. The aorta is first severed, and will serve as blood way-out. 
The pulmonary circulation is flushed with Heparin/saline through a catheter in the caudal vena 
cava. The cranial vena cava is sutured to orientate the injected Heparin/saline and synthetic 
blood directly through the pulmonary circulation. The trachea is catheterised and clamped in 
situ during the surgery. 
The ventilation chamber is connected to a ventilation syringe (Figure 2.19.a) 
placed in the coil within the spectrometer. The hp gas delivery composed of the 
hyperpolarizer and the recompression unit is attached to the bottom of the 
ventilation chamber, at the entrance of the trachea. The hp gas is shuttled to the 
recompression unit, which will deliver the gas at ambient pressure to the lungs. 
Passive inhalation is realised by pulling the ventilation syringe to the wanted 
volume (Figure 2.19.b). This will create a negative pressure in the back of the 
lung, mimicking the action of the diaphragm. This way, the excised lung will 
passively inhale the recompressed hp gas. 
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Figure 2.19 Overview of an ex vivo lung MRI experiment apparatus. (a) Simplified laboratory 
setup for an ex vivo rat lung experiment. The 129Xe or 83Kr is hyperpolarized at low pressure (< 
1 bar) in a custom built polarizer, and delivered to a recompression unit. The recompressed gas 
will be delivered to a transmission line located at the opening of trachea. (b) Ex vivo lungs 
passive inhalation using a ventilation syringe. 
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CHAPTER 3 
HYPERPOLARIZED 83KR MAGNETIC RESONANCE 
IMAGING OF ALVEOLAR DEGRADATION IN A RAT 
MODEL OF EMPHYSEMA 
 
The results presented in this chapter appear in parts in the journal publication: 
David M.L. Lilburn, Clémentine Lesbats, Joseph S. Six, Eric Dubuis, Liang 
Yew-Booth, Dominick E. Shaw, Maria G. Belvisi, Mark A. Birrell, Galina E. 
Pavlovskaya and Thomas Meersmann, “Hyperpolarized 83Kr magnetic 
resonance imaging of alveolar degradation in a rat model of emphysema”, J. R. 
Soc. Interface (2015) 12:20150192 (1). 
Experiments presented in this chapter were performed collectively at the Sir 
Peter Mansfield Imaging Centre at the University of Nottingham and at the 
Respiratory Pharmacology group at Imperial College London. Original concept 
and protocol design were developed by Prof. Meersmann and Dr. Lilburn. The 
animal model preparation, handling and care, and histological analysis were 
performed by Dr. Birrell, Mr. Dubuis and Ms. Yew-Booth at Imperial College 
London. The lungs harvesting was performed by Dr. Lilburn and Dr. Birrell. 
The hyperpolarized 83Kr imaging was carried out by Dr. Lilburn, Dr. Six, and 
Ms. Lesbats at the Sir Peter Mansfield Imaging Centre. Image processing and 
𝑇1  map reconstruction were performed by Dr. Pavlovskaya. The first data 
analyseis were performed by the authors included in the published article cited 
above. Further image and statistical analysis by Ms. Lesbats is presented at the 
end of this chapter. 
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3.1. Introduction 
83Kr quadrupolar relaxation behaviour has been shown to be of interest in 
biomedical research. Hyperpolarized 83Kr had originally been investigated 
using packed beads surface models, showing a relationship between the 
relaxation rate, 𝑅1, and the surface to volume (
𝑆
𝑉⁄ ) ratio, the surface chemistry 
and temperature (2). An augmentation in 𝑆 𝑉⁄  ratio induced a reduction of 𝑇1, 
and a reduction of the signal intensity. The 83Kr surface quadrupolar relaxation 
(SQUARE) has subsequently been demonstrated in ex vivo lungs where the 𝑇1 
relaxation was observed to be shorter in the alveoli as compared to the main 
airways, confirming the 𝑆 𝑉⁄  ratio dependency of the 
83Kr relaxation behaviour 
(3). 
In this chapter, the surface to volume ratio-sensitive SQUARE contrast in the 
lungs is investigated in an animal model of a component of chronic obstructive 
pulmonary disease (COPD), namely emphysema. COPD is a complex and not 
yet fully understood pulmonary disease composed of an airways obstruction 
(chronic bronchiolitis) and a parenchymal destruction (emphysema). 
Emphysema is characterised by a progressive alveolar destruction over time 
caused by inflammation and hyperinflation (4). New screening techniques are 
of particular interest considering COPD is the fourth leading cause of death 
worldwide and is estimated to become the third in 2030 (5). The main cause of 
such parenchymal tissue damage is chronic inflammation. The principal known 
risk factor is cigarette smoking, but pollution, occupational exposure, intrinsic 
factors, gender and aging seem to be involved as well (6,7). Smoking has been 
the cause of death of 73 % of COPD patients in the high-income countries, and 
40 % of low-income countries (5). An intrinsic genetic risk factor is also 
involved in emphysema causing an α-1 antitrypsin enzyme imbalance in 1-3 % 
of the patients with COPD, inducing an antiprotease deficiency, and an 
increased extracellular matrix proteolysis from the neutrophil elastase (6,8,9). 
The destruction of the parenchyma leads to a loss in lung elasticity and of gas 
exchange surface area, inducing a decrease in airflow (ventilation defects), and 
in the ability to transfer the oxygen from the air to the blood (diffusing 
capacity) respectively (10). Patients will suffer of increasing dyspnoea and 
congestion over time, and various other symptoms ranging from sleep 
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disturbance to anxiety or even alienation, decreasing the overall quality of life 
(11). The only treatment at the moment is avoidance or reduction of the 
exposure to the risk factors such as cigarette smoke accompanied by 
bronchodilators treating the associated asthmatic symptoms, and in some cases 
bullectomy to excise the extremely damaged lung areas, or in cases of extreme 
severity lung transplant (12). 
Lung function tests are currently used to diagnose pulmonary impairments 
such as emphysema (4). However, they do not allow a diagnosis before an 
advanced stage of the disease, when most symptoms are already established, 
and more importantly they give a global measurement of the lung function. 
High resolution computed tomography (HRCT) also show some bigger 
alveolar holes, called bullae within the distal lung (13). Because of this late 
diagnosis and high mortality, the importance of investigating emphysema and 
finding new biomarkers is paramount for an early diagnosis and the 
preservation of the lung function at an early stage of the disease. Numerous 
clinical and preclinical studies used computed tomography (CT), providing an 
excellent resolution of the scattered alveolar ‘holes’, but also a lowered 
diaphragm caused by the whole lung enlargement (14). Magnetic resonance 
imaging (MRI) has also been of interest for clinical imaging research of 
emphysema. When 1H imaging is already a difficult method for healthy lung 
imaging, the decreased tissue density due to the emphysematous injuries makes 
1H MRI even more challenging (15). On the other hand, hyperpolarized 3He 
and 129Xe MRI can provide ventilation imaging, showing ventilation defects in 
the lungs (16). The most interesting hyperpolarized 3He MRI exploration is the 
gas diffusion in the lungs, directly correlated to histological analysis of the 
alveolar dimensions (17). The 3He apparent diffusion coefficient (ADC) has 
been shown to increase from 0.225 cm2/s to 0.452 cm2/s in human 
emphysematous lungs (18,19). In the same way, hyperpolarized 129Xe MRI 
allows ventilation imaging and ADC analysis (20,21). 
Several animal models have been used to reproduce the emphysematous 
pulmonary damages. The traditional rodent model created in the 1960’s (22) 
uses an elastase proteinase, such as the human neutrophilic elastase papain or 
the porcine pancreatic elastase PPE, that destroys the extracellular matrix 
protein elastin, inducing the emphysematous lesions. These injuries cause a 
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destruction of the alveolar macrostructure, therefore decreasing the surface 
area in the parenchyma (23,24). These structural changes go along with a 
secretory cell metaplasia, comparable to chronic bronchitis (25). Animal 
models of emphysema have been assessed using histology (26), micro-CT (27), 
lung function tests (28), exercise capacity evaluation (29), but also 
hyperpolarized noble 3He and 129Xe MRI (30,31). 
This chapter aims to confirm the 83Kr SQUARE contrast using the established 
PPE animal model of emphysema. This ex vivo rat lung hyperpolarized 83Kr 
MRI study demonstrates that the 83Kr 𝑇1 contrast can be used as a biomarker 
for emphysema. A global and regional analysis shows a 83Kr 𝑅1 correlation 
with the 𝑆 𝑉⁄  ratio changes in the alveolar parenchyma. 
3.2. Material and methods 
3.2.1 Motivation 
The 83Kr nuclear spin 𝐼 = 9 2⁄  leads to a non-uniform nuclear charge 
distribution. The non-spherical symmetry of the nuclear charges distribution 
creates a nuclear electric quadrupole moment. Any interaction of the noble gas 
with a surface, such as collisions or adsorption, will induce an electronic cloud 
distortion and create an electric field gradient (EFG). Quadrupolar relaxation 
ensues from interactions between the EFG and the nuclear electric quadrupolar 
moment, resulting in shorter 𝑇1  relaxation in the presence of surfaces as 
compared to the bulk gas phase (more detail in Section 2.7.2.). 
The low gyromagnetic ratio and the surface-induced 𝑇1 relaxation create low 
intensity NMR hp 83Kr signal and thus make structural gas imaging 
challenging but not impossible at lower resolution (32). However, the 83Kr 
surface quadrupolar relaxation (SQUARE) MRI contrast is influenced by the 
𝑆
𝑉⁄  ratio but also by surface chemistry, temperature, and surface adsorption of 
molecules (32-35). In this study, hyperpolarized 83Kr is used to introduce a 
new source of contrast within the lungs, dependent on the 𝑆 𝑉⁄  ratio. The 
confirmation of 83Kr contrast caused by emphysematous damages represents a 
first stage in the 83Kr lung imaging development. This contrast can also be 
extended to other lung diseases caused by lung surfactant chemistry changes 
that can be due for instance to prematurity (36). 
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3.2.2. Elastase-induced pulmonary emphysema in rats: 
induction and preparation for ex vivo MRI 
12 male Sprague-Dawley rats, ranging between 260 and 300 g (Harlan UK 
Ltd., Bicester, IK) were used for imaging and histology. 2 in 5 control rats and 
2 in 7 elastase-treated rats were used solely for histology purposes. The other 
rats were used for both ex vivo imaging and histology. 
Animals were anaesthetised using Isoflurane 4% with medical grade O2 for 3 
to 4 min. Emphysema was induced by intratracheal instillation of one dose of 
120 U/kg Porcine Pancreatic Elastase, PPE (Merk Chemicals Ltd, Nottingham, 
UK) at 1 mL/kg. Control animals were similarly treated with 1 mL/kg sterile 
saline (Fresenus Kabi Ltd., Manor Park, UK). 28 days after intratracheal 
instillation, animals were weighted (see Table 3.1) and euthanized with an 
intraperitoneal overdose of sodium pentobarbital 200 mg/Kg (Merial Animal 
Health, Harlow, UK). Death was confirmed by assessing: the cessation of the 
circulation, and the non-response to a painful stimulus by pinching the legs 
with surgical forceps. Severing the aorta and caudal vena cava as rapidly as 
possible will cause the exsanguination, and avoid quick coagulation in the 
heart and pulmonary circulation, therefore minimising the presence of 
paramagnetic iron that would depolarize the hyperpolarized 83Kr. A catheter is 
placed in the caudal vena cava and tightened with a suture. This catheter is 
used to flush the pulmonary circulation with 20 mL heparin 100 IU/mL 
(Wockhardt UK Ltd., Wrexham, UK) in 0.9 % saline solution (Baxter 
Healthcare Ltd., Thetford, UK). Then, 20 mL Dublecco’s phosphate buffer 
solution (D-PBS, Sigma Aldrich Ltd, Gillingham, UK) were flown through it 
to remove residual blood. The lungs and heart are excised en masse. A 
polytetrafluorethylene (PTFE) adaptor tube is inserted in the trachea 5 – 10 
mm above the carina and tightened with a suture. A syringe is inserted in the 
adaptor, the lungs are inhaled to 10 mL and exhaled a few times to ensure they 
are not leaking. Finally, the lungs are suspended in 5 % (weight/volume) 
glucose solution (Baxter Healthcare Ltd., Thetford, UK) in a custom-built 
acrylic 30 mm diameter ventilation chamber, pointing downwards for 
hyperpolarized gas experiments (37). 
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Identifier 
Rat 
Weight 
(g) 
Whole lung MAA  
(104 μm2) 
Lung usage: 
MRI: hp 83Kr MRI 
including histology 
Histology: satellite 
group 
Inhaled volume 
in MRI, 
Vi (mL) 
C
o
n
tr
o
l 
CL.1 492 - MRI 7.0 ± 0.3 
CL.2 555 2.5 ± 0.1 MRI 6.8 ± 0.1 
CL.3 499 3.7 ± 0.6 MRI 6.8 ± 0.1 
CL.4 400 1.9± 0.1 Histology N/A 
CL.5 412 2.5± 0.4 Histology N/A 
E
la
st
a
se
 (
P
P
E
) 
tr
e
a
te
d
 
EL.1 390 6.3 ± 1.1 MRI 5.9 ± 0.7 
EL.2 508 6.8 ±1.1 MRI 6.1 ± 0.6 
EL.3 416 5.1 ± 1.0  MRI 6.9 ± 0.3 
EL.4 440 4.5 ± 0.6  MRI 7.3 ± 0.4 
EL.5 513 3.6 ± 1.0 MRI 6.1 ± 0.2 
EL.6 382 4.8 ± 1.4  Histology N/A 
EL.7 436 10.8 ± 6.2 Histology N/A 
Table 3.1 Demographic data from satellite animals (histology) and those used for hp 83Kr 
imaging. Summary of rat weights, whole lung mean alveolar area ± standard deviation of the 
mean, inhaled volumes (Vi) ± standard deviation corresponding to inflation (syringe) volume 
Vs = 8 mL. No values for Vi were determined in the histology groups. Values omitted were not 
measured. 
3.2.3. Alveolar cross-section measurements 
Emphysema is described as a degradation of the alveolar sacs structure, leading 
to enlarged airways and resulting in a decreased gas exchange area. Elastase-
induced emphysema is a well-known animal model in rats, reproducing the 
human histological feature of emphysema: the airspace enlargement (25,38). 
The porcine pancreatic elastase (PPE) is a protease degrading elastic fibres, 
giving rise to a rapid enlargement of the airspace. 
Experimental emphysema can be assessed by measuring the average air space 
area. This technique was first described by Belloni et al. (39) and used 
previously (40). The lungs were inflated to forced vital capacity (25 cm H2O) 
with 5 % formalin – saline solution (Sigma-Aldrich Ltd, Gillingham, UK). The 
trachea was tied off and the lungs were then placed in formalin. After at least 
24 h in formalin, an experienced histologist processed the lungs. The lungs 
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were wax-embedded, sectioned using a microtome, and stained with 
hematoxylin and eosin (H&E) stain. Five slices per lobe were selected in each 
lung for analysis using an Olympus BX40 microscope and a Zeiss image-
processing software (Imaging Associates, Bicester, UK), excluding slices from 
the fields containing vasculature and large airways. The mean air space area 
was averaged for each lobe, and subsequently averaged for each lung, giving a 
mean alveolar area (MAA). Results are displayed in Table 3.1 and illustrated in 
Figure 3.1. 
 
Figure 3.1 Line and whiskers diagram of the histological data. The individual data from control 
lungs (in blue) and emphysematous lungs (in red) are displayed for each group, overlaid with 
the mean, and standard error of the mean, SEM (in grey). No significant difference is observed 
between the lungs used for MRI and subsequent mean alveolar area (MAA) determination 
(‘MRI + histology’ group) and the histology-only group within the control group and the 
emphysema group. 
As described in Table 3.1 some lungs were used for MRI and histological 
analysis, whereas some other rats were only utilised for histology. In order to 
compare the whole lung MAA results for each sub-group of the control and 
emphysema groups, results were displayed in Figure 3.1. Despite the small 
sample size, the Mann-Whitney U-test shows a non-significant difference 
between the MRI + histology and histology groups within the control (p-value 
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= 0.33) and emphysema groups (p-value = 0.57). This non-significant different 
between the sub-groups allows us to cluster them into a control group and an 
emphysema group for statistical analysis (see results Section 3.3.3.). 
Furthermore, although the ex vivo lung functional 129Xe imaging methodology 
has already been demonstrated to be of use for physiological studies, the non-
significant difference between the sub-groups in this work validates the ex vivo 
experimental protocol for the study of histological features of lungs using hp 
83Kr. No significant alveolar damage has been induced by ex vivo mechanical 
ventilation and MR imaging. 
3.2.4. Hyperpolarization, gas recompression, transfer and hp 
gas inhalation 
Hp 83Kr was produced in batch mode spin exchange optical pumping (SEOP). 
The gas mixture used was composed of 15 % enriched 83Kr (99.925 % 83Kr, 
CHEMGAS, Boulogne, France) and 85 % N2 (99.999 % purity, Air Liquide, 
Coleshill, UK). The SEOP was realised at 55 – 65 kPa with a build-up time 
was 12 min. A recompression unit described in (41) was used to bring back up 
the hp gas to ambient pressure, an inhalable pressure. The spin polarization 
reached P = 16 – 17 % after extraction and recompression of the gas, and an 
apparent polarization of Papp = 2.5 % (42). The method produced 12 – 16 mL 
of hp gas mixture every 12 min. This volume was enough to fill the 
transmission lines and allow the inhalation of 6 – 7 mL of hp gas by the ex vivo 
lungs. 
3.2.5. MRI protocol 
The 83Kr imaging has been performed using a 9.4 T Bruker Avance III 
microimaging system (Bruker Biospin GmbH, Rheinstetten, Germany) and a 
30 mm inner diameter Bruker double saddle coil tuned to the 83Kr resonance 
frequency (15.40 MHz). 
Non-slice selective coronal imaging of the lungs was performed by using a 
variable flip angle (VFA) FLASH sequence (43). The 32 x 32 matrix was 
acquired with a rectangular RF pulse of constant width of 0.3 ms and variable 
power, and the parameters TE = 1.8 ms, and TR = 12.6 ms, leading to a field of 
view FOV = 50.9 x 40.7 mm2. The total acquisition time was 0.405 s. 
 61 
𝑇1 -weighted imaging was realised by acquiring five images as in previous 
works published by Six and coworkers (3). Each image acquisition was started 
after a post-inhalation delay τd = 0.2 s, 0.7 s, 1.2 s, 1.7 s, 2.2 s. Note that some 
maps were calculated from a series of 0.5 s, 1.0 s, 1.5 s, 2.0 s. The manual 
inhalation of the hp gas was achieved by pulling a ventilation syringe, leading 
to a reduction of the pressure in the artificial pleural cavity created by the 
ventilation chamber (as in Figure 2.19). 
3.2.6. Image reconstruction and analysis 
The 32 x 32 data were reconstructed in Prospa (Magritek, Wellington, New 
Zealand). Sine-bell squared apodization, zero filling to 64 points, and Fourier 
transform are applied to the raw data. 64 x 64 magnitude data are then exported 
to Igor Pro (Wavemetric, Lake Oswego, OR, USA) for 𝑇1 analysis. 𝑇1 data sets 
were created for each series of images by combining the images acquired at the 
individual time delays τd into a three dimensional dataset with increasing τd 
(see Figure 3.3). As described by Six et al. (3), spatially resolved 𝑇1  was 
calculated from the linear regression of the natural logarithm of the signal 
intensity as a function of delay time. All 𝑇1 values out of the range 0 ≤ 𝑇1 ≤
6𝑠  were rejected as physically not meaningful. Furthermore, a ROI was 
defined by selecting the lung contour on the image acquired with the shortest 
τd. Any 𝑇1 values out of this ROI were also rejected. The resulting 𝑇1 maps 
were used to plot 𝑇1 histograms for each lung. 𝑇1 data were binned into 200 
intervals with 0.03 s increments. The Igor Pro Multipeak 1.4 function was used 
for an automated peak picking. A bi-modal Gaussian distribution was fitted on 
each histogram. The parameters of the distribution provided numerical 
biomarkers that were used for analysis. Moreover, a 𝑇1 bimodal distribution 
was assumed due to the existence of two pulmonary compartments of different 
dimension scales, the large airways and the small alveolar areas, where 83Kr 
would experience different relaxation behaviours. 
The results of the histogram analysis returned the most probable (expected 
value, EV) relaxation time and the full width at half maximum (FWHM) for 
each of the two Gaussian components (see Figure 3.2). The fast component 
was described by its highest probability (the highest number of voxels) 𝑇1
𝐸𝑉(𝑓)
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and its full width at half maximum 𝐹𝑊𝐻𝑀(𝑇1
(𝑓)
). The slow component was 
described by 𝑇1
𝐸𝑉(𝑠𝑙)
 and 𝐹𝑊𝐻𝑀(𝑇1
(𝑠𝑙)
). All the bimodal fitting parameters 
were stored in Table 3.2. 
 
Figure 3.2 Description of the bi-modal fitting parameters. The 𝑇1 distribution within the lungs 
(dashed grey curve) is decomposed into two Gaussian in blue and green. Two modes are 
therefore identifiable 𝑇1
𝐸𝑉(𝑓)
 and 𝑇1
𝐸𝑉(𝑠𝑙)
, with their respective full width at half maximum 
𝐹𝑊𝐻𝑀 (𝑇1
(𝑓)) and 𝐹𝑊𝐻𝑀 (𝑇1
(𝑓)). 
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 Rat identifier 
𝐓𝟏
𝐄𝐕(𝐟)
 (s) 
mean 
𝐅𝐖𝐇𝐌(𝐓𝟏
(𝐟)
) (s) 
mean 
𝐓𝟏
𝐄𝐕(𝐬𝐥)
 (s) 
mean 
𝐅𝐖𝐇𝐌(𝐓𝟏
(𝐬𝐥)
) (s) 
mean 
C
o
n
tr
o
l 
lu
n
g
 
CL.1 0.9958 0.19619 1.2353 0.53927 
CL.2 1.0130 0.091234 1.2189 0.30050 
CL.3 1.0099 0.14987 1.3556 0.48057 
Average ± 
standard deviation 
1.00620 ± 0.009 0.14576  ± 0.053 1.2699 ± 0.075 0.44011 ± 0.124 
Combined histogram of 
control lungs (Figure 3.6 
– blue histogram) 
1.0112 0.13073 1.2494 0.38797 
E
la
st
a
se
 (
P
P
E
) 
tr
e
a
te
d
 
lu
n
g
 
EL.1 1.2559 0.12770 1.4787 0.32787 
EL.2 1.2311 0.30498 1.7067 0.52674 
EL.3 1.3697 0.28202 2.0474 0.63887 
EL.4 1.1576 0.21975 1.5708 0.71203 
Average ± 
standard deviation 
1.25358 ± 0.088 0.23361 ± 0.079 1.7009 ± 0.249 0.55138 ± 0.167 
Combined histogram of 
elastase (PPE) treated 
lungs (Figure 3.6 – red 
histogram) 
1.2734 0.28201 1.7288 0.54928 
 EL.5 0.94994 0.1333 1.2257 0.4500 
Table 3.2 Characteristic 𝑇1 times from bimodal fitting of the histograms of all lungs used in 
this work. 
3.3. Results and discussion 
3.3.1. SQUARE contrast in the control and emphysema 
groups 
An example of hp 83Kr MRI of a control lung and a PPE-treated lung is shown 
in Figure 3.3. The series of coronal images at different τd show the signal decay 
caused by the 𝑇1 relaxation, with a faster decay in the alveolar space than in the 
bronchial tree. The bronchial signal is persisting longer than the alveolar 
signal, and is still visible at 2.2 s. The PPE-treated lungs show more signal 
heterogeneity than the control lungs. However, heterogeneous ventilation was 
not the scope of the study and was even observed in some control lungs (Figure 
3.4.c) and can be caused by various physiopathological reasons. The hp 83Kr 𝑇1 
relaxation time has been measured to be 90 – 150 s in a 10 mm diameter 5 cm 
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long glass cylinder, at 289 K, 100 kPa and 9.4 T (2). Shorter 𝑇1  values 
recorded in the lungs are predominantly caused by the 83Kr atoms interaction 
with the lung surface. The alveolar space has a significantly higher 𝑆 𝑉⁄  ratio 
than the bronchi. As reported in Six et al. paper (3), a faster 𝑇1 relaxation was 
expected in the alveolar space due to the SQUARE effect. Regions with a low 
𝑆
𝑉⁄  ratio such as the bronchi will have a longer 
83Kr 𝑇1 relaxation, and remain 
“bright” longer than regions with a higher 𝑆 𝑉⁄  ratio and shorter 𝑇1 such as the 
alveolar regions. This prolonged 𝑇1 relaxation time in the airways is illustrated 
in the 𝑇1 map in Figure 3.3. The PPE-treated lung SQUARE 𝑇1 map (Figure 
3.3.d) reveals higher 𝑇1 values than the control lung (Figure 3.3.b), displaying 
an elevated level of green colour. 
 
Figure 3.3 Series of hp 83Kr images with resultant 𝑇1 maps in control and PPE-treated lungs. 
VFA FLASH MRI with no slice selection in control lung CL.2 using a variable relaxation 
delay τd values, ranging from 0.2 s to 2.2 s between the hp gas inhalation and acquisition of the 
image. Each image in (a) and (c) was acquired using a new delivery of hp 83Kr. (b) The 
resultant SQUARE 𝑇1 map displays longer 𝑇1 values for the major airways and shorter values 
for the alveolar region. (c) VFA FLASH MRI in the PPE-treated lung EL.1. (d) The resultant 
SQUARE 𝑇1 map displays prolonged relaxation times in the alveolar area compared with the 
control 𝑇1 map (b). 
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Three control lungs 𝑇1 maps are displayed in Figure 3.4. The data were plotted 
into histograms for comparative analysis. The pixel count for each 𝑇1, between 
0.0 and at 4.0 s at intervals of 0.03 s, were analysed using a bi-modal Gaussian 
distribution function. The Gaussian distribution of the fast relaxing component 
is represented in blue under the histograms, whereas the slow relaxing 
component is represented in green. The sum of the two Gaussians results in the 
histogram contour, in black, suggesting the bimodal fitting is an accurate 
method to characterise the SQUARE behaviour in lungs. Figure 3.5 represents 
the 𝑇1 maps and their histograms for four PPE-treated lungs. The SQUARE 𝑇1 
maps depict visually some marked differences between the control lungs and 
the PPE-treated lungs, revealing more green and yellow colour than the control 
maps in Figure 3.4. The characteristic parameters from the bimodal fitting are 
listed in Table 3.2. 
Control lungs show some average values of 1.0 s and 1.3 s for 𝑇1
𝐸𝑉(𝑓)
 and 
𝑇1
𝐸𝑉(𝑠𝑙)
 respectively, with the corresponding full width at half maximum 0.1 s 
and 0.4 s. On the other hand, PPE-treated lungs seem to have longer 𝑇1
𝐸𝑉 and 
broader Gaussian distributions with 1.3 s and 1.7 s for 𝑇1
𝐸𝑉(𝑓)
 and 𝑇1
𝐸𝑉(𝑠𝑙)
 
respectively and 0.3 s and 0.6 s as full width at half maximum. 
3.3.2. T1 maps and histograms comparison 
Some ventilation defects are observed in two out of the three control lungs 
(Figure 3.4.a and c). This ventilation heterogeneity might be due to the 3-hours 
transport of the ex vivo lungs between the Respiratory Pharmacology 
Laboratory at Imperial College London and the hp MRI facility in Nottingham. 
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Figure 3.4 83Kr MRI 𝑇1  maps (SQUARE contrast) of three control lungs and their 
corresponding histograms: (a) Lung CL.1, (b) CL.2 and (c) CL.3. Blue colour in the alveolar 
regions indicates short 𝑇1 values around 1 s. The histograms represent the pixel count from the 
𝑇1  maps of 𝑇1  values within 0.03 s intervals. A bimodal fitting leads to a narrow Gaussian 
distribution of fast relaxing pixels (blue sold line) centred around 𝑇1
𝐸𝑉(𝑓)
≈ 1𝑠, and a broader 
distribution (green solid line) centred around 𝑇1
𝐸𝑉(𝑠𝑙)
≈ 1.3𝑠. 
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Figure 3.5 83Kr MRI 𝑇1  maps (SQUARE contrast) of four PPE-treated lungs and their 
corresponding histograms as described in Figure 3.4: (a) EL.1, (b) EL.2, (c) EL.3 and (d) EL.4. 
The characteristic 𝑇1 values are shifted to larger values than the control lungs (Figure 3.4) with 
𝑇1
𝐸𝑉(𝑓)
≈ 1.3𝑠 (blue solid line) and 𝑇1
𝐸𝑉(𝑠𝑙)
≈ 1.7𝑠 (green solid line). 
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Combined histograms for the three control lungs and four PPE-treated lungs 
are represented in Figure 3.6. This summary of the two groups represents the 
sum of all pixels for each 𝑇1. The 𝑇1
𝐸𝑉 and FWHM parameters resulting from 
these combined histograms are listed in Table 3.2 along with the individual 
histograms values. 
 
 
Figure 3.6 Combined histograms of all added 𝑇1 in the control and PPE-treated groups. Data 
were obtained from three control lungs (blue) in Figure 3.4 and PPE-treated (red) in Figure 3.5. 
The characteristic 𝑇1 data from bimodal fitting (solid lines) are decomposed into slow and fast 
components (dashed lines). 
A fifth lung (EL.5) from the PPE-treated group was excluded from the 
statistical analysis because the MAA increased developed asymmetrically in 
the left lobe only, possibly due to a very localised elastase deposition. The 
histological data for this lung in Table 3.1 (MAA = 3.6 x 104 μm2) prefigure a 
𝑇1 map similar to those in control lungs. All lobar MAA were in line with the 
control group except for the left lung that exhibits very high MAA values 
(Figure 3.7.c). The 𝑇1 map for this lung EL.5 and the corresponding histogram 
(Figure 3.7.a and b) are very similar to the control lungs’. Although the left 
lobe has very high MAA values, the 𝑇1 map and histogram are not showing the 
expected locally high 𝑇1 values in this lobe. This might be due to the extreme 
damage of the lung on this side, preventing any ventilation of these areas 
during the imaging. The unventilated areas should appear as ‘dark’ regions on 
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the hp 83Kr SQUARE map, but they also could be masked by other ventilated 
areas, contributing to the non-slice selective image. 
 
 
Figure 3.7 (a) 83Kr MRI 𝑇1 map (SQUARE contrast) of the PPE-treated lung EL.5 with (b) its 
corresponding histogram and (c) comparative lobar mean alveolar area values. The grey 
histogram has a bimodal function fitted in black solid line and decomposed in two Gaussians in 
blue (fast mode) and green (slow mode). For comparison, the outline of the histograms 
represented in Figure 3.6 are displayed in blue (control) and red (PPE-treated) dashed line. The 
𝑇1 maps (SQUARE contrast) and the histogram seem to demonstrate that the lung EL.5 has 
similar 83Kr 𝑇1 values to the control lungs. 
The boxplots in Figure 3.8 illustrate a graphical overview of all of the bimodal 
parameters for the control lungs (in blue) and the PPE-treated lungs (in red) 
also listed in Table 3.2. The boxes represent the first quartile, the mean and 
third quartile, and the whiskers represent the minimum and maximum of each 
group’s dataset. Note that the control group was only composed of 3 lungs, not 
allowing a box plot. A Student’s t-test (α = 0.05) has been used to test the 
statistical difference between the two groups. The null hypothesis is assuming 
no statistically significant difference between the control and the PPE-treated 
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groups. 𝑇1
𝐸𝑉(𝑓)
 and 𝑇1
𝐸𝑉(𝑠𝑙)
 exhibited p-values of 0.00517 and 0.03629 
respectively. These values suggest that the two 𝑇1
𝐸𝑉  markers are useful 
biomarkers for the elastase model of emphysema and may be used as a sensor 
for changes of the MAA in the lungs. 
 
 
Figure 3.8 Boxplot of the characteristic data listed in Table 3.2. The MRI 𝑇1
𝐸𝑉(𝑓)
 data between 
control and elastase (PPE) group do not overlap. The same observation is made for the 𝑇1
𝐸𝑉(𝑠𝑙)
 
data. In contrast, the distribution of 𝑇1  values for the two modes of the histograms 
(characterized by 𝐹𝑊𝐻𝑀(𝑇1) ) significantly overlaps between control and PPE groups, 
indicating no significant statistical difference from the 𝑇1  spread. However, the variation in 
𝑇1
𝐸𝑉(𝑠𝑙) is more pronounced in the treated animals than in the control animals. 
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3.3.3. 83Kr T1 relaxation as a biomarker of the alveolar 
dimensions 
The non-significant difference of the whole lung MAA between the lungs used 
for histology only and the lungs used for MRI and histology allows for a 
clustering of the data in a control group and an emphysema group (Figure 3.1). 
The mean control MAA was 26654 ± 7586 𝜇𝑚2  whereas the mean PPE-
treated MAA was 59809 ± 23788 𝜇𝑚2 (Figure 3.9), confirming an increase 
of the alveolar dimensions caused by the proteinase. As expected, a p-value of 
0.0121 calculated with the Mann-Whitney U-test reveals a significantly 
different MAA in the control and the emphysema groups. 
 
Figure 3.9 Box and whiskers plot representing the repartition of the histological data in the 
control and emphysema groups. Bars in the box represent the mean, the first and third quartiles 
of the distribution, the whiskers bars represent the minimum and maximum. A significant 
difference between the two groups’ whole lung MAA is observed. 
The potential relationship between the SQUARE data 𝑇1
𝐸𝑉, and the histological 
data MAA has been analysed. It has been previously shown that 83Kr 𝑇1 ∝
𝑉
𝑆⁄  
(2). In this work, a significant statistical difference has been observed between 
the control group and the PPE-treated group lungs for the 𝑇1
𝐸𝑉(𝑓)
, 𝑇1
𝐸𝑉(𝑠𝑙)
 and 
 72 
the whole lung MAA (Figure 3.8 and Figure 3.9). The correlation between 
𝑇1
𝐸𝑉(𝑓)
, 𝑇1
𝐸𝑉(𝑠𝑙)
 and MAA was evaluated. Previous findings in material science 
showed that in presence of packed spherical beads, a relationship between the 
83Kr relaxation rate 𝑅1 and the surface-to-volume ratio was observed, 
83Kr 𝑅1 
was therefore proportional to the inverse radius of the beads (2). Consequently, 
the assumption that 83Kr 𝑅1  was behaving similarly in the lungs was 
established. Assuming naively a spherical alveolar geometry, 𝑅1 is expected to 
be proportional to the inverse of the alveolar radius (𝑟 ) (Eq. 3.1 to 3.3), 
therefore proportional to the inverse of the √𝑀𝐴𝐴. 
 1 𝑇1
⁄ ∝ 𝑆 𝑉⁄  Eq. 3.1 
 𝑆 𝑉⁄ ∝
1
𝑟⁄  Eq. 3.2 
 𝑅1 =
1
𝑇1
⁄ ∝ 1 𝑟⁄  Eq. 3.3 
Note that even in the cases of model surfaces, deviation from this dependency 
was observed due to non-uniform bead size and varying beads surfaces 
microstructure (2). Nevertheless, this behaviour can be assumed as an initial 
guess for the pulmonary data where it provides a reasonable starting point. In 
the following, the relationship between the two 𝑇1  modes of the SQUARE 
maps histograms and the whole lung mean alveolar area will be evaluated. 
Subsequently, the mean lobar 𝑇1 calculated from regions of interest directly in 
the SQUARE maps will be compared to the corresponding histological lobar 
mean alveolar area. 
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 𝑹𝟏
𝑬𝑽(𝒇)
= 𝟏
𝑻𝟏
𝑬𝑽(𝒇)⁄  
(s-1) 
𝒆𝒓𝒓𝒐𝒓
= 𝑻𝟏
−𝟐×𝑭𝑾𝑯𝑴 
(s-1) 
𝟏
√𝑴𝑨𝑨
⁄  
(10-3 μm-1) 
𝒆𝒓𝒓𝒐𝒓
=
𝟏
𝟐
𝑴𝑨𝑨−
𝟑
𝟐
×𝒔𝒕𝒅𝒆𝒗𝑴𝑨𝑨 
(10-3 μm-1) 
CL.2 0.987167 0.0889074 6.32455 0.126491 
CL.3 0.990197 0.146946 5.19875 0.42152 
EL.1 0.796242 0.0809619 3.98409 0.347818 
EL.2 0.812282 0.201226 3.83483 0.31017 
EL.3 0.730087 0.150324 4.42807 0.434125 
EL.4 0.863856 0.163988 4.71405 0.31427 
EL.5 1.0527 0.147719 5.27046 0.732009 
Table 3.3 Characteristic 83Kr 𝑅1
𝐸𝑉(𝑓)
 parameters and 1 √𝑀𝐴𝐴⁄   histological data with their 
respective errors used for correlation analysis. 
 𝑹𝟏
𝑬𝑽(𝒔𝒍)
= 𝟏
𝑻𝟏
𝑬𝑽(𝒔𝒍)⁄  
(s-1) 
𝒆𝒓𝒓𝒐𝒓
= 𝑻𝟏
−𝟐×𝑭𝑾𝑯𝑴 
(s-1) 
𝟏
√𝑴𝑨𝑨
⁄  
(10-3 μm-1) 
𝒆𝒓𝒓𝒐𝒓
=
𝟏
𝟐
𝑴𝑨𝑨−
𝟑
𝟐
×𝒔𝒕𝒅𝒆𝒗𝑴𝑨𝑨 
(10-3 μm-1) 
CL.2 0.820411847 0.820411847 6.32455 0.126491 
CL.3 0.737680732 0.737680732 5.19875 0.42152 
EL.1 0.676269696 0.149948296 3.98409 0.347818 
EL.2 0.585926056 0.180834763 3.83483 0.31017 
EL.3 0.488424343 0.152407766 4.42807 0.434125 
EL.4 0.636618284 0.28857354 4.71405 0.31427 
EL.5 0.815860325 0.299532631 5.27046 0.732009 
Table 3.4 Characteristic 83Kr 𝑅1
𝐸𝑉(𝑠𝑙)
 parameters and 1 √𝑀𝐴𝐴⁄   histological data with their 
respective errors used for correlation analysis. 
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3.3.3.1. Whole lung 83Kr relaxation as a biomarker 
for whole lung mean alveolar area 
Tables 3.3 and 3.4 show data for the fast and slow relaxation components of 
the bimodal relaxation behaviour 𝑅1
𝐸𝑉(𝑓)
, 𝑅1
𝐸𝑉(𝑠𝑙)
 and the inverse square root of 
the whole lung mean alveolar area, 1
√𝑀𝐴𝐴
⁄ . As functions of the measured 
variables were used for correlation analysis, the uncertainty was calculated for 
each plotted variable using the propagation of uncertainty equation (Eq. 3.4). 
 Δ(𝐹) = √(
𝜕𝐹
𝜕𝑥
)
2
Δ2(𝑥) Eq. 3.4 
Where the error is Δ(𝑥) = 𝐹𝑊𝐻𝑀  for the 𝑇1
𝐸𝑉  variables and Δ(𝑥) =
𝑆𝑡𝐷𝑒𝑣(𝑀𝐴𝐴) for the MAA variable. 
The relationship between the relaxation rates 𝑅1
𝐸𝑉(𝑓)
 and 𝑅1
𝐸𝑉(𝑠𝑙)
 and 1
√𝑀𝐴𝐴
⁄  
is represented in Figure 3.10 where the error bars represent the error 
propagated from the 𝑇1
𝐸𝑉 and MAA measurements. 
Linear regression following the least-square method using GraphPad Prism 
version 6.0 (GraphPad Software, La Jolla, California, USA) led to linear fitting 
(Figure 3.10), following the linear equations Eq. 3.5 and Eq. 3.6 for the fast 
and the slow 𝑇1 mode respectively. 
 𝑅1
𝐸𝑉(𝑓)
= 107.5× 1
√𝑀𝐴𝐴
⁄ + 0.3719 Eq. 3.5 
 𝑅1
𝐸𝑉(𝑠𝑙)
= 105.7× 1
√𝑀𝐴𝐴
⁄ + 0.1704 Eq. 3.6 
A linear correlation is observed between the relaxation rates 𝑅1
𝐸𝑉(𝑓)
 and 
𝑅1
𝐸𝑉(𝑠𝑙)
and the histological measurements 1
√𝑀𝐴𝐴
⁄  with a coefficient of 
determination 𝑟2 = 0.59 and 𝑟2 = 0.56  respectively, the value 0.5 < 𝑟2 < 1 
suggests that the linear model is an appropriate model confirming a strong 
association between the MRI variables 𝑅1
𝐸𝑉  and the histological variable 
1
√𝑀𝐴𝐴
⁄ . In fact, 59 % of the variation in 𝑅1
𝐸𝑉(𝑓)
 and 56 % of the variation in 
𝑅1
𝐸𝑉(𝑠𝑙)
 can be explained by a change in 1
√𝑀𝐴𝐴
⁄ . 
A F-test has also been used to confirm the slope was significantly deviated 
from a zero-slope line, about the mean value of 𝑅1
𝐸𝑉. A 𝑝 − 𝑣𝑎𝑙𝑢𝑒 = 0.0436 
 75 
and 𝑝 − 𝑣𝑎𝑙𝑢𝑒 = 0.0536  was observed for the 𝑅1
𝐸𝑉(𝑓)
 and 𝑅1
𝐸𝑉(𝑠𝑙)
 fittings 
respectively, confirming a significant deviation of the correlation line from the 
zero-slope for the 𝑅1
𝐸𝑉(𝑓)
 linear fitting, whereas 𝑅1
𝐸𝑉(𝑠𝑙)
 was not significantly 
deviating from a zero-slope line. This can be explained by the higher 𝑇1 values 
in the 𝑇1 map predominantly arising from the main airways, which were not 
included in the MAA measurements. But it can also be caused by an important 
alveolar destruction due to the elastase treatment; in which case, the relaxation 
behaviour will depend on many other variables such as the diffusion of the hp 
83Kr atoms to adjacent intact alveoli, or even a modification of the surface 
chemistry in the alveoli. 
A higher correlation was observed between 𝑅1
𝐸𝑉(𝑓)
 and 1
√𝑀𝐴𝐴
⁄  (Figure 
3.10.a) than 𝑅1
𝐸𝑉(𝑠𝑙)
 (Figure 3.10.b). This higher correlation was expected as 
the fast mode 𝑇1
𝐸𝑉(𝑓)
 was exhibiting higher significant difference between the 
two groups (Figure 3.8). The fastest 𝑅1
𝐸𝑉(𝑓)
 values are produced by the alveolar 
parenchyma. Consequently, the correlation between 𝑅1
𝐸𝑉(𝑓)
 and 1
√𝑀𝐴𝐴
⁄  
means changes in 𝑅1
𝐸𝑉(𝑓)
 directly depend on the alveolar radius. 
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Figure 3.10 Scatter diagram of the relaxation rates 𝑅1
𝐸𝑉(𝑓)
 (a) and 𝑅1
𝐸𝑉(𝑠𝑙)
 (b) of the fast mode 
and slow mode of the bimodal fitting respectively against 1 √𝑀𝐴𝐴⁄ . Error bars represent the 
propagated error for the two variables in x and y. The best-fitting linear regression line is 
plotted in solid red line with the 95 % confidence interval in dotted red line. 
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3.3.3.2. Regional 83Kr relaxation as a biomarker for 
lobar mean alveolar area 
Six et al. showed longer 𝑇1 in the airways than in the parenchyma where the 
𝑆
𝑉⁄  ratio is higher (3). One could expect that the alveolar wall degradation 
caused by the elastase proteinase will create a regional 83Kr SQUARE contrast. 
Region of interests were manually selected when clearly visible using ImageJ 
(Imagej.nih.gov/ij/, National Institutes of Health, USA). The mean 𝑇1  value 
and standard deviation were measured in regions of interest from the right 
cranial lobe, the right caudal lobe, and left lobe, which were the only lobes 
identifiable with certainty. The right middle lobe and the right accessory lobe 
were not included because of their difficulty to differentiate from the 
surrounding lobes. More lobes were excluded from the data analysis when a 
ventilation defect was observed in this lobe or near the region of interest. The 
average 𝑇1 and corresponding standard deviation are measured for each lobar 
region, and the calculated 𝑅1  data and inversed squared root of MAA are 
reported in Table 3.5. 
The relationship between the lobar 𝑅1  and 
1
√𝑙𝑜𝑏𝑎𝑟𝑀𝐴𝐴
⁄  is represented in 
Figure 3.11. Linear regression using the least-square method led to a linear 
fitting with the equation (Eq. 3.7): 
 𝑅1 = 71.7×
1
√𝑙𝑜𝑏𝑎𝑟𝑀𝐴𝐴
⁄ + 0.4735 Eq. 3.7 
A linear correlation is observed between the two parameters, with a coefficient 
of determination 𝑟2 = 0.61 . Similarly to the whole lung characteristic 𝑅1
𝐸𝑉 
modes analysis, this coefficient suggests that the linear model is an appropriate 
model to quantitatively correlate the two variables. More than 60 % of the 
changes in lobar 𝑅1 can be explained by the changes in 
1
√𝑙𝑜𝑏𝑎𝑟𝑀𝐴𝐴
⁄ . This is 
in agreement with the previous results correlating 𝑅1
𝐸𝑉 with 1 𝑟⁄ . 
A F-test confirmed the slope was significantly deviated from a zero-slope line, 
about the mean value of lobar 𝑅1, with a 𝑝 − 𝑣𝑎𝑙𝑢𝑒 < 0.0001. 
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 Lobe 
ROI 
area 
(voxels) 
𝑹𝟏
= 𝟏 𝑻𝟏
⁄  
(s-1) 
𝒆𝒓𝒓𝒐𝒓
= 𝐓𝟏
−𝟐
×𝐬𝐭𝐝𝐞𝐯𝐓𝟏 
(s-1) 
𝟏
√𝐥𝐨𝐛𝐚𝐫𝐌𝐀𝐀
⁄  
(10-3 μm-1) 
𝒆𝒓𝒓𝒐𝒓
=
𝟏
𝟐
𝐌𝐀𝐀−
𝟑
𝟐
×𝐬𝐭𝐝𝐞𝐯𝐌𝐀𝐀 
(10-3 μm-1) 
C
L
.2
 
Left 189 0.9751341 0.072771 0.006437618 0.000527179 
Right cranial 48 0.8928571 0.128348 0.006318761 0.000503071 
Right caudal 89 0.9242144 0.064063 0.006668633 0.00078311 
C
L
.3
 Right cranial 60 0.9337068 0.209234 0.005533474 0.000865373 
Right caudal 91 0.9578544 0.111016 0.006875601 0.000330779 
E
L
.1
 
Left 96 0.8237232 0.054282 0.005558919 0.001667787 
Right cranial 58 0.7593014 0.078986 0.004738923 0.000650874 
Right caudal 149 0.7867821 0.095330 0.003811215 0.000574466 
E
L
.2
 
Left 69 0.6161429 0.192473 0.003535096 0.000762941 
Right cranial 80 0.7980846 0.112101 0.004050135 0.001570891 
Right caudal 98 0.7042254 0.047610 0.003964682 0.000797613 
E
L
.3
 
Left (upper) 57 0.7220217 0.037013 0.005199137 0.000389679 
Left (lower) 98 0.7593014 0.067455 0.003413924 0.001215676 
Right cranial 47 0.7220217 0.037013 0.004596865 0.000687732 
Right caudal 93 0.8591065 0.071592 0.003675152 0.000659299 
E
L
.4
 Left (upper) 55 0.8012821 0.066774 0.004200986 0.000965453 
Right cranial 69 0.8474576 0.076846 0.004258851 0.000853734 
E
L
.5
 Right cranial 77 0.9514748 0.077856 0.007354658 0.001105535 
Right caudal 158 1.1248594 0.129061 0.006907996 0.001492845 
Table 3.5 Mean lobar 83Kr 𝑅1 and 1 √𝑙𝑜𝑏𝑎𝑟𝑀𝐴𝐴⁄   lobar histological data with their respective 
errors used for correlation analysis. 
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Figure 3.11 Scatter diagram of the lobar relaxation rate 𝑅1 against 1 √𝑙𝑜𝑏𝑎𝑟𝑀𝐴𝐴⁄ . Error bars 
represent the propagated error for the two variables in x and y. The best-fitting linear 
regression line is plotted in solid red line with the 95 % confidence interval in dotted red line. 
3.4. Conclusions 
This study investigated the effect of the alveolar destruction on the 
hyperpolarized 83Kr relaxation in the elastase animal model of emphysema. 
The elastase rat model consists in degrading the alveolar extracellular matrix 
using the porcine pancreatic elastase (PPE). The induced increase in surface-to-
volume (𝑆 𝑉⁄ ) ratio in the parenchyma of the treated animals was observed post 
mortem with a significant increase of the mean alveolar area (MAA) (Figure 
3.9). 
Hyperpolarized 83Kr ventilation coronal imaging of the lungs shows some spin 
density heterogeneities where the gas is not delivered to the lungs (Figure 3.3). 
An heterogeneous gas distribution was also observed in hyperpolarized 3He 
and 129Xe human studies of COPD (20,44-47) and rodent models of 
emphysema (48,49). These ventilation defects can be explained by some 
airways obstruction, but also by a loss of elasticity inducing a reduced inflation 
of the diseased overdistended rigid parenchyma (24). These ventilation defects 
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were emphasized by using 129Xe spin density imaging as 129Xe has a higher 
viscosity than 3He and a 6 times lower diffusion coefficient (50). It has been 
shown that ventilation imaging was not an adequate technique to at early stages 
of COPD (30) whereas the apparent diffusion coefficient imaging has shown to 
be more effective and was correlated to the alveolar 𝑆 𝑉⁄  ratio (18,19). 
The hyperpolarized 83Kr imaging of the elastase animal model permitted a 
three levels analysis of the surface quadrupolar relaxation (SQUARE) contrast 
in the lungs. 
Pulmonary 𝑇1 maps with an appropriately chosen colour code permit a visual 
assessment of the hyperpolarized 83Kr relaxation behaviour within the lungs. 
The two groups were easily differentiable just by their respective 𝑇1  maps 
overall appearance. The control lungs were showing a mostly blue map 
whereas the PPE-treated lungs were more heterogeneously coloured with a 
tendency towards the greens (Figure 3.4 and Figure 3.5). This first level of 
analysis gives a qualitative evaluation of the slower relaxation in the impaired 
lungs. 
The pixel counts of the previously described 𝑇1  maps were plotted in 
histograms (Figure 3.4 and Figure 3.5). A cohort analysis of the histograms 
resulting from the 𝑇1  maps from 3 control lungs and 4 PPE-treated lungs 
indicated a bi-modal Gaussian 𝑇1  distribution within all lungs. The two 𝑇1 
modes are very likely to originate from two different pulmonary compartments. 
A fast component 𝑇1
𝐸𝑉(𝑓)
 and a slow component 𝑇1
𝐸𝑉(𝑠𝑙)
 were observed in all 
lungs. Both were evaluated significantly faster in control lungs than PPE-
treated lungs (Figure 3.8) and can therefore be considered as relevant 
biomarkers for surface degradation in the emphysematous rat lungs. 
A correlation is observed between the two characteristics whole lung 𝑅1
𝐸𝑉 and 
the whole lung mean 1
√𝑀𝐴𝐴
⁄ . This correlation between whole lung MRI data 
and histological data could allow some non-spatially resolved NMR evaluation 
of emphysematous lungs. However, the low 𝑆 𝑉⁄  ratio in the main airways 
providing a significantly longer 𝑇1 would bias the results, overestimating the 
alveolar destruction in all lungs. It is certainly possible to realise such a 
spectroscopic experiment, but it would require a well designed inhalation 
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scheme for the hyperpolarized 83Kr, so that it is delivered to the alveoli only, 
filling the airways with thermal gas (51). This way, the signal would arise from 
the parenchyma only and the recorded 𝑇1 would be comparable to 𝑇1
𝐸𝑉(𝑓)
, that 
was recorded in the parenchymal areas of the imaged lungs. 
The quadrupolar property of 83Kr gives the atom the unique property to have a 
surface-induced relaxation. This property has been demonstrated in a porous 
model composed of packed beads of defined size (2). The 83Kr relaxation rate 
𝑅1 was shown to be linearly correlated to the inverse of the beads radius. In 
this study, hyperpolarized 83Kr relaxation behaviour has been directly 
compared with the alveolar radius. However, the alveolar radius was not a 
measured value. Considering the alveolus as a spherical unit, the histological 
mean alveolar area (MAA) was assumed circular. The alveolar radius was 
therefore estimated proportional to √𝑀𝐴𝐴. 
The relaxation values resulting from the whole lung 𝑇1
𝐸𝑉(𝑓)
 and 𝑇1
𝐸𝑉(𝑠𝑙)
, 𝑅1
𝐸𝑉(𝑓)
 
and 𝑅1
𝐸𝑉(𝑠𝑙)
 respectively are shown to be inversely proportional to the whole 
lung √𝑀𝐴𝐴 (Figure 3.10). 
The regional 83Kr relaxation was analysed by selecting regions of interest in 
each lobe from all the 𝑇1 maps, without differentiating the cohorts. The lobar 
𝑅1 was inversely proportional to √𝑙𝑜𝑏𝑎𝑟 𝑀𝐴𝐴 (Figure 3.11). 
83Kr 𝑅1
𝐸𝑉 and lobar 𝑅1 were correlating only imperfectly with 
1
√𝑀𝐴𝐴
⁄ , with 
coefficients of determination evaluating the correlation not higher than 0.61. 
The initial hypothesis was that 83Kr 𝑅1  is correlated to the inverse of the 
alveolar radius. The deviation from this linear model might be due to the use of 
the MAA as histological data for an estimate of the alveolar radius despite a 
non-perfect spherical geometry of the alveoli. This imperfect correlation is also 
in accordance with the previously shown 83Kr properties. Indeed, the 
hyperpolarized 83Kr 𝑅1 is not only dependent on the 
𝑆
𝑉⁄  ratio, but also on the 
surface chemistry. Different surface chemical compositions have been 
authenticated using hp 83Kr NMR and MRI of hydrophobic-treated beads and 
non-treated beads (2,32), but also hp 83Kr NMR and MRI of surfactant-treated 
beads, some of them exposed also to tobacco smoke (34). An acceleration of 
the 𝑇1 relaxation was observed when the surface was coated with hydrophobic 
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agents, but also when in presence of tobacco smoke deposit. In the elastase-
induced emphysema animal model, the proteolysis of extracellular matrix 
induces a secretory cells metaplasia, and a subsequent increase in mucous 
production, comparable to bronchitis (25,52,53). This change in alveolar 
surface chemistry, not measured in the MAA, is very likely to induce a faster 
relaxation of the hp 83Kr. In addition, an imperfect spherical alveolar shape 
would also reduce the correlation between the two variables. 
On an additional note, although the 83Kr MRI results presented in this chapter 
were correlating with the histological marker mean alveolar area (MAA), some 
comparisons should be done with the intercept measurement, which is the most 
commonly used histological estimator for the volume-to-surface ratio in the 
lung (54). 
This study has identified 83Kr 𝑇1 as an appropriate biomarker for the alveolar 
surface-to-volume ratio. This unique property allows the hyperpolarized noble 
83Kr gas to be used as a probe for the alveolar wall degradation induced by the 
elastase in a widely used animal model of emphysema in rodents. Some more 
experiments should be conducted to evaluate whether the numerical biomarker 
𝑅1 would also correlate with a pathologic alveolar change in surface chemistry. 
For example, an animal model of chronic bronchitis could be used to evaluate 
the 83Kr 𝑇1  relaxation behaviour in presence of a significantly increased 
production of mucus. All investigation should be accompanied by appropriate 
histological analysis measuring the mucous quantity changes. 
The potential of this technique will be tested by Prof. Thomas Meersmann’s 
research group at lower field, in a 7 T research human scanner. The 𝑇1 
relaxation will be measured for the first time at 7 T and in a larger scale 
alveolar system, close to the human alveolar dimensions. The first stage in this 
project towards human 83Kr pulmonary imaging would be to acquire some 83Kr 
spectroscopy in some large animal ex vivo lungs. The knowledge of the 𝑇1 
relaxation time in such a system will help to image the hyperpolarized 83Kr in 
live human lungs. The expensive cost of a lung scan using isotopically 
enriched 83Kr is an obstacle to the fast development of this technique for 
clinical application  and broad use of it. Such problem can however be tackled 
thanks to the use of hydrogen as a buffer gas during the hyperpolarization 
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process. The replacement of nitrogen by hydrogen followed by a catalytic 
removal of this buffer gas induces a sevenfold increase of the apparent 
polarization (55), when isotopic enrichment provides an approximately 
eightfold signal increase. Even with the use of the expensive isotopically 
enriched gas, this technique could be useful for pharmaceutical trials where the 
cost of an experiment is less of a limitation. This technology could be used for 
drug testing in the case of novel treatments for COPD such as emphysema. 
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CHAPTER 4 
HP 129XE CHEMICAL EXCHANGE RELAXATION 
TRANSFER OF CRYPTOPHANE-GDDOTA 
BIOSENSORS 
 
The results presented in this chapter appear in the journal communication: 
Francesco Zamberlan†, Clémentine Lesbats†, Nicola J. Rogers, James L. 
Krupa, Galina E. Pavlovskaya, Neil R. Thomas, Henryk M. Faas and Thomas 
Meersmann, “Molecular Sensing with Hyperpolarized 129Xe Using Switchable 
Chemical Exchange Relaxation Transfer”, ChemPhysChem. (2015) 16: 2294–
2298. 
Chemical synthesis of the different molecules was carried out by Dr. Francesco 
Zamberlan with the assistance of James L. Krupa and supervision of Prof. Neil 
R. Thomas and Henryk M. Faas. The samples preparation was done by Dr. 
Francesco Zamberlan. The experimental apparatus for the NMR experiments 
was designed and assembled by Clémentine Lesbats and Dr. Nicola Rogers, 
supervised by Prof. Thomas Meersmann and Galina E. Pavlovskaya. 
Relaxation measurements were performed by Clémentine Lesbats, Dr. Nicola 
J. Rogers and Dr. Francesco Zamberlan. Clémentine Lesbats would be 
responsible of the polarizer and gas delivery while Dr. Nicola J. Rogers or Dr. 
Francesco Zamberlan would run the spectrometer. Clémentine Lesbats 
performed the data processing. 
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4.1. Introduction 
The xenon’s high solubility in biologic tissues and fluids is used in medical 
anaesthesia, and is now of great interest to research in hyperpolarized gas lung 
imaging. 129Xe’s solubility in tissue, red blood cells and plasma has been vastly 
studied in the last decade. The wide chemical shift arising from the different 
phases has allowed dissolved phase spectroscopy and imaging in animal and 
human lungs (1-4). 
The National Institutes of Health (NIH) defined a biomarker as “a 
characteristic that is objectively measured and evaluated as an indicator of 
normal biological processes, pathogenic processes, or pharmacologic responses 
to a therapeutic intervention” (5). By monitoring biomarkers in vivo, molecular 
imaging has allowed progress in disease or treatment monitoring but also drug 
development. Hp 129Xe can be used for molecular sensing. This is usually 
realised thanks to encapsulating agents such as cryptophane cages (6-8). 
Cryptophane A is a large molecule which main characteristic is its 5.7 Å 
diameter cavity (9) able to encapsulate the hyperpolarized 129Xe (4.3 Å 
diameter) dissolved in solution. 129Xe encapsulated in molecular cages 
produces a signal located at an independent chemical shift, about 100 ppm 
upfield to the 129Xe signal from the bulk solvent often located around 200 ppm. 
The biosensors pioneered by Pines, Wemmer, and co-workers, but also used by 
Berthault, Schröder and their respective coworkers were composed of a 
cryptophane A (CrA) able to encapsulate 129Xe, connected by a linker to a 
ligand that will bind another molecule. The chemical shift of the signal 
produced by the biosensor will vary depending on its molecular conformation 
or the complexation with the ligand or not for example. The first functionalised 
CrA biosensor was composed of a short linker and a biotin ligand, capable of 
complexation with avidin (6, 7). The protein binding led to an important 
broadening of the signal and a shift of the signal 3 ppm downfield. Berthault 
and coworkers modified the cryptophane molecule, making it soluble in water 
at a physiological pH, suitable for injection in the bloodstream (10). 
A major difficulty with the detection of the hyperpolarized biosensor signal is 
the low signal intensity due to low concentration of cages (i.e. the actual 
biosensors molecules) and by extension of the cage bound hp 129Xe. In order to 
improve the signal to noise ratio (SNR), one could increase the concentration 
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to the extent possible for in vivo application. The hp 129Xe local concentration 
has also been increased by using the bacteriophage M13 as a scaffold for 
numerous CrA to covalently bind to its outer proteins (11). Another way to 
improve the SNR would be to do some signal averaging and selective 
excitation of the cage-bound 129Xe, allowing for some fast exchange with the 
bulk hyperpolarized 129Xe. The large chemical shift between the bulk signal 
and the 129Xe in cage signal easily allows selective excitation pulses. 
Hyperpolarized 129Xe Chemical Exchange Saturation Transfer (HyperCEST) 
uses this selective excitation to destroy the encapsulated 129Xe signal, the 
constant chemical exchange with the dissolved phase induces a decrease of the 
dissolved phase signal, and this indirect detection allows a drastic improvement 
of the sensitivity over direct detection and averaging of the encapsulated hp 
129Xe (11, 12). 
4.2. Motivation 
Molecular sensing using encapsulated 129Xe is usually based on the detection 
of a small chemical shift change up created by the change in conformation of 
the biosensor after interaction with a biomarker, such as an enzyme or a 
receptor (6, 7). This has been of particular interest for biomolecular NMR 
applications such as for in vitro assays and cells suspensions explorations (13), 
but the in vivo applications are often limited by the lower spectral resolution 
achievable in bigger coils and lower field, and more importantly in complex 
organisms. 
Moreover, the cryptophane-bound 129Xe phase signal intensity is very small to 
be detected; this work focuses on the 129Xe signal from the solution in which 
the biosensor is dissolved, providing a larger source of signal. 
Paramagnetic relaxation causes the rapid decay of the non-renewable 129Xe 
signal, and is therefore usually avoided for hyperpolarized gases probes. As 
discussed in Chapter 3, noble gas induced relaxation can however be used as a 
source of contrast. 83Kr longitudinal relaxation was shown to be linearly 
dependent on the surface-to-volume ratio in ex vivo rat lungs. The concept 
underlying this project is to use this disadvantage as a tool to create a positive 
contrast. In this work, the 129Xe’s solubility property is used to investigate a 
new sensor composed of a CrA, tethered to a gadolinium-DOTA chelate. The 
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paramagnetic property of gadolinium chelated in DOTA and attached to the 
CrA induces the fast decay of the dissolved hyperpolarized 129Xe signal 
through fast exchange with the cage-bound 129Xe. The rapid relaxation of the 
dissolved 129Xe induced by the CrA-GdDOTA has been explored. This proof-
of-concept study demonstrates a ‘switchable’ paramagnetic relaxation contract 
agent. The finale aim is to develop a biosensor that would lead to a positive 
contrast, providing a high hp 129Xe signal when deactivated by the presence of 
the biormarker of interest. 
Of course, the future design of the depolarizing biosensor will have to include 
some considerations, such as the length of the linker. Förster resonance energy 
transfer (FRET) shows a 𝑟−6  dependence of the fluorescence transfer 
efficiency between the donor and the acceptor (14). Similarly, the 
depolarization of the cage-bound 129Xe caused by the paramagnetic GdDOTA 
will be dependent on the distance between them. The enzymatic cleavage of 
the linker will increase the distance between the paramagnetic agent and the 
host cage and deactivate it. The resulting cleavable biosensor will enable the 
detection of a biomarker and its spatial distribution, providing insights on 
physiological process such as enzymatic reactions within an organ. 
4.3. Material and methods 
4.3.1. Synthesis of the molecule 
In this work, the model sensor consists of a Cryptophane A (CrA) and a 
gadolinium-DOTA (GdDOTA) chelate, a symmetrical linker was used to tether 
them together. CrA-GdDOTA was retrosynthesized from a DOTA chelator, 
modified with a short linker, and cryptophanol. This section gives a brief 
overview of the reactions leading to the final molecules. Further details on the 
chemical synthesis can be found in the supplementary information of the 
communication presenting this work (15). 
CrA (Figure 4.1) was synthesized following Berthault and coworkers report 
(16). They used their biosensor in vitro as an intracellular probe for 129Xe. 
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Figure 4.1 Cryptophane A molecule. 
DOTA-linker was obtained by reacting an appropriately protected Do3A with 
one of the α-bromoacetyl termini of a short bisamide linker. The cryptophanol 
was then reacted with the other α-bromoacetyl group, leading to the CrA-
DOTA compound in Figure 4.2. 
 
 
Figure 4.2 CrA-DOTA compound. 
After deprotection of the DOTA carboxylic groups, the Gd3+ cation was 
successfully chelated, yielding to the compound CrA-GdDOTA, as showed in 
Figure 4.3. 
 
 
Figure 4.3 CrA-GdDOTA compound. 
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The biosensor was not soluble in H2O. A 1:1 v/v mixture water and acetonitrile 
(H2O/ACN) was found to be the most suitable solvent for the sensor, Gd
3+
(sol), 
and 129Xe. In this study, relaxation properties of 5 molecules, called Rx, have 
been compared: 
- GdDOTA 
- CrA-GdDOTA 
- CrA-DOTA + Gd3+(sol) 
- Gd3+(sol) 
- CrA-DOTA 
4.3.2. Experimental design 
Hp 129Xe gas was produced using batch mode spin exchange optical pumping 
(SEOP) in a custom built polarizer extensively described in Six et al. paper 
(17) with a 25 % natural abundance 129Xe and 75 % N2 gas mixture. The 
polarization build-up was achieved for 6 minutes at a temperature of 110 °C 
and a pump cell pressure of about 1300 mbar. Experiments have been 
performed on a 9.4 T spectrometer (Bruker BioSpin GmbH, Germany) at 293 
K. All NMR spectra were obtained using a custom-built 15 mm double saddle 
coil tuned to the 129Xe resonance frequency of 110.71546 MHz. 
Prior to any spectrum acquisition, the sample was degassed from any trace of 
oxygen dissolved in solution by bubbling through it for 2 minutes with 
research grade nitrogen at 40 mL/min. 
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Figure 4.4 Overview of the experimental setup for hp 129Xe(sol) relaxation measurements. The 
gas mixture enters the polarizer to be hyperpolarized. After 6 minutes, it is delivered to the 
sample at a flow of 40 mL/min determined by the flowmeter at the end of the circuit. For 
spectrum acquisition no valve is closed, whereas valves A and B are closed for small flip angle 
𝑇1 measurement. 
As sketched in Figure 4.4, a 5 mm sample tube containing 2 mL of the 
molecules Rx dissolved in 1:1 H2O/ACN at different concentrations is 
connected to the polarizer delivering the hyperpolarized noble gas, and to a 
flowmeter and exhaust line. A research grade nitrogen line is also located 
before the test tube in order to degas the sample as described previously. 
The hyperpolarized noble gas is flowed for 45 seconds at 40 mL/min before 
starting the spectrum acquisition sequence or 𝑇1 measurement. This process 
allows replacing any nitrogen or dark gas (depolarized gas mixture) by freshly 
polarized noble gas mixture. 
4.3.2.1. Continuous flow spin exchange optical 
pumping 
The hyperpolarized noble gas is continuously delivered (40 mL/min) during 
the initial spectrum acquisition. This qualitative spectrum was used to verify 
the signal-to-noise level in both gas phase and dissolved phase. It also 
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permitted to determine the resonance frequency offset for later selective 
radiofrequency (RF) excitation pulses on the 129Xe dissolved in solution. 
4.3.2.2. Stopped flow spin exchange optical 
pumping 
The hyperpolarized noble gas flow is interrupted during the longitudinal 
relaxation (𝑇1) sequence measurement. This is achieved by closing two manual 
valves A and B located before and after the sample tube (Figure 4.4). 
4.3.3. NMR protocol for longitudinal relaxation measurements 
129Xe spectrum 
A hyperpolarized 129Xe spectrum is acquired prior to any relaxation 
measurements in order to identify and set the radiofrequency (RF) pulse to the 
dissolved phase resonance frequency. 
A previously calibrated 90 ° hard pulse (63 μs, 3 dB) induces a free induction 
decay (FID). The spectral width was set to 30 kHz, with 8192 complex points. 
These parameters allowed a spectral width of 268.8 ppm, covering the entire 
range of 129Xe frequencies in our system. Signal is averaged 8 times to 
compensate the weaker dissolved signal. The FID is Fourier transformed 
directly in Topspin 2.0 (Bruker, Germany) and the dissolved 129Xe resonance 
frequency is determined. 
 
129Xe longitudinal relaxation 
A sequence composed of 16 equally spaced small flip angle RF pulses (12 °) 
has been used to measure the 𝑇1 relaxation times (Figure 4.5). As the time 
increases, signal decay will be caused by the 𝑇1 relaxation, diffusion, but also 
by the RF pulse polarization destruction (18). 
  
 98 
 
 
Figure 4.5 (a) Illustration of the hp 129Xe dissolved in solution signal decay during a Small Flip 
Angle sequence and (b) schematics of the pulse sequence used. Spectra in black represent the 
dissolved 129Xe in 0.07 mM CrA-GdDOTA in 1:1 H2O/ACN, fitted with the Eq. 4.1 in red. 
The FIDs were composed of 4096 complex points, with a spectral width of 6 
250 Hz (equivalent to 56.4 ppm). The spectra are Fourier transformed, phase 
corrected and baseline corrected using Prospa (Magritek, Wellington, New 
Zealand). After Fourier transform, the signal intensity is integrated for each 
spectrum and normalised to the first and greater spectrum. 𝑇1  is calculated 
using Igor Pro (Wavemetrics, Portland, USA) from a linear fitting of the 
natural logarithm of the normalised integrated signal of the spectra as a 
function of time (19) described by Eq. 4.1 to Eq. 4.4. 
 𝑀𝑧(𝑛) = 𝑀𝑧(0)×𝑐𝑜𝑠 
𝑛(𝜃)×𝑒−𝑛×𝜏 𝑇1⁄  Eq. 4.1 
 𝑀𝑧(𝑛)
𝑀𝑧(0)
= cos𝑛 𝜃 ×𝑒−𝑛×𝜏 𝑇1⁄  
Eq. 4.2 
 
ln (
𝑀𝑧(𝑛)
𝑀𝑧(0)
) = 𝑛× ln(cos 𝜃) −
𝑛×𝜏
𝑇1
 
Eq. 4.3 
 
ln (
𝑀𝑧(𝑛)
𝑀𝑧(0)
) = 𝑛× (ln(cos 𝜃) −
𝜏
𝑇1
) 
Eq. 4.4 
 
The decay of the longitudinal magnetization 𝑀𝑧 as a function of the excitation 
pulse number 𝑛, is caused by 𝑇1 relaxation during the time 𝑡 = 𝑛×𝜏. The fixed 
time constant 𝜏  is the time duration between two successive RF pulses. 
Furthermore, the polarization is diminished by 𝑠𝑖𝑛(𝜃) by each of the small flip 
angle pulses. The remaining signal after 𝑛  RF pulses is proportional to 
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𝑐𝑜𝑠𝑛(𝜃) and this term is multiplied by the exponential 𝑇1 relaxation decay in 
the full equation (20). 
 
1H longitudinal relaxation 
The proton signals produced from the bulk solution of water and acetonitrile 
have been identified prior to acquiring an inversion-recovery sequence that was 
used in order to evaluate 𝑇1 in water. 
1H from the H2O and the ACN molecules 
resonate at 4.79 ppm and 2.44 ppm respectively (Figure 4.6) in accordance 
with reported common laboratory solvents chemical shifts (21, 22). 
 
 
Figure 4.6 1H spectrum in a 2 mL sample of 1 mM GdDOTA dissolved in 1:1 ACN/H2O. The 
spectral width was 10 000 Hz acquired with 8192 complex points. 
The Topspin inversion-recovery ‘T1ir’ inbuilt sequence has been used to 
measure 𝑇1 of proton in H2O. The sequence consists of consecutive 180 ° and 
90 ° pulses, separated by a delay τ (Figure 4.7.b). The first pulse rotates the net 
magnetization in the orientation of the –z axis. After a delay τ, the second pulse 
will rotate the magnetization of 90 ° in the xy plane. The signal intensity will 
therefore vary as a function of τ, time during the spin-lattice relaxation 𝑇1 
occurs. When 𝜏 < 𝑇1, very little of the magnetization will have returned to the 
+z axis, inducing a negative phase signal after the 90 °, resulting in a negative 
signal. When 𝜏 ≫ 𝑇1 , the magnetization will have fully recovered from the 
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inversion pulse, and the second 90 ° pulse will produce a maximal positive 
signal. 
 
Figure 4.7 Inversion recovery NMR sequence. (a) in blue the experimental data point acquired 
with different τ in 0.5 mM GdDOTA dissolved in 2 mL 1:1 ACN/H2O, fitted with the Eq. 4.2. 
in red. The inversion-recovery sequence has been sketched in (b). 
The signal intensity for different τ has been plotted Figure 4.7.a with a zero-
crossing point at 𝜏 = 𝑇1×𝑙𝑛2 . The resulting fit can therefore be used to 
extrapolate 𝑇1, according to Eq. 4.2. 
 𝐼(𝜏) = 𝐼0× (1 − 2𝑒
−
𝜏
𝑇1) Eq. 4.2 
4.3.4. HPLC 
High-Performance Liquid Chromatography (HPLC) is an analytical tool 
allowing the separation and identification of organic compounds. The different 
molecules will be separated depending on their adsorption level on a column 
they are flown through. In this experiment, HPLC has been used to follow the 
transformation of CrA-GdDOTA into CrA-DOTA, induced by the acidification 
of the solvent. 
HPLC was performed using an Agilent 1200 series system at 1.0 mL/min 
equipped with a 4.6 x 150 mm Agilent Eclipse XDB-C18 analytical column 
with a 5 μm pore size and a single channel UV detector at λ = 215 nm. The 
mobile phase used was a 0.1 % formic acid in milli Q water solvent, followed 
by a gradient elution (0 to 95 % over 30 min) of a second solvent composed of 
0.1 % formic acid in acetonitrile. 
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4.4. Results and discussion 
After synthesis of CrA, a hp 129Xe spectrum of CrA dissolved in chloroform 
(CDCl3) has been acquired to verify that the 
129Xe signal arises from the three 
different phases. As illustrated in Figure 4.8 the three peaks identified as 129Xe 
signal appear from the gas phase at 0 ppm, from the chloroform phase at 216 
ppm and from the CrA cage at 64 ppm. Spence et al. already reported a 129Xe 
signal in CrA peak located at 71 ppm using water as solvent in their study (6). 
In this study, the highly concentrated 13 mM CrA solution in CDCl3 only 
allows a very small and broad peak arising from the CrA. 
 
 
Figure 4.8 Hp 129Xe spectrum of 13 mM CrA in chloroform (CDCl3). A hard pulse (63 μs, 3 
dB) has been used to acquire 64 averages during the bubbling of hp gas. The FID was 
multiplied by an exponential weighted function (lb = 30) before Fourier transformed. 
Once the full synthesis of the three parts of the molecules, i.e. CrA, GdDOTA 
and the linker; and tethering of the GdDOTA to the CrA have been 
accomplished successfully, spectra were acquired and relaxation rates 
measured. Longitudinal relaxation rates 𝑇1 were measured as a function of the 
concentration of the CrA-GdDOTA and its derivatives, [Rx]. 
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As showed in Figure 4.9, when hp 129Xe is bubbled in the solution, the 129Xe 
exchanges from the gas compartment to the dissolved compartment (H2O/ACN 
solvent), but also gets encapsulated in the CrA cage. The encapsulation of the 
129Xe in the CrA cages prolongs the 129Xe’s presence in close proximity to the 
paramagnetic chelated Gd3+ and induces a fast decay of the 129Xe(sol) NMR 
signal. 
 
 
Figure 4.9 Hp 129Xe spectrum of 0.035 mM CrA-GdDOTA in 1:1 H2O/ACN. Signal from the 
129Xe encapsulated in Cryptophane A is not visible due to important line broadening. The FID 
was multiplied by an exponential weighted function (lb = 30) before Fourier transformed. 
The dissolved phase chemical shift, δXe(sol), is varying with the concentration of 
the different CrA-GdDOTA derivatives. Figure 4.10 shows an illustration of 
the chemical shift dependency on the concentration of the molecules [Rx]. 
Only GdDOTA and CrA-GdDOTA allowed linear fitting. GdDOTA and CrA-
GdDOTA have a chemical shift dependence of 𝛿𝑋𝑒(𝑠𝑜𝑙) = 1.3 ±
0.1𝑝𝑝𝑚. 𝑚𝑀−1  and 𝛿𝑋𝑒(𝑠𝑜𝑙) = 3.5 ± 0.4𝑝𝑝𝑚. 𝑚𝑀
−1  respectively. A large 
variation of the concentration will only induce a small change in chemical 
shift. The small chemical shift range does not appear to be useful as a sensor of 
the different molecules concentrations. 
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Figure 4.10 Chemical shift dependency on the concentration of CrA-GdDOTA (blue triangles), 
Gd3+(sol) (red diamonds), CrA-DOTA (black circles), GdDOTA (green squares) dissolved in 1:1 
H2O/ACN. Note that the Gd3+(sol) has also been fitted in red with a dependency of 2.3 ±
0.5𝑝𝑝𝑚. 𝑚𝑀−1. 
4.4.1. T1 characterization of the compound and its derivatives 
The solubility of hyperpolarized 129Xe gas in solvents allows for a quick 
dissolved signal build up after the start of bubbling at 40 mL/min. The signal 
typically reached a saturated plateau after 40 s. The dissolved 129Xe will and 
continuously exchange with the CrA cages where it is temporarily 
encapsulated. The 129Xe’s temporary confinement in the cages causes it to 
remain in close proximity of the paramagnetic GdDOTA for the duration of the 
encapsulation. During this time period, 129Xe experiences very fast 
paramagnetic relaxation leading to accelerated hp 129Xe depolarization. The 
continuous chemical exchange between the cages and the solvent will transfer 
the depolarized atoms to the dissolved phase where the effect is measured by 
an increase in the relaxation (or depolarization) rate. 
As explained in Section 4.3.3., a low flip angle series of RF pulses has been 
used to characterise 𝑇1. The signal from the dissolved phase, at 190 ppm, is 
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integrated, and the 𝑇1  value is calculated from the natural logarithm of the 
normalised integrated signal. 
 
 
Figure 4.11 Relaxation rates of the dissolved phase 129Xe in different concentrations of CrA-
GdDOTA (green squares), CrA-DOTA + Gd3+ (red diamonds), Gd3+ (purple circles), 
GdDOTA (blue triangles), and CrA-DOTA (yellow circles). All the compounds are dissolved 
in a 1:1 H2O/ACN solution. (i)-(v) represent the time course of CrA-GdDOTA before and after 
addition of HCl. (i) shows the 0.4 mM CrA-GdDOTA start point before acidification (n=3), (ii) 
the start point after acidification and dilution to 0.3 mM (n=7), (iii) after 20 h (n=10), (iv) after 
24 h (n=4), and (v) after 96 h (n=6). 
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 Concentration (mM) #1 𝑻𝟏 (s) #2 𝑻𝟏 (s) #3 𝑻𝟏 (s) 
C
rA
-G
d
D
O
T
A
 
0.035 33.673 42.708 39.721 
0.07 28.878 27.149 27.522 
0.175 12.059 11.775 11.423 
0.35 4.9935 5.0901 4.7121 
0.7 4.255 3.194 3.9558 
C
rA
-D
O
T
A
 
+
 
G
d
3
+
 
0.1 89.387 91.688 95.341 
0.225 34.737 32.305 33.085 
0.5 17.979 16.835 16.399 
0.8875 14.405 11.61 10.675 
C
rA
-D
O
T
A
 
0.041 205 197.48 233.85 
0.0825 217.03 207.84 239.14 
0.165 161.4 163.63 174.41 
0.33 144.03 132.86 153.92 
G
d
D
O
T
A
 
0.33 46.899 45.218 46.768 
0.67 24.703 22.327 25.222 
1.35 12.839 11.311 11.105 
2.7 7.292 7.1942 7.3708 
G
d
3
+
 
0 191.39 190.03 185.01 
0.05 214.89 217.84 214.39 
0.1 126.62 129.93 127.98 
0.25 46.476 46.92 45.652 
0.8 13.675 13.578 15.831 
Table 4.1 𝑇1 individual data for different concentrations of all biosensor derivatives. 3 repeats 
#1, #2 and #3 have been acquired at each biosensor concentration. 
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The longitudinal relaxation 𝑇1  has been recorded 3 times for each 
concentration of each derivative of the CrA-GdDOTA molecule, dissolved in 
1:1 H2O/ACN. These values are displayed in Table 4.1. 
129Xe(sol) relaxation 
rates  have been measured and plotted as a function of the 
concentration in Figure 4.11 and summarized in Table 4.2. 
The relaxivity of GdDOTA for 129Xe(sol) was 𝑅1 = 0.0515 ±
0.0014𝑠−1. 𝑚𝑀−1. This value means that a high concentration of GdDOTA 
would induce only a minor acceleration in the 129Xe relaxation in vivo. Indeed, 
a 1 mM of GdDOTA shows a 𝑇1 for 
129Xe of 𝑇1 = 19𝑠, that will have a very 
little effect if injected in vivo where 129Xe 𝑇1 in the whole lung is of the order 
of 20 s (23). 
The synthesis precursor CrA-DOTA, free of Gd3+ had a relaxivity for 129Xe of 
𝑅1 = 0.00725 ± 0.0007𝑠
−1. 𝑚𝑀−1  (Table 4.2). This very low relaxivity is 
explained by the absence of paramagnetic gadolinium. This control experiment 
demonstrates the very small relaxation induced by the CrA cage itself on the hp 
129Xe. 
Once Gd3+ has been introduced to the system and chelated with the DOTA, the 
relaxivity of CrA-GdDOTA for 129Xe(sol) was recorded to be 
. This eightfold relaxivity increase as compared to 
CrA-DOTA can be explained by the encapsulation of 129Xe(sol) in the 
cryptophane cages, placing the hyperpolarized atoms in the immediate 
proximity of the paramagnetic GdDOTA. Paramagnetic relaxation follows an 
r6 dependence (24), where r is the distance between the nuclear spin 
(encapsulated 129Xe) and the paramagnetic centre. The chemical exchange 
transfers the relaxation effect from the encapsulated 129Xe to the dissolved 
phase, leading to an acceleration of 𝑅1 rates for the dissolved 
129Xe(sol). 
The relaxivity of GdDOTA and CrA-GdDOTA for H2O protons is 150 times 
higher than that of 129Xe (see Table 4.2), explained by proton’s highest 
gyromagnetic ratio and the γ2 dependence of paramagnetic relaxation. In 
addition, the paramagnetic relaxation will be more efficient on water’s proton 
as they will directly coordinate with the Gd3+ centre in the GdDOTA chelates 
(23, 24). 
 
  
R1 =1 T1
  
R1 = 0.416 ± 0.023s
-1mM-1
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 129Xe 𝑹𝟏 (s
-1.mM-1) 1H 𝑹𝟏 (s
-1.mM-1) 129Xe δ (ppm.mM-1) 
GdDOTA 0.0515 ± 0.0014 7.66 ± 0.17 1.3 ± 0.1 
CrA-GdDOTA 0.416 ± 0.023 7.36 ± 0.11 3.5 ± 0.4 
CrA-DOTA + Gd3+(sol) 0.0955 ± 0.0051 15.0 ± 0.14 - 
Gd3+(sol) 0.0847 ± 0.0029 23.4 ± 0.4 2.3 ± 0.5 
CrA-DOTA 0.00725 ± 0.0007 - - 
Table 4.2 129Xe and 1H relaxation rates, 𝑅1 , and chemical shift variation, δ, of the CrA-
GdDOTA compound and its derivatives. 
To demonstrate the deactivation of the sensor’s paramagnetic effect on hp 
129Xe, a few drops (0.66 mL) of concentrated HCl (37 % v/v) were added to a 
0.4 mM CrA-GdDOTA solution, giving a finale concentration of 0.3 mM. The 
change in pH causes a protonation of the DOTA and the Gd3+ to dislodge from 
the chelator, reducing the 129Xe presence time in the close vicinity of the 
paramagnetic agent. Relaxation measurements have been acquired before 
addition of HCl, and at different times after addition of the HCl. 
A time-course of this experiment is represented in Figure 4.12 and Table 4.3, 
illustrating the relaxivity changes during the acidification and the leach of Gd3+ 
from the molecule. The immediate dilution when adding HCl provokes a large 
increase of 𝑇1 and a decrease of 𝑅1. The acidification process led to a 3-fold 
decrease in the relaxivity in 96 hours. Figure 4.12 shows the relaxivity 
decrease from the CrA-GdDOTA 𝑅1 = 0.416 ± 0.023𝑠
−1. 𝑚𝑀−1 to the CrA-
DOTA + Gd3+(sol) 𝑅1 = 0.0955 ± 0.0051𝑠
−1. 𝑚𝑀−1  during the acidification 
time course. This 4.3-fold drop in the relaxivity is found to be 2 times greater 
than the one found for GdDOTA (𝑅1 = 0.0515𝑠
−1. 𝑚𝑀−1). This is likely to be 
caused by the increased contact with the unchelated paramagnetic Gd3+(sol), as a 
similar effect is observed for 1H relaxivity (Table 4.2). 
In an additional experiment, the relaxivity of Gd3+(sol) for 
129Xe was found to be 
𝑅1 = 0.0847 ± 0.0029𝑠
−1. 𝑚𝑀−1 (Table 4.2), close to the relaxivity obtained 
96 hours after acidification of the CrA-GdDOTA solution (pH = 0) and 
complete extraction of the Gd3+ out of the DOTA chelator. 
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Figure 4.12 CrA-GdDOTA relaxivity before and after adding concentrated HCl to the 1:1 
H2O/ACN solution. (i) shows the relaxivity of a 0.4 mM CrA-GdDOTA solution. The 
acidification induces the dilution of the solution to 0.3 mM (ii) and the conversion of CrA-
GdDOTA into CrA-DOTA + Gd3+(sol). Relaxivities of the conversion process have been 
acquired 20 h (iii), 24 h (iv) and 96 h (v) after HCl addition to the solution. Note that the data 
are also represented in Figure 4.11 (black triangles).  
 
Time (h) 𝑻𝟏 ± st dev. (s) 𝑹𝟏 ± st dev. (s-1) 
Before HCl 6.63 ± 1.46 0.150798 ± 0.034085 
0.3 9.51 ± 1.02 0.105106 ± 0.010737 
21 16.77 ± 2.06 0.059623 ± 0.008251 
26 21.55 ± 1.90 0.046404 ± 0.004410 
96 28.45 ± 0.83 0.035150 ± 0.001047 
Table 4.3 129Xe(sol) relaxation data for the time-course experiment. 
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HPLC has been performed on the sampled 20 min, 24 hours and 96 hours after 
acidification. The chromatograms displayed in Figure 4.13. show the front 
solvent detection in the early times (peaks before 5 min), the CrA-DOTA peak 
at 17.2 min, and the CrA-GdDOTA peak at 18.4 min. Integrals of these two 
peaks are shown in Table 4.4. The chromatogram 20 min after acidification 
only shows a CrA-GdDOTA peak, illustrating the start point of the experiment, 
before the Gd3+ leaches out of the DOTA. At 24 hours, the second peak for 
CrA-DOTA appears, confirming a mixture of 13.9 % CrA-DOTA and 86.1 % 
CrA-GdDOTA. Indeed, the protonation of the DOTA induces the escape of the 
Gd3+ out of the DOTA. Finally, only the CrA-DOTA peak appears at 96 hours, 
demonstrating the reaction completion and the full leakage of the Gd3+ out of 
the DOTA. 
 
Figure 4.13 Time-course HPLC of the 0.3 mM CrA-GdDOTA in 1:1 H2O/ACN solution 20 
min (blue), 24 h (red) and 96 h (green) after adding concentrated HCl. The CrA-GdDOTA 
peak (a) appears at 18.4 min of retention time. The CrA-DOTA peak (b) appears at 17.2 min 
from the 24 h chromatogram in red. 
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 (a) area (a.u.) (b) area (a.u.) %(a) %(b) 
t = 20 min 9443.75 533.04 94.7 0.0 
t = 24 h 6210.44 3.85 × 104 13.9 86.1 
t = 96 h - 3.38 × 104 0.0 95.8 
Table 4.4 HPLC data. Integration of the indicated peaks in Figure 4.13. (a) refers to the CrA-
GdDOTA peak at 18.4 min. (b) refers to the CrA-DOTA peak at 17.2 min. Note that the purity 
at t = 96 h has been calculated by taking the ratio of peak (b) divided by (b) + impurities peak 
at 23.8 min. 
4.5. Conclusions 
The relaxation behaviours obtained in this work show an important increase in 
the relaxivity of GdDOTA for 129Xe when the chelate is linked to a 
cryptophane cage. The cage prolongs the presence of the hp 129Xe close to the 
paramagnetic centre, inducing its depolarization (Figure 4.14). Results showed 
a 59 % decrease in relaxivity when the chelate does not include the 
paramagnetic Gd3+. Although the paramagnetic relaxation occurs when the 
129Xe is in the cryptophane cage, when the NMR signal appears at about 64 
ppm, it is then transferred to the solvent phase at 189 ppm through chemical 
exchange. The dissolved phase 129Xe relaxation rate will therefore be a 
weighted average of the solvent phase and the cage phase relaxation rates. 
Unlike HyperCEST, this technique does not require radiofrequency irradiation 
for saturation to accomplish depolarization. The depolarization occurs 
consequently to the hyperpolarized nuclei’s encapsulation, followed by 
chemical exchange with the dissolved phase, leading to the fast decay of the 
dissolved phase signal. 
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Figure 4.14 Paramagnetic relaxation of the encapsulated 129Xe induced by the activated 
biosensor (top). No relaxation induced by deactivated biosensor (bottom). 
A cleavable linker would functionalize the separation of the cage from the 
paramagnetic gadolinium that, in turn, would deactivate this relaxation 
mechanism. In this work, this process has been illustrated by an acidification of 
the GdDOTA inducing the leakage of the Gd out of the DOTA chelator, 
deactivating the paramagnetic effect of the complex on the encapsulated 129Xe, 
and decreasing the relaxation mechanism. This property can be used to gauge 
enzymatic reactions, and will necessitate a different linker that will be targeted 
by an enzyme to be cleaved. Matrix metallopeptidase 9 (MMP-9) is a 
collagenase involved in the degradation of the extracellular matrix and in the 
lung remodelling. This enzyme is implicated in numerous pulmonary 
pathologies such as cancer but also IPF and COPD (25). The replacement of 
the linker by a MMP-9 target peptide will allow the cleavage of the 
cryptophane cage from the depolarizing GdDOTA where the enzyme is present 
in the organ. In this future application, the uncleaved biosensor will induce a 
fast relaxation of the dissolved 129Xe when MMP-9 is absent, therefore 
producing a positive contrast where the enzyme is present and cleaves the 
biosensor, preserving the 129Xe magnetization. 
After in vitro experiments assessing whether the switchable biosensor can 
quantify the amount of enzyme in the medium, the biosensor can be directly 
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injected to excised rat lungs via the blood. This method can help gauging the 
enzymatic composition changes in animal models of lung diseases. The 
molecule could also be directed to the lung cavity in the form of droplets using 
a nebulizer or in the form of a powder with a simple inhaler. The deposition of 
the biosensor in the alveoli could permit a non-invasive evaluation of the 
enzymatic activity in the airway surface liquid and mucus. 
This switchable biosensor is 129Xe specific and does not show any change in 1H 
relaxation. The paramagnetic relaxation on 1H would allow probing the 
biosensor location and concentration, independently of the activation state. The 
129Xe relaxation is however necessary to differentiate activated and deactivated 
biosensors with similar relaxation behaviour. Even though a chemical shift 
change had already been observed using an enzymatic cleavage of a hp 129Xe 
biosensor (26), this chemical exchange relaxation transfer contrast will not 
require a high spectral resolution and might be of interest to design new 
biosensors for in vivo application. 
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CHAPTER 5 
FLUORINATED SYNTHETIC BLOOD AS A CONTRAST 
AGENT FOR 129XE NMR OF EX VIVO RAT LUNGS 
 
The preliminary results presented in this chapter are based on experiments that 
were developed by Prof. Thomas Meersmann and Clémentine Lesbats. 
In vitro and ex vivo spectroscopy measurements were performed by 
Clémentine Lesbats. The animal preparation and lungs harvesting was 
performed by Clémentine Lesbats, and Anthony Habgood when using the 
animal model of pulmonary fibrosis. The recompression unit that allowed for 
the delivery of hyperpolarized gas to the excised lungs was built and semi-
automated by Zahra Rahemtulla, during the course of her M.Sc. The pulse 
sequences were written by Clémentine Lesbats, supervised by Dr. Galina E. 
Pavlovskaya and Prof. Thomas Meersmann. Data analysis was carried out by 
Clémentine Lesbats. 
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5.1. Introduction 
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive interstitial lung 
disease associated with severe morbidity. At present the aetiology of IPF is 
unknown, there are no effective means for monitoring disease progression and 
no treatments available. Whilst structural imaging is useful for diagnostic 
purposes, and conventional pulmonary function testing gives reliable global 
assessments of lung function, functional imaging would represent a significant 
step forward in assessing and monitoring novel therapeutics. 
The solubility of 129Xe in lung tissue, and blood plasma, makes hp 129Xe 
particularly promising for imaging of lung fibrosis (1). The tissue solubility of 
129Xe enables regional monitoring of gas-blood exchange in IPF providing a 
significant advantage over current technology (2, 3). 
Due to its large compressible outer electron shell, 129Xe has been shown to 
exhibit an observable chemical shift between the gas and dissolved phase (4). 
Furthermore, there are differences in the resonance frequency when 129Xe is 
bound to a variety of molecules, including haemoglobin (5, 6). This unique 
property has allowed imaging of hp 129Xe dissolved in the lung tissue and 
pulmonary circulation and imaging of 129Xe moving in the reverse direction, 
diffusing from the bloodstream into the lung airspaces (7). The large chemical 
shift (200 ppm) between the 129Xe gas phase and the dissolved phase permits 
the study of the diffusing capacity in human and rodent lungs (8-12). 
One limiting factor in these experiments is the rather poor solubility of 129Xe in 
plasma and red blood cells (RBCs) with the result that the intensity of the 
dissolved phase signal in the lungs is a factor of 100 times smaller than the gas 
phase signal after inhalation of hp 129Xe (13). Methods to increase the 
concentration of 129Xe in solution have been investigated using various carrier 
agents and membrane technologies (14-16). 
Another limitation is that the NMR peaks associated with the 129Xe in the 
tissue and in the blood are adjacent –at approximately 200 ppm, and can be 
difficult to differentiate. It has been shown that 129Xe dissolved in 
perfluorocarbon emulsion (PFCE) resonates around 100 ppm (14, 17). In this 
chapter, a PFCE will be explored to enhance the MRI contrast of hp 129Xe 
diffusing through the lung parenchyma into the vascular system. The addition 
of PFCE to the blood will facilitate the discrimination of the hp 129Xe dissolved 
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in the blood stream from the tissue. The purpose is to provide new MRI 
contrast for the study of pulmonary gas transfer dynamics in health and 
disease. For example, gas transfer to the blood compartment is reduced in 
interstitial diseases such as idiopathic pulmonary fibrosis (18, 19). 
It has been shown to be less technically demanding and less invasive to prepare 
hp 129Xe into a solution and then infuse the prepared solution into the animal 
itself (20, 21). Hollow-fibre membranes used in blood oxygenators have been 
employed to increase the concentration of dissolved 129Xe both in blood and in 
solutions (15, 16, 22, 23). Membranes have been used as they greatly reduce 
the degree of foaming that occurs when the relatively insoluble gas is delivered 
to solution as only small bubbles diffuse across. In vivo imaging is however 
still limited by the poor solubility of 129Xe in the blood requiring continuous 
perfusion of hp 129Xe directly into the bloodstream via a gas exchange module 
(16). This method may be suitable for in vivo animal experimentation but is 
unlikely to find widespread clinical acceptance due to issues with invasiveness 
and coagulation within the gas exchange device itself. In addition, numerous 
signal averaging over many breaths is still required for dissolved phase 
imaging, limiting resolution at present. Biologically “inert” substances that 
produce little coagulation can avoid the need for delivery of blood products or 
the extracorporeal circulation of blood. Carrier agents have been investigated, 
as 129Xe solubility is much higher in lipid and perfluorocarbon based 
compounds (24). 
5.2. Motivation 
Excised rodent lung imaging has been validated and used to study excised 
healthy rodent lungs with hp 129Xe (25) and 83Kr (26), allowing for the imaging 
of the lungs prior to histological studies. In this research, a bleomycin-induced 
animal model of pulmonary fibrosis has been used (19). The initial hypothesis 
is that if a synthetic blood, perfluorocarbon emulsion (PFCE), is added to the 
blood compartment of excised lungs (Figure 5.1), the dissolved peaks will be 
better resolved, allowing an enhanced discrimination of the 129Xe signal in the 
parenchyma and the capillaries. 
The objectives of this project are to investigate the solubility of 129Xe in two 
PFCEs and assess their suitability for use as a contrast agent in ex vivo lungs in 
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order to study the gas diffusion through the pulmonary parenchyma. This will 
lead to a new non-invasive monitoring of the gas diffusion kinetics parameters 
in animal models of pulmonary fibrosis. The practicability of the use of 
synthetic blood as a hp 129Xe contrast agent in excised rat lungs will be 
evaluated, involving in vitro measurements of the 129Xe chemical shift 
dissolved in the synthetic blood, and longitudinal relaxation measurements, 
alongside with some ex vivo rat lung spectroscopy applications. These results 
can be used for the exploration of the gas exchange in small animal disease 
models where the pulmonary gas diffusion is impaired, or the evaluation of 
pulmonary treatments on the gas transfer. 
 
 
Figure 5.1 Gas diffusion through the lung parenchyma from the alveolar space, through the 
tissue, to the pulmonary capillaries before (a) and after (b) blood replacement by PFCE. 
5.3. Material and methods 
5.3.1. Ex vivo rat lung MRI protocol 
The rat lungs were extracted and were all suitable for hyperpolarized noble gas 
MR experiments, i.e. they were not damaged nor leaking. Lungs were 
suspended in a 25 mm or 30 mm ventilation chamber filled with saline solution 
that was then placed into the magnet, set to 17 °C. 
As described in Chapter 2, and similarly to Chapter 3 (Section 3.2.4.), 
hyperpolarized 129Xe was produced in batch mode spin exchange optical 
pumping (SEOP). The gas mixture used was composed of 25 % enriched 129Xe 
(enriched to 83 % 129Xe, Nova Gas Technologies, Charleston, SC, USA) and 
75 % N2 (99.999 % purity, Air Liquide, Coleshill, UK). Low pressure SEOP 
was performed at 65 – 75 kPa during 6 min. The hp gas mixture was then 
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delivered to the pre-vacuumed recompression piston (27). The recompression 
unit was allowing for recompression of the hp gas up to above ambient 
pressure to permit delivering the gas to the excised lung trachea as described in 
Section 2.8. 
An active inhalation of the hp 129Xe into the excised lungs was accomplished 
by a ventilation syringe producing a suction in the ventilation chamber (25). 
The inhalation volume was determined prior to the MR experiments. The lungs 
were completely inhaled at a fixed volume. The exhaled gas volume was 
delivered to an inversed measuring cylinder filled with water, and the gas 
volume was directly measurement by the volume of displaced water. The 
average inhaled volume in 6 representative rats are listed in Table 5.1. 
Rat ID Experiment 
day 
Weight 
(g) 
Inhaled 
volume 
(mL) 
Inhalation 
pressure 
(mbar) 
129Xe 
NMR and 
MRI 
83Kr 
NMR 
Control 2_2 1 324 4.8 ± 0.1 19 ± 0.9 Yes No 
Bleo 1_1 1 304 4.2 ± 0.4 21 ± 1.5 Yes Yes 
Bleo 1_3 1 302 4.2 ± 0.6 26 ± 0.6 Yes Yes 
Control 2_3 2 330 5.2 ± 0.05 23 ± 2.3 Yes No 
Bleo 3_3 2 307 4.8 ± 0.2 22 ± 1.1 Yes No 
Bleo 3_4 2 302 5.3 ± 0.1 22 ± 0.0 Yes No 
Table 5.1 Demographic data for the emphysematous rat lungs used for 129Xe MRI and NMR, 
rat weights, inhaled volumes ± standard deviation (𝑛 = 5), and experiments done with the 
lungs. 
5.3.2. Animal model of pulmonary fibrosis: the bleomycin rat 
model 
Lewis male rat (300-350 g) lungs were used for preliminary investigation on 
the 129Xe gas transfer through the lung parenchyma in excised fibrotic rat 
lungs. An ex vivo rat model of pulmonary fibrosis was produced by 
oropharyngeal delivery of bleomycin. Bleomycin is a chemotherapeutic 
antibiotic well known for its adverse effect of activating fibroblasts and 
subsequently inducing fibrosis (28). The lungs were excised 21 days after 
treatment for MR experiment. 
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A second set of rats was composed of one bleomycin-treated and one control 
rat received a post mortem blood replacement by a perfluorocarbon emulsion 
as explained in the next section. 
5.3.3. Perfluorocarbon emulsion as synthetic blood and 129Xe 
carrier 
Two perfluorocarbon emulsions (PFCE) were used, Oxycyte (Tenax 
Therapeutics, Inc, Morrisville, USA) and Perftoran (OJSC SPC Perftoran, 
Moscow, Russia). These two agents were developed to be used as a human 
blood replacements and oxygen carrier agents (29, 30). In the purpose of this 
study, they were utilised as 129Xe carrier in the ex vivo rat lungs. The synthetic 
blood was administered post mortem to the lungs through the caudal vena cava 
after flushing of the blood off the heart and lung capillaries. For more detail, 
the lung extraction and blood replacement were extensively detailed in Section 
2.8. 
Table 5.2 lists the aims of the three experiments involving rat lungs, the PFCE, 
and the number of rat that was used for each of them. 
Some 129Xe MRI and NMR were first done in some fibrotic and control rat 
lungs (Stage 1). In a second experiment, 129Xe NMR was evaluated in a treated 
and a control rat lungs which underwent a blood replacement by Oxycyte 
(Stage 2). 
Finally, for the particularity of the Stage 3 experiment, the original Perftoran 
10 % was concentrated by evaporation of the solvent phase. This was achieved 
using a water bath (RE 300 DB, Stuart equipment, Bibby Scientific Limited, 
Stone, UK) and a rotary evaporator (RE 300, Stuart equipment, Bibby 
Scientific Limited, Stone, UK). A 60 mL initial volume of commercial 
Perftoran, defined by 10 % v/v lipid emulsion, was added, and intermittently 
warmed up to 313 K bath while rotating in order to preserve the emulsion, with 
a 50 to 100 mbar vacuum. The final volume was 32 mL, producing a Perftoran 
solution concentrated to 19.2 % v/v lipid emulsion. This concentrated solution 
was made to improve the 129Xe signal arising at 90 ppm when dissolved in the 
lipid emulsion and is used in the latest section of this chapter. 
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P
F
C
E
 
Aim of the experiment 
Number 
of rats 
MRI NMR 
Stage 1 
N
/A
 
Comparing the hp 129Xe gas 
phase MRI and dissolved phase 
NMR in bleomycin and control 
Lewis rat lungs 
6 Yes Yes 
Stage 2 
O
x
y
cy
te
 Comparing the hp 129Xe PFCE 
signal from a bleomycin and a 
control Lewis rat lung 
2 No Yes 
Stage 3 
P
er
ft
o
ra
n
 1
9
.2
 %
 
Utilizing two control Sprague-
Dawley rats to assess the hp 
129Xe gas transfer from the 
alveoli to the blood 
compartment containing the 
PFCE 
2 No Yes 
Table 5.2 Experiments overview: PFCE that was used as blood replacement, aim of the 
experiment, and number of rat used. 
5.3.4. 129Xe lung MRI protocol 
Imaging experiments were performed using a 9.4 T Bruker Avance III 
microimaging system (Bruker BioSpin GmbH, Germany). A custom-built 25 
mm low-pass birdcage coil tuned to the resonance frequency of 129Xe gas in the 
rat lung of 110.69 MHz was used for 129Xe gas phase imaging. 
Images were acquired using a variable flip angle (VFA) FLASH gradient echo 
sequence. A sinc shaped pulse of 1000 µs was used to accomplish a 3.8 mm 
slice selection. The images were acquired in 128 x 64 voxels matrices, and 
with a field of view (FOV) of 47 x 33 mm in a total acquisition time of 4 s. 
5.3.5. 129Xe NMR protocol 
Spectroscopy of the ex vivo lungs was realised using a 30 mm Bruker-made 
coil tuned to the 129Xe gas phase (110.69 MHz), tissue (110.715 MHz) or 
PFCE phase (110.703 MHz) resonance frequency. 
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A qualitative spectrum was first acquired using a 140 µs hard pulse centred 
between the gas phase (0 ppm) and the tissue (193 ppm), and a spectral width 
of 𝑆𝑊 = 60 𝑘𝐻𝑧 covering all of the 129Xe phases in a rat lung. 
A chemical shift selective gauss pulse was also calibrated in order to 
selectively excite the tissue or the Perftoran phase, with minor excitation of the 
two other peaks. A 750 µs gauss pulse led to an excitation bandwidth of 𝐵𝑊 =
3000 𝐻𝑧. 
Chemical shift selective gauss pulses were calibrated to minimize the effect of 
the excitation on the bulk gas phase (0 ppm) that is used as a reservoir during 
longer experiments. Figure 5.2 represents three spectra acquired using a single 
hard pulse centred on the Perftoran phase (grey), compared to 64 averages 
using a chemical shift selective gauss pulse (750 µs) in a healthy rat lung with 
blood replacement using Perftoran 19.2 %. The gas phase peak appears smaller 
when the carrier frequency of the gauss pulse is centred on the tissue phase 
(red) as compared to the Perftoran phase (blue). 
 
 
Figure 5.2 Hp 129Xe NMR spectra using a single non-selective hard pulse (grey), or a chemical 
shift selective gauss pulse (64 averages), centred on the Perftoran phase (blue) or tissue phase 
(red). Note that the phase was inversed for an easier visualisation. 
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5.3.6. 129Xe Chemical Shift Saturation Recovery (CSSR) 
Dynamic spectroscopy of the 129Xe gas transfer through the parenchyma has 
been performed using a Chemical Shift Saturation Recovery (CSSR) pulse 
sequence. The pulse sequence consists in sequentially measuring 129Xe NMR 
spectra after a selective saturation of the dissolved phase and an increasing 
exchange time (Figure 5.3). In addition, the saturation pulse was followed by a 
dephasing gradient (1771.74 Hz/mm, 0.1 ms). 
 
Figure 5.3 (a) Schematics of a chemical shift saturation recovery (CSSR) pulse sequence used 
in this chapter. The chemical shift selective saturation gauss pulse is followed by an exchange 
time. A similar chemical shift excitation pulse is employed for signal acquisition. The 
exchange time is incremented for each new loop. (b) an example of spectra acquired in a single 
acquisition using the different exchange times in a CSSR sequence, with a tissue phase signal 
build-up. 
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5.3.7. 83Kr longitudinal relaxation measurement 
In order to evaluate whether the bleomycin instillation induced an alveolar 
degradation, the 83Kr longitudinal relaxation was measured. A train of 16 small 
flip angle pulses with an interpulse delay of 1 ms was used. The 𝑇1 relaxation 
was obtained by linear regression of the natural logarithm of the signal 
intensity as a function of delay time as explained in Section 2.4.2. 
5.3.8. Data analysis 
All raw data were processed using Prospa (Magritek, Wellington, New 
Zealand) and subsequent processing using Igor Pro (Wavemetrics, Lake 
Oswego, Oregon, USA), followed by figure adjustments using the illustration 
tool Adobe Illustrator® CS5. A sine-bell squared function was applied in the 
images k-space both directions and zero filled to 256 x 128 in order to smooth 
the magnitude images after 2D Fourier transform. NMR raw data were resized 
to remove the zero-value points present prior to the FID, and an exponential 
function was applied on them before Fourier transform. Similarly, CSSR 
matrices were also resized, an exponential function was applied before being 
Fourier transformed in the direct direction. 
5.4. Results and discussion 
5.4.1. Preliminary 129Xe MRI and NMR of ex vivo fibrotic lungs 
The purpose of this first study was to observe the dissolved 129Xe in excised 
fibrotic lungs (see Stage 1 in Table 5.2). 4 bleomycin-treated and 2 control rats 
were used, during the course of two days, with 2 bleomycin and 1 control on 
each day. The excised lungs are the subject of a blood replacement by PBS 
solution (Sigma-Aldrich Ltd, Gillingham, UK) during the lung dissection. 
Therefore, we can assume that the sharp peak appearing at 193 ppm in all lungs 
spectra was arising from the 129Xe dissolved in saline, accompanying the 
parenchymal tissue phase peak at 195 ppm (see Figure 5.4 for an example). 
The Tissue/Total 129Xe ratio was calculated after a single hard pulse spectrum 
was acquired in the 4 bleomycin rats and 2 control, phase and baseline 
corrected. Results are listed in Table 5.3. The results are very similar for both 
control and fibrotic lungs, and do not allow for any correlation between the 
proportion of the 129Xe dissolved in the lungs and the bleomycin treatment. 
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Figure 5.4 Hp 129Xe NMR spectrum in the excised lung Bleo 1_1. The gas phase is set to the 
conventional 0 ppm and the tissue peak appears at 195 ppm, accompanied by a sharp saline 
peak at 193 ppm. 
 
 
Rat ID Tissue/Total 
129Xe signal 
D
ay
 1
 
Control 2_2 3.34 % 
Bleo 1_1 2.70 % 
Bleo 1_3 2.33 % 
D
ay
 2
 
Control 2_3 2.51 % 
Bleo 3_3 2.76 % 
Bleo 3_4 2.73 % 
Table 5.3 Proportion of the 129Xe signal arising from the tissue over the total 129Xe signal in the 
bleomycin-treated lungs and control lungs. One control lung and two bleomycin-treated lungs 
were studied during two consecutive days. The peaks were integrated after phase correction 
and baseline correction of the spectra, and the tissue signal ratio was calculated. 
 
 126 
A narrower spectral width allowed zooming in on the dissolved peak. Figure 
5.5 shows the tissue peak for the 2 control lungs and the 4 fibrotic lungs. Less 
total signal was observed in both control and fibrotic on the second day due to 
the SEOP pump cell aging. Spectra were therefore normalised to match similar 
integral in the control lungs on both days. On days of measurement the control 
lung showed more signal in the tissue than the two fibrotic lungs. The higher 
signal in the control lungs on both days can be explained by their 20 – 30 g 
higher weight. Indeed, the bleomycin instillation induces a weight loss in the 
treated animal, causing the control rats to be heavier than the rats with the 
disease model. Finally, a red blood cell peak remains noticeably visible at 213 
ppm (see light blue spectrum from the Control lung 2_3 in Figure 5.5), 
probably due to some very small amount of blood that remained in the heart 
and pulmonary capillaries. 
 
 
Figure 5.5 Hp 129Xe spectra of the six excised lungs presented in Table 5.1. The control rat 
lungs are displayed in blue solid lines, the bleomycin-treated rat lungs are presented in dashed 
and dotted lines. Due to lower signal caused by the SEOP performance, the spectra acquired on 
the second day were normalised to match the same control spectrum integral (blue spectra). 
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Hyperpolarized gas phase 129Xe MRI of excised lungs was used to position the 
lungs in the coil and magnet, prior to the spectroscopy measurements, but also 
to observe some qualitative characteristics of a bleomycin treatment on excised 
rat lungs. Slice selective coronal and transverse imaging was done using the 
VFA FLASH imaging sequence described in Section 5.3.4. 
Figure 5.6 and Figure 5.7 present the transverse and coronal images in two 
representative control and bleomycin lungs respectively. The slice selective 
transverse images allow for a clear visualisation of the bronchi, brighter than 
the parenchymal 129Xe signal. The coronal images show the trachea, the 
division into bronchi, and the different lobes. Numerous ventilation defects are 
observed in all fibrotic lungs (see also the appendices for all rats MRI). The 
slice selective coronal images of the fibrotic lung (Figure 5.7, images vii and 
viii) depict some ventilation defects mostly located around the main airways on 
both sides, confirming the disease induction in these animals. The bleomycin-
treated lung 1_3 was presenting a collapsed upper left lobe (Appendix, Figure 
A.5) that might be due to severe fibrosis that weakened the lung structure, but 
might also have collapsed during the travel or any experimental procedure. 
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Figure 5.6 Transverse (a) and coronal (b) slice selective VFA FLASH images of the excised 
Control lung 2_2 accompanied by a non-slice selective image showing the location of the 
slices. 
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Figure 5.7 Transverse (a) and coronal (b) slice selective VFA FLASH images of the excised 
Bleo lung 1_1 accompanied by a non-slice selective image showing the location of the slices. 
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5.4.2. 83Kr NMR of ex vivo fibrotic lungs 
Whole lung hyperpolarized 83Kr NMR spectroscopy is used to assess whether 
the whole lung 𝑇1 can be used as a measure for global alveolar impairment. 
Alveolar degradation not being the main scope of this study, the technically 
more demanding 83Kr MRI as demonstrated in Chapter 3 was not evaluated on 
this animal model of fibrotic thickening. It has been shown that fibrotic lungs 
also show emphysematous damages due to scarring (31). Hp 83Kr 𝑇1  was 
measured in the two fibrotic Lewis lungs, Bleo 1_1 and Bleo 1_3, without 
spatial resolution nor specific inhalation scheme. This whole lung longitudinal 
relaxation measurement was also measured in the emphysematous and control 
rat lungs used in Chapter 3. The average 𝑇1  for each pathological group is 
listed in Table 5.4. 
 
No. of 
measurements 
Average 𝑇1 ± 
standard 
deviation (s) 
Average 
weight ± 
standard 
deviation (g) 
Inhaled 
volume 
Control rats 𝑛 = 5 1.354 ± 0.101 513 ± 35 6.5 ± 0.6 
Elastase-
treated rats 
𝑛 = 9 1.401 ± 0.178 453 ± 55 6.9 ± 0.1 
Bleo 1_1 𝑛 = 4 1.255 ± 0.051  304 4.2 ± 0.4 
Bleo 1_3 𝑛 = 4 1.208 ± 0.037  302 4.2 ± 0.6 
Table 5.4 83Kr longitudinal relaxation (𝑇1) in the control rats and elastase-treated rats from 
Chapter 3, and in two bleomycin-treated rat lungs. 
The whole lung 83Kr 𝑇1 appear to be lower in the bleomycin-treated rat lungs 
as compared to both elastase-treated and control rat lungs utilised in Chapter 3. 
This can perhaps be explained by the difference of species in the rats that are 
used for both animal models. Indeed, the preferred rat species for emphysema 
are Sprague-Dawley rats while Lewis rats are used for fibrosis models. This 
difference of species might induce a difference in the alveolar morphology. 
In addition, there was an animal weight difference between elastase and 
bleomycin-treated rats. The bleomycin rats before lung dissection were 303 g 
on average, which was more than 150 g lower than that of the Sprague-Dawley 
rats used for the 83Kr study in Chapter 3. 
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Finally, the inhaled volume in the bleomycin-treated rats was also lower than 
that of the elastase-treated ones. The reduced alveolar inflation due to a 
reduced inhalation volume might induce the partial recruitment of some alveoli 
and could explain the lower 𝑇1 in these lungs (32). 
5.4.3. In vitro 129Xe NMR of synthetic blood 
Hyperpolarized 129Xe was bubbled through the synthetic bloods Oxycyte and 
commercial Perftoran, containing 10 % v/v lipid emulsion (see Section 5.3.3.). 
The protocol was the same as used in Chapter 4 (see Section 4.3.2.). The 
spectra obtained by such protocol allows locating the 129Xe signal dissolved in 
the perfluorocarbon emulsions. 
 
Figure 5.8 129Xe spectra in three carriers: Oxycyte (blue), Perftoran (orange) and water (green) 
after bubbling some hp 129Xe through a 2 mL sample for 45 s. 
Figure 5.8 displays the in vitro 129Xe spectra for Oxycyte and Perftoran. The 
signal arising from a water sample is also displayed for reference. Hp 129Xe 
signal from the Oxycyte (blue) appears to be notably bigger and narrower than 
the Perftoran 10% (orange). This is explained by the higher perfluorocarbon 
concentration in Oxycyte that contains 60 % v/v as compared to Perftoran that 
contains only 10 % v/v. The chemical shift or each synthetic blood and water, 
and their full width at half maximum (FWHM) are listed in Table 5.5. Both 
Oxycyte and Perftoran 10% peaks appear at 97 and 122 ppm respectively, 
notably apart from the tissue or water peak that would arise from a hp 129Xe 
lung spectrum between 192 and 213 ppm. Moreover, 129Xe 𝑇1 was measured in 
vitro (𝑛 = 4) in degassed Oxycyte, giving 𝑇1 = 97.1 ± 13.5 𝑠. This long 𝑇1 
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and specific chemical shift are used in the next part of this chapter to 
selectively excite the 129Xe tissue or the PFCE phase in excised rat lungs. 
 
 
Table 5.5 Hp 129Xe dissolved in vitro in Oxycyte, Perftoran and water peaks chemical shift and 
full width at half maximum (FWHM). 
The 129Xe-O2 relaxivity in Oxycyte was measured in vitro. The O2 was added 
to the hp gas mixture before being bubbled in vitro to the Oxycyte. 𝑇1 was 
measured using a train of 8 x 24 ̊ flip angles pulse sequence and calculated 
using the Eq. 2.16 described in Section 2.4.2. The relaxivity plot is presented in 
Figure 5.9. The effect of O2 on the 
129Xe relaxation in Oxycyte (Eq. 5.1) will 
permit the mixing of hp gas with oxygen before inhalation for future 
preclinical in vivo studies. 
 𝑅1 = (0.003678 ± 0.000517)×%𝑂2 Eq. 5.1 
 
 
Figure 5.9 In vitro 129Xe-O2 relaxivity in Oxycyte. In black, the measured longitudinal 
relaxations, and in blue the calculated relaxivity as a function of the % O2 in the hp gas 
mixture. 
 Chemical shift FWHM 
Oxycyte 97 ppm 2.4 kHz 
Perftoran 10 % 122 ppm 3.6 kHz 
Water 192 ppm 250 Hz 
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5.4.4. 129Xe NMR of synthetic blood in excised rat lungs 
5.4.4.1. Preliminary results in excised bleomycin-
treated rat lungs 
For the stage 2 study, some dissolved 129Xe spectroscopy has been done on a 
bleomycin-treated lung and a control rat lung. The two rats underwent a post 
mortem blood replacement of the heart and pulmonary capillaries using 
Oxycyte. The protocol for the dissection and the blood replacement can be 
found in Section 2.8. 
 
Figure 5.10 (a) Illustration of a set of chemical shift selective spectra acquired on a bleomycin-
treated rat with increasing TR (64 averages). Each point represents an averaged acquisition 
with a given TR. (b) Oxycyte/Gas ratio in a saline-treated lung (blue) and a bleomycin-treated 
lung (red) and their respective noise levels. The lines represent an exponential fit of the data. 
A spectrum was acquired right after inhalation of the hp gas. A chemical shift 
selective pulse centred on the PFCE frequency is applied, and averaged 64 
times, with different repetition times. A 785 µs chemical shift selective sinc 
pulse was used, allowing for the excitation of the Oxycyte phase, with minor 
depolarization of the gas phase and the tissue phase. The acquisition of spectra 
with different repetition times TR ranging from 0.01 s to 1 s allows to evaluate 
the diffusion from the tissue to the vascular system. In the case of a gas 
diffusion that is slower than the repetition time, the signal will not increase, 
whereas a diffusion that is faster than the repetition time will induce a signal 
build-up. 
The replenishment of the 129Xe signal dissolved in Oxycyte is represented in 
Figure 5.10 b. This diffusion curve has been done by integrating the PFCE 
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peak for each spectrum with different repetition times. The diffusion in the 
bleomycin-treated lung from the tissue to the vasculature appears to be faster 
than in the saline-treated lung, in agreement with previous reports (11). This 
method enables for the measurement of hp 129Xe diffusion from the gas to the 
tissue and the vascular phases but also passage of hp 129Xe from the tissue to 
the vascular liquid. 
5.4.4.2. Dynamic spectroscopy of the gas transfer in 
excised lungs with Perftoran 19.2 % 
Chemical Shift Saturation Recovery (CSSR) is a straightforward spectroscopic 
technique to study the 129Xe uptake by the lung parenchyma and blood in the 
course of a single acquisition. This technique is possible thanks to the large 
129Xe chemical shift between the different compartments that are the alveolar 
space, the lung parenchyma and the blood. By varying the delay between the 
RF saturation pulse and the acquisition of the spectrum, the amount of 129Xe 
that has dissolved in the lung tissue will vary. In an in vivo setting, the 129Xe 
signal arising from the parenchyma and the blood are however located very 
close to each other, at 198 and 218 ppm respectively, with overlapping peaks 
(33, 34), and is therefore challenging to selectively saturate one compartment. 
Hyperpolarized 129Xe uptake by the ex vivo lung parenchyma has been 
explored: the 129Xe gas phase diffuses from the alveoli to the pulmonary tissue, 
and can then either come back to the alveolar space or advance further to the 
capillaries. The excised lungs underwent a post mortem blood replacement 
with Perftoran 19.2 %, allowing for a shift of the 129Xe signal from the 
capillaries from 218 ppm to that of the PFCE, i.e. 90 ppm in the case of 
Perftoran 19.2 %. Such a chemical shift between the 129Xe signal coming from 
the gas, the tissue or the blood compartments allows for the selective saturation 
and excitation of each of them. A 750 µs gauss shape chemical shift selective 
RF pulse was used to both saturate and excite each phase. 
The following experiments show how selective saturation of each dissolved 
phase has been realised to observe 129Xe build-up in the Perftoran phase and 
the tissue phase. 
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129Xe dynamic spectroscopy in ex vivo rat lung Perftoran phase 
The chemical shift selective RF pulse was centred on the Perftoran phase (90 
ppm) in order to saturate the 129Xe signal from the lung capillaries and evaluate 
the uptake of fresh hp 129Xe in the Perftoran from the surrounding tissue, after 
varying diffusion delays. The pulse sequence consisted in a saturation RF 
pulse, followed by a diffusion delay Δ𝜏 and a spectrum acquisition, repeated 
with different diffusion delays (Figure 5.11 a). The RF saturation pulse is 
followed by a spoiler gradient dephasing the residual transverse magnetization. 
Most experiments shown in this chapter were composed of 10 to 12 increasing 
delays in a single breath-hold acquisition. The Perftoran phase (at 90 ppm) was 
integrated and normalised to the gas phase (0 ppm) integral. CSSR build-up 
curves of the 129Xe Perftoran/Gas signal are displayed in Figure 5.12. 
 
Figure 5.11 CSSR pulse sequences used in this section. (a) Single selective saturation, 
followed by a dephasing gradient, and selective excitation of a given dissolved 129Xe phase. (b) 
4 saturations spoilers followed by excitation. The 4 saturation pulses can be set to a single 
frequency ( 𝑠𝑎𝑡1 = 𝑠𝑎𝑡2 = 𝑡𝑖𝑠𝑠𝑢𝑒 ) to saturate a single compartment or two frequencies 
(𝑠𝑎𝑡1 = 𝑡𝑖𝑠𝑠𝑢𝑒, 𝑠𝑎𝑡1 = 𝑃𝑒𝑟𝑓𝑡𝑜𝑟𝑎𝑛) to saturate all dissolved 129Xe. 
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Figure 5.12 Replenishing of the 129Xe magnetization in Perftoran (90 ppm) in an ex vivo 
healthy rat lung. Each signal recovery curve was acquired during a single breath-hold, after 
inhalation of the hyperpolarized 129Xe gas mixture and lung using the CSSR pulse sequence 
illustrated in Figure 5.11 a. 
The Perftoran signal build-up appears repeatable, and not dependent on the 
diffusion delays (Δ𝜏) that were used during a single acquisition. Data have 
been clustered when identical diffusion delays (Δ𝜏 ) were used during the 
acquisition as listed in Table 5.6 and were displayed in Figure 5.13. 
The 129Xe gas transport through the alveolar structure was following an 
exponential diffusion. The augmentation of the 129Xe magnetization that has 
built-up in the dissolved compartments is described by Eq. 5.2 and displayed 
on Figure 5.13. 
 𝑆(𝑡) = 𝑆𝐴 − 𝑆𝐵× exp (−
𝑡
𝑇𝑑𝑖𝑓𝑓
) Eq. 5.2 
where (𝑆𝐵 − 𝑆𝐴)  is the intercept at 𝑡 = 0  and 𝑇𝑑𝑖𝑓𝑓  the exponential time 
constant. The fitting parameters for the data sets summarizing the two 
Perftoran/Gas signal build-up curves from Figure 5.13 are listed in Table 5.7. 
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Scans 21 - 23 
Green 
Scans 24 - 30 
Red 
0.001 0.001 
0.005 0.008 
0.01 0.01 
0.02 0.02 
0.03 0.03 
0.04 0.05 
0.05 0.075 
0.075 0.1 
0.1 0.2 
0.2 0.3 
- 0.5 
Table 5.6 List of the diffusion delays Δ𝜏 (in s) that were used for all magnetization recovery 
experiments displayed in Figure 5.12 and 5.13. 
 
Figure 5.13 Replenishing of the 129Xe magnetization dissolved in Perftoran (90 ppm) in an ex 
vivo healthy rat lung. Data sets from Figure 5.12 were regrouped when identical diffusion 
delays between the saturation and the excitation pulses were used (see Table 5.6 for delay 
lists). Averages and standard deviations are displayed; an exponential function as in Eq. 5.2 
was fitted on each signal build-up. 
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 n 𝑆𝐵 − 𝑆𝐴 𝑇𝑑𝑖𝑓𝑓 (s) 
Green 3 0.208 ± 0.050 0.063 ± 0.024 
Red 7 0.227 ± 0.055 0.049 ± 0.019 
All scans 10 0.228 ± 0.053 0.058 ± 0.016 
Table 5.7 Fitting parameters on the two datasets displayed in Figure 5.13. n represents the 
number of build-up curves with identical diffusion delays (Δ𝜏) that were averaged together. All 
scans were also put in a single data set and displayed in Figure 5.14. 
The red and green data sets present similar fitting results with an exponential 
time constant 𝑇𝑑𝑖𝑓𝑓 of 63 and 49 ms respectively. This time constant illustrates 
the 129Xe diffusion from the tissue to the Perftoran in the capillaries. 
The 10 Perftoran signal recovery datasets were gathered to a single build-up 
curve and displayed in Figure 5.14. The fitting parameters are also listed in 
Table 5.7. The 129Xe signal arising from the Perftoran phase increases to its 
maximum within 150 ms to reach a plateau. This plateau would increase with a 
light slope in the case of a live experiment with blood flow (10, 11). 
 
 
Figure 5.14 Replenishing of the 129Xe magnetization dissolved in Perftoran (90 ppm). All data 
from Figure 5.12 (n = 10) were grouped. Averages and standard deviations are displayed; an 
exponential fit was applied to the signal build-up. 
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As a summary, the Perftoran signal is observed to increase up to a maximum 
reached within 150 ms. For more consistent results, averaging of the same 
diffusion delay could be done within the same CSSR acquisition and one 
breath hold. This way the signal scattering could be reduced. 
 
129Xe dynamic spectroscopy in ex vivo rat lung tissue phase 
The 129Xe signal dissolved in the tissue represents a much bigger proportion of 
the overall signal than that of the Perftoran, described in the previous section. 
The detection of the 129Xe dissolved in the tissue is therefore easier. Moreover, 
the larger chemical shift between the gas phase and the tissue phase allows for 
minimal saturation and excitation of the bulk gas phase during the CSSR 
experiment (Figure 5.8). A better repeatability is expected when studying this 
129Xe phase. 
All individual tissue signal recovery curves are displayed in Figure 5.15, where 
slightly different pulse programs were used (Figure 5.11). The first CSSR pulse 
sequence that was used consisted on a single saturation of the tissue phase and 
the observation of the tissue signal build-up (Figure 5.11 a) similarly to the 
previously shown Perftoran signal build-up acquisition. The second CSSR 
pulse sequence introduced the saturation of the Perftoran phase interlaced with 
the saturation of the tissue phase (Figure 5.11 b), with a total of 4 saturation 
pulses before each excitation and CSSR step. Data are displayed in Figure 5.15 
a and b. 
The fitting parameters for clustered data (experiments with identical diffusion 
delays Δ𝜏 as listed in Table 5.8), and their saturation scheme are listed in Table 
5.9. Curves fitting the diffusion model are showed in Figure 5.16. 
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Figure 5.15 Replenishing of the 129Xe magnetization dissolved in the tissue (195 ppm) in an ex 
vivo healthy rat lung. Individual signal recovery curves are represented. (a) Saturation of the 
tissue only as in Figure 5.11 a. (b) Saturation of the tissue and Perftoran following a 4 RF 
saturations scheme as in Figure 5.11 b. 
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Scans 
8 - 10 
Green 
Scans 
600 - 602 
Yellow 
Scans 
52 - 58 
Blue 
Scans 
63 - 64 
Grey 
Scans 
592 - 594 
Red 
Scan 
591 
Pink 
0.001 0.001 0.001 0.008 0.02 0.001 
0.01 0.005 0.005 0.01 0.03 0.005 
0.02 0.008 0.008 0.015 0.05 0.008 
0.03 0.01 0.01 0.02 0.075 0.01 
0.04 0.02 0.02 0.05 0.1 0.02 
0.05 0.03 0.03 0.1 0.2 0.03 
0.075 0.05 0.05 0.2 0.3 0.05 
0.1 0.075 0.075 0.3 0.4 0.075 
0.2 0.1 0.1 0.8 0.5 0.1 
0.3 0.2 0.2 - 0.6 0.2 
- 0.3 0.3 - - 0.3 
- 0.4 0.5 - - 0.5 
- 0.5 - - - 1 
- 0.6 - - - - 
Table 5.8 List of the diffusion delays Δ𝜏 (in s) that were used for all scans displayed in Figure 
5.15 and 5.16. Colours indicate the build-up curves in Figure 5.16 and Table 5.9. 
  
 142 
 
Figure 5.16 Replenishing of the 129Xe magnetization dissolved in the lung parenchyma (195 
ppm) in an ex vivo healthy rat lung. Data sets were regrouped when identical diffusion delays 
Δ𝜏 between the saturation and the FID acquisition were used. Averages and standard deviations 
are displayed; an exponential function was fitted on each signal build-up. Details on the 
saturation schemes for each colour group can be found in Table 5.9. 
Not perceptible in the integrated signal build-up curves (Figure 5.16), when 
fitted with an exponential function, the 129Xe dissolved in the tissue appears to 
build-up faster when only the tissue has been saturated as compared to a 
saturation of both tissue and Perftoran phases as listed in Table 5.9. 
The exponential component of the signal build-up 𝑇𝑑𝑖𝑓𝑓 is equal to 57 ms on 
average when both tissue and Perftoran have been saturated, and the hp 129Xe 
can only be provided from the gas phase alveolar reservoir. On the other side, 
𝑇𝑑𝑖𝑓𝑓 is reduced to 47 ms when the tissue only has been saturated and the hp 
129Xe can therefore either come from the alveolar reservoir, or diffuse back 
from the Perftoran seating in the vascular system. 
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 n Saturation scheme 𝑆𝐵 − 𝑆𝐴 𝑇𝑑𝑖𝑓𝑓 (s) Average 𝑇𝑑𝑖𝑓𝑓  ± 
st. deviation (s) 
Green 3 Tissue 2.04 ± 0.12 0.057 ± 0.016 
0.047 ± 0.016 
Yellow 3 Tissue 1.91 ± 0.21 0.040 ± 0.019 
Blue 7 Tissue + Perftoran 1.46 ± 0.21 0.059 ± 0.017 
0.057 ± 0.024 
Grey 2 Tissue + Perftoran 1.68 ± 0.67 0.206 ± 0.072 
Red 3 Tissue + Perftoran 1.18 ± 0.28 0.034 ± 0.014 
Pink 1 Tissue + Perftoran 1.06 0.027 
Table 5.9 CSSR scan saturation schemes and fitting parameters for the diffusion model for six 
magnetization build-ups displayed in Figure 5.16. The average 𝑇𝑑𝑖𝑓𝑓  for the tissue signal build-
up after saturation of the tissue only or tissue + Perftoran is indicated. 
The choice of diffusion delays used during the CSSR acquisition appears to be 
an important parameter inducing some variability in the obtained data. The 
grey data set represented in Figure 5.16 does not display a similar growth as 
the other build-up curves. This might be due to the high number of very low Δ𝜏 
delays and unique longer Δ𝜏 (see Table 5.8). 
The 129Xe diffusion from the alveolar gas space to the parenchyma follows a 
1D and 2-phase system diffusion through a single layer of porous medium (35) 
and should follow: 
 𝑆(𝜏) ∝ √2𝐷𝜏 Eq. 5.3 
where D is the diffusion coefficient of 129Xe in the dissolved phase and τ the 
diffusion delay. The build-up data collected after saturation of the tissue phase 
or both tissue and blood compartments were plotted against √𝜏 (Figure 5.17). 
The dissolved signal increases linearly with √𝜏 for short times before the tissue 
saturates (35). The septal uptake curves represent how fast the 129Xe builds up 
in the tissue. 129Xe diffuses back from the alveolar airspace when the tissue and 
Perftoran phases were saturated (Figure 5.17, green points) whereas it will 
diffuse from the airspace and the capillaries in the case of the saturation of the 
sole tissue phase (Figure 5.17, orange points). The normalised signal shows a 
non-zero y-intercept due to an immediately saturated thin layer of tissue at the 
interface with the gas phase and the capillaries. The amount of tissue very 
quickly saturated is 1.5 times higher in the case of the saturation of the tissue 
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only, as some 129Xe will rapidly enter the tissue on the alveolar side and the 
capillaries side. 
The difference in the build-up slopes can also be explained by the different 
saturation schemes as well. As explained in the previous paragraph, they do not 
start with the same amount of signal. Furthermore, both build-ups reach a 
plateau of full saturation of the tissue with 129Xe at around √𝜏 = 0.3 𝑠1 2⁄ . 
Therefore, the slope in Figure 5.17 is decreased from 7.4 ± 0.7 𝑠−1/2 when the 
tissue and Perftoran phases were saturated to 5.8 ± 0.9 𝑠−1/2 when the tissue 
only was saturated, explaining the previously observed slightly different build-
up times Tdiff for each saturation schemes (Table 5.9). 
 
Figure 5.17 Experimentally measured and normalised signal from the tissue phase as a function 
of √Δ𝜏. Orange data were acquired after saturation of the tissue phase (195 ppm) whereas 
green data were acquired after saturation of both the tissue phase and the Perftoran phase (90 
ppm). 
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5.5. Conclusions 
In this study, we have used hyperpolarized 129Xe to evaluate the gas diffusion 
through excised rat lungs. We have demonstrated that CSSR dynamic 
spectroscopy with perfluorocarbon emulsion as a blood replacement in excised 
lungs allows for the selective saturation and detection of the 129Xe dissolved in 
the tissue or the blood compartments. The technique is sensitive enough to 
detect the Perftoran signal located in the capillaries, independently to the tissue 
signal, with a clear chemical shift difference and no peak overlap with neither 
the tissue nor the gas phase. The selective saturation has allowed the 
measurement of the signal build-up in each phase, with no saturation of the 
other 129Xe phases. Different exponential time constants for the signal build-up 
were observed in the tissue phase when the tissue only or both the tissue and 
the Perftoran phases have been saturated. This difference was emphasised by 
the representation of the signal build-up against √𝜏, showing a faster build-up 
at short times when only the tissue was saturated (Figure 5.17). 
The measurement of such parameter should be further studied in animal 
models where the gas exchange is impaired. This technique would replace the 
technically difficult lung function tests in small animals, but however 
necessitate sacrificing the animal and replacing the blood by PFCE. The use of 
theoretical models such as the Månsson model (11) on these build-up curves, 
or even the Patz model (10) and the MOXE model (36) will allow for the 
exploration of animal models such as the bleomycin rat model described by a 
parenchymal thickening, in synergy with DLCO (diffusing capacity of the lung 
for carbon monoxide), a clinical test measuring the gas transfer from the 
airspace to the RBC. These mathematical models use CSSR build-up data and 
fitting parameters to provide thickness measurements of the parenchyma, or the 
alveolar diameter. Histological studies would confirm the fibrotic thickening 
(37). Moreover, a regional mapping of the gas uptake in the PFCE will be 
possible using the XTC technique developed by Ruppert et al. (7). The 
multimodality of the hyperpolarization techniques would allow the evaluation 
of both parenchymal thickening and alveolar degradation using hp 129Xe 
magnetization kinetics and hp 83Kr 𝑇1  relaxation mapping respectively. The 
bleomycin-induced viscoelastic changes and alveolar degradation will be 
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assessed using plethysmography (38). Finally, recent advances on 19F 
sensitivity (39) allowed for the quantification of the minimum detectable 
fluorine concentration in the sample under the given laboratory hardware 
settings, and would allow the 19F MRI of the PFCE in the lungs. 
Even if the three 129Xe phases are separated by a large chemical shift and do 
not require a very narrow and selective pulse (e.g. reference (12) used a 
custom-designed RF pulse), particular considerations should be taken to avoid 
the possible hardware difficulties that we encountered during the course of this 
study. The coils should have an homogeneous excitation in order to allow a 
precise calibration of the chemical shift selective low power RF pulse. The coil 
should also have a sufficient shielding to avoid any RF noise. Indeed, the 
CSSR spectra acquired for this work were presenting a low frequency noise 
that appeared at a very close frequency to that of the 129Xe dissolved in tissue 
and at the early diffusion delays, therefore substantially altering the calculated 
diffusion constants 𝑇𝑑𝑖𝑓𝑓. 
The partial blood replacement with PFCE for in vivo exploration would 
complicate the model as the red blood cells 129Xe peak would appear close to 
the tissue peak and there would be two peaks representing one compartment, 
therefore reducing the amount of signal in both. This study is however 
possible, and both peaks should show similar build-ups. Moreover, the use of 
breathable hyperpolarized gas mixed with 21% O2 would provide a sufficiently 
long 𝑇1 = 12.9 𝑠 in the PFCE phase (Figure 5.9). 
The perfluorocarbon emulsion (PFCE) concentration appeared to be an 
important factor. The original Perftoran 10 % was not providing sufficient 
dissolved 129Xe signal within the excised lungs (data not shown) and required 
concentrating it up to 19.2 %. The concentration process involves slight 
heating and vacuum of the solution, which might be deleterious for the 
emulsion compound. Some investigations on the Perftoran structural change 
upon concentration should be done.  
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CHAPTER 6 
CONCLUSIONS AND FUTURE OUTLOOK 
The work presented in this thesis investigates hyperpolarized 83Kr and 129Xe as 
biomarkers for pulmonary diseases. Three potential markers have been 
evaluated in ex vivo rat lungs and in solution. 
 
(i) The 83Kr surface quadrupolar relaxation (SQUARE) has been validated in 
excised healthy rat lungs prior to the work realised for this thesis (1). Chapter 
3 and (2) detail an application of this technique to an animal model of 
emphysema, where the surface-to-volume ratio within the lungs is decreased 
due to an alveolar wall destruction. The 83Kr SQUARE 𝑇1 maps allow for a 
qualitative discrepancy between healthy and emphysematous lungs. The 
analysis of the overall 𝑇1  distribution within the lungs demonstrated a 
significant difference between the control and treated animals. A correlation 
analysis also indicated a relationship between the regional 83Kr relaxation 
behaviour and the histologically measured alveolar dimensions in each lobe. 
Some further work can be done on the ex vivo animal model of emphysema. 
The obtained results can be compared to 129Xe ADC MRI that has been 
correlated to the alveolar radius (3). Furthermore, the mean alveolar area 
(MAA) has been proved to be an efficient measurement for the 𝑆 𝑉⁄  in the 
lungs, but most hyperpolarized studies were using the gold standard 
histological intercept measurement. In future works, this could be addressed 
with a new cohort of rats. Further comparisons with the 𝑆 𝑉⁄  obtained through 
SQUARE with that from hp 129Xe ADC measurements and hp 129Xe dissolved 
phase measurements would shine further light on this new biomarker. 
Such surface-to-volume ratio dependent 83Kr contrast will be implemented to a 
human scale MRI system at the Sir Peter Mansfield Imaging Centre. Once the 
threshold for healthy human alveolar 𝑇1  will be determined, the SQUARE 
maps will provide an easy and early diagnosis of emphysema. The translation 
of this technology from excised rat lungs to human lungs involves a 3-fold 
increase in the alveolar diameter. The 𝑇1  relaxation is therefore expected to 
increase by three times (4). The shift from 9.4 T to lower 𝐵0 magnetic field, 7 
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T, might however shorten the 𝑇1  relaxation (5). Better imaging protocols 
should be implemented to improve the image signal-to-noise ratio (SNR) with 
a bigger coil. It should be noted that there is a lot of room for optimization of 
the experimental protocol. For example, the production of hp 83Kr can be 
further improved leading to higher signal intensity (6). Furthermore, EPI 
acquisition schemes utilizing the long 𝑇2  relaxation time of 
83Kr and 
compressed sensing can be explored and counteract sensitivity limitations. EPI 
would have the advantage of using 90° pulses instead of small flip angle 
excitation, thereby potentially improving signals 5-fold over what is currently 
been used. Lastly, better coil design for the low radiofrequency of 83Kr may 
further improve sensitivity. 
 
(ii) The investigations on a new 129Xe biosensor has been presented in Chapter 
4 and (7). It is based on the tethering of a cryptophane A to a paramagnetic 
GdDOTA group inducing the fast depolarization of the encapsulated 129Xe, that 
subsequently exchanges with the surrounding dissolved 129Xe atoms. Different 
molecular derivatives of the model biosensor were tested in vitro. 129Xe 
relaxation was induced by the close vicinity of the noble gas atom and the 
paramagnetic GdDOTA, and is displaced by fast chemical exchange from the 
cage to the medium. This sensor showed clearly different relaxation behaviour 
when the cage was tethered to a GdDOTA and when it was not. Unlike most 
129Xe biosensors, it is not based on the detection of a small chemical shift but 
the measurement of the dissolved phase (~200 ppm) and will not require a high 
spectral resolution thanks to a low background noise level. 
A functionalised biosensor will be evaluated. This time, the linker between the 
cryptophane A cage and the paramagnetic GdDOTA will be the target of 
MMP-9, an abundant enzyme in diseased lungs. The presence of the enzyme 
would induce the cleavage of the biosensor and therefore no relaxation will be 
generated. In the absence of the MMP-9 enzyme, the biosensor remains intact 
and a fast relaxation of the hyperpolarized 129Xe would be induced as shown in 
Chapter 4. This will induce a positive contrast, with a higher signal appearing 
from the places where the enzyme is present. This would however necessitate 
an homogeneous repartition of the biosensor in the organ. This issue will be 
overcome by assessing the biosensor repartition in the organism, using 1H MRI 
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as it has been shown that the proton relaxation is unaffected by the cleavage of 
the molecule. 
 
(iii) In Chapter 5, the use of synthetic blood has permitted for a clear 
distinction of the blood compartment on an ex vivo rat lung 129Xe NMR 
spectrum. The complete blood replacement in the excised organ tackles the 
problem of the dissolved 129Xe overlapping peaks in vivo. Instead of displaying 
three peaks for the red blood cells, the plasma and adipose cells, and the lung 
parenchyma, the dissolved 129Xe spectrum only shows two peaks for the lung 
tissue (195 ppm) and the synthetic blood (90 ppm). The two compartments can 
be selectively excited thanks to their separated respective chemical shifts. This 
compartmentalization in excised lungs will allow for novel evaluation of the 
gas transfer in animal models. 
The use of better coil could improve the selective saturation and excitation, and 
homogeneity across the sample region. The synthetic blood needed to be 
concentrated to be able to detect the 129Xe dissolved in the lung capillaries. The 
129Xe chemical shift and 𝑇1 should be evaluated in the synthetic blood after 
concentrating it, in order to verify the good quality of the product after the 
procedure. More improvements can be done on the dynamic spectroscopy 
protocols, with optimized delays, saturations, randomisation, and averaging. 
This will allow for more applications in excised lungs of animal models. The 
difference in 129Xe diffusion through the parenchyma should be observed in an 
animal model of pulmonary fibrosis and analysed using diffusion models (8-
10). Some imaging techniques such as XTC (11) can be derived from the 
knowledge of the gas diffusion behaviour in the healthy and pathologic lungs. 
Finally, despite the complex 19F spectrum in vitro and in vivo, recent advances 
in 19F NMR and MRI sensitivity will allow for a mapping of the capillaries in 
the organ. 
 
The work presented in this document intends to find biomarkers for specific 
characteristics of pulmonary diseases. Multimodal imaging will facilitate 
pulmonary diagnosis by addressing the variety and complexity of lung 
pathologies. The combination of 129Xe and 83Kr with the markers described in 
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this work seeks to enable the evaluation of both the alveolar structural integrity 
and the parenchymal thickness. 
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APPENDICES 
 
Appendix 1: Birdcage coil construction for 129Xe excitation and 
detection in the University of Nottingham preclinical MRI facilities 
 
This section details a custom-built 129Xe coil for the in vivo preclinical MRI 
Bruker scanner, located in the psychology department of the university of 
Nottingham. 
Radiofrequency (RF) coils are used for the detection of the NMR signal. MRI 
imposes additional field homogeneity requirements on the RF coil. To date, the 
most commonly used in MRI and the most volume homogeneous RF 
resonators have the cylindrical geometry and are commonly termed “birdcage 
coils”. Unlike a solenoid coil, the 𝐵1  magnetic field in birdcage coils is 
generated perpendicular to the main axis of the cylinder of the coil. This allows 
for the alignment of the opening of the coil with the magnet bore thus giving a 
great opportunity to study live animals in relatively small bores (gradients bore 
diameter: 12 cm). In addition, the open bore design allows for a better delivery 
of life support and breathing for the animals during the experiments in vivo. 
The birdcage coil for 129Xe resonance frequency (83.8 MHz) was designed 
using the shareware program “BirdcageBuilder”, distributed by the College of 
Medicine of Pennsylvania State University, USA (1). 
The low-pass concept of the present birdcage coil was borrowed from a 
commercial Bruker coil used for measurements in small animals in vivo in 
scanner with the same bore size. 
The critical geometric parameters were the diameter of the coil, the number 
and length of the rungs and the diameter of the RF shield surrounding the coil. 
The RF shield surrounding the coil is a very important component in the coil 
design as it alters the resonance frequency of the coil by inductive coupling and 
also ensures that no detuning of the tuning and matching capacitors occurs 
outside the magnet. Therefore, the ratio of the coil diameter to the RF shield 
diameter was approximately 0.66 to minimise the inductive coupling between 
the shield and the coil. 
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The following additional geometric parameters were used in the calculations of 
the rung capacitance to ensure that the coil resonates at 83.023 MHz: coil 
diameter = 74 mm; length of rungs = 148 mm and shield diameter = 112 mm. 
In principle, at least 50 % of the coil surface has to be covered by the 
conductor. The following calculations were used to evaluate the width of an 
individual rung. The circumference of the coil is 𝜋×74 𝑚𝑚 = 233 𝑚𝑚 , 
therefore at least 117 mm have to be covered by the conductor. This results in 
approximately 7.3 mm for an individual rung and 16 rungs in total. 
A1.1. Rung capacitor value determination 
To determine the value of the rung capacitors of the low pass birdcage coil, the 
parameters displayed in Table A.1 were used in the simulation using the 
“BirdcageBuilder” software. The simulation returned a rung capacitor value of 
13.9 pF. 
Resonance frequency 83.8 MHz 
Type of ER Rectangular 
Nb of rungs 16 
Coil radius (cm) 3.7 
Leg Length (cm) 14.8 
Leg Width (cm) 0.8 
RF shield radius (cm) 5.6 
ER segment length (cm) 1.45 
ER segment width (cm) 0.8 
Table A.1 Geometrical parameters for the construction of the 129Xe birdcage coil resonating at 
83.8 MHz at 7 T. 
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A1.2. Conductor thickness in the RF shield 
In simplest terms, the main purpose of the RF shield is to avoid the detuning of 
the tuning and matching capacitors when the coil is placed inside the magnet 
bore for measurements. Therefore, the thickness of the shield conductor should 
exceed the required skin depth 𝛿  for an efficient isolation from unwanted 
irradiation. The skin depth can be determined using the well-known 
relationship (2): 
 𝛿 = √
2𝜌
2𝜋𝜐𝜇
 Eq. A.1 
where 𝜈 is the frequency in Hz, 𝜌 is the resistivity of the conductor in Ω. m, 
and 𝜇 is the magnetic permeability of the conductor in 𝐻. 𝑚−1. 
Using the 129Xe resonance frequency at 7 T 𝜐 = 83.8 𝑀𝐻𝑧, the resistivity of 
copper 𝜌 = 1.678×10−8Ω. 𝑚  and the magnetic permeability of copper 𝜇 =
1.256×10−6𝐻. 𝑚−1, we get a skin depth of 𝛿 = 7.13×10−6𝑚. 
This means that the thickness of the copper conductor chosen for the shield 
manufacturing has to exceed 7 μm in order to provide efficient isolation from 
unwanted irradiation. 
A1.3. 129Xe birdcage coil outline and manufacturing 
The outline of the coil is given in Figure A.1. The birdcage coil is composed of 
16 equally spaced rungs connected by two end-rings as shown in the left panel 
of Figure A.1. To ensure the desired low-pass band, the rung capacitors were 
placed in the centre of each rung. 
 
 160 
 
Figure A.1 Left panel - The outline of the coil with all relevant sizes. Central panel – mounting 
points of tuning and matching capacitors are shown. The capacitive matching circuit was used 
in this particular design to ensure that the coil resonates at the 129Xe frequency at 7 T. Right 
panel – schematic of the capacitive matching circuit. 
Copper tape (Saint Gobain, France) was used to manufacture rungs, end rings 
and other conducting components. 15 pF non-magnetic chip ceramic high 
power capacitors (ATC, New York, USA) have been used as rung capacitors. 
A 2 mm thick acrylic cylinder with OD = 74 mm and length = 271 mm was 
used as a coil holder. The capacitive matching network shown in the right 
panel of Figure 2.2 was used to match the impedance to 50 Ohm and to tune 
the coil to the resonance frequency of 83.8 MHz. The circuit was attached to 
the coil as shown in the middle panel of Figure A.1. Glass trimmer capacitors 
(Voltronics Corporation, Maryland, USA) were used as variable tuning and 
matching capacitors. 
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Figure A.2 Photographs of the components of a 129Xe birdcage coil for a preclinical 7 T Bruker 
MRI scanner: (a) the birdcage coil, (b) the RF shield, (c) mounting points of the capacitive 
matching network, (d) the coil body with mounted 15pF rung capacitors, and (e) BNC plug and 
matching rods as positioned in the MRI scanner. 
The RF shield composed of 9 copper foil strips of 40 mm in width and 270 mm 
in length was mounted onto 2 mm acrylic holder of OD = 112 mm and of 
length = 271 mm. The strips have been place evenly around the acrylic 
cylinder leaving gaps of equal size between the strips. The gaps were produced 
to quench eddy currents during the gradient pulsing of MRI experiments. 
The coil and the shield were held together by two acrylic end-rings of OD = 
108 mm. All components are displayed in Figure A.2. 
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A1.4. Testing, troubleshooting 
The coil is loaded with a 129Xe thermal sample and is matched to the 50 Ohm 
impedance. The RF homogeneity of the coil will also be determined to ensure 
the MR image quality. The coil stability and linear response will also be 
checked during RF pulsing. An example of thermal sample signal is given in 
Figure A.3. 
 
Figure A.3 Longitudinal (a) and axial (b) view of the 129Xe thermal sample using the birdcage 
coil. Scale bar: 10 mm. 
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Appendix 2: Hp 129Xe MRI of bleomycin-treated and control lungs 
using a Variable Flip Angle (VFA) FLASH pulse sequence 
 
This section presents all of the images acquired for comparison of fibrotic 
lungs with control lungs (see Section 5.4.1.). 
 
Figure A.4 Transverse (a) and coronal (b) slice selective VFA FLASH images of the excised 
Control lung 2_3 accompanied by a non-slice selective image showing the location of the 
slices. 
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Figure A.5 Transverse (a) and coronal (b) slice selective VFA FLASH images of the excised 
Bleo lung 1_3 accompanied by a non-slice selective image showing the location of the slices. 
The left upper lobe is collapsed. 
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Figure A.6 Transverse (a) and coronal (b) slice selective VFA FLASH images of the excised 
Bleo lung 3_3 accompanied by a non-slice selective image showing the location of the slices. 
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Figure A.7 Transverse (a) and coronal (b) slice selective VFA FLASH images of the excised 
Bleo lung 3_4 accompanied by a non-slice selective image showing the location of the slices. 
References 
1. Chin CL, Collins CM, Li SH, Dardzinski BJ, Smith MB. 
BirdcageBuilder: Design of specified-geometry birdcage coils with desired 
current pattern and resonant frequency. Concepts Magn Resonance. 
2002;15(2):156-63. 
2. Horowitz P, Hill W. The Art of Electronics: Cambridge University 
Press; 1980. 
